syndrome	score	normalized_score
NEUROFIBROMA	6.54625669	100.0
TUBEROUS SCLEROSIS COMPLEX	5.2383763	80.0209424723918
MUIR-TORRE SYNDROME; MRTES	3.7293866	56.96975808628122
NEUROFIBROMATOSIS, TYPE II	3.51601925	53.71037856445559
BIRT-HOGG-DUBE SYNDROME	3.4739060999999998	53.067062055582184
FAMILIAL MULTINODULAR GOITER	3.2573062	49.75830240472895
UVEAL MELANOMA	3.25	49.64669358237464
JUVENILE POLYPOSIS SYNDROME	3.14316728	48.014727024094135
CARNEY COMPLEX	3.1337352000000003	47.870643459292765
GARDNER SYNDROME	3.0455758000000004	46.523928776767846
CUTANEOUS NEUROENDOCRINE CARCINOMA	2.9914860000000005	45.697658091681106
PITUITARY CARCINOMA	2.67294605	40.83167184817496
PEUTZ-JEGHERS SYNDROME	2.62682216	40.12708765320353
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	2.57797253	39.38086531098126
TUBEROUS SCLEROSIS-1	2.5506009000000005	38.96273887176277
PHACE ASSOCIATION	2.509979514	38.342210409106336
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	2.5073806	38.302509643874046
MULTIPLE ENDOCRINE NEOPLASIA TYPE 4	2.5044332000000002	38.25748543936184
NEUROENDOCRINE NEOPLASM OF APPENDIX	2.41446867	36.883195761148805
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	2.383333	36.40757020177283
TUBEROUS SCLEROSIS 2; TSC2	2.3006009	35.14376244234933
BASAL CELL NEVUS SYNDROME	2.29597502	35.073097935608146
HYPERPARATHYROIDISM 2	2.2126082000000005	33.79959425330754
MENINGIOMA	2.20057897	33.61583686997157
BROOKE-SPIEGLER SYNDROME	2.19199295	33.484677637961674
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	2.1702838	33.15305070935127
RETINOBLASTOMA	2.10727493	32.19053315185537
NUT MIDLINE CARCINOMA	2.08125	31.79297877486683
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1; CFEOM1	2.02066968	30.867559518201542
FAMILIAL PAPILLARY THYROID CARCINOMA WITH RENAL PAPILLARY NEOPLASIA	2.0097431	30.70064611230514
FAMILIAL GLUCOCORTICOID DEFICIENCY	2.00922439	30.692722347250335
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	2.0	30.551811435307467
TURCOT SYNDROME WITH POLYPOSIS	1.99529001	30.47986207213637
MSH3-RELATED ATTENUATED FAMILIAL ADENOMATOUS POLYPOSIS	1.9713477000000001	30.114121601913542
WERNER SYNDROME	1.94010632	29.636881226544144
MUIR-TORRE SYNDROME	1.9375211	29.597389649564754
BECKWITH-WIEDEMANN SYNDROME	1.91082073	29.189517314818282
MULTIPLE ENDOCRINE NEOPLASIA TYPE 1	1.9024852999999997	29.062186072022172
PRIMARY SCLEROSING CHOLANGITIS	1.8697913300000002	28.562756068766383
NEUROFIBROMATOSIS TYPE 1	1.8418026299999997	28.13520332640668
PARAGANGLIOMAS 1	1.82152137	27.82538871081146
MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	1.8155618999999996	27.73435240896427
BENIGN SCHWANNOMA	1.7982143	27.469352106936707
HEREDITARY MIXED POLYPOSIS SYNDROME	1.7487488000000002	26.713721792660106
NTHL1-RELATED ATTENUATED FAMILIAL ADENOMATOUS POLYPOSIS	1.7432851	26.63025882659056
SILVER-RUSSELL SYNDROME; SRS	1.7276823639999999	26.391912902517117
APC-RELATED ATTENUATED FAMILIAL ADENOMATOUS POLYPOSIS	1.7269251999999997	26.380346536640314
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	1.7215848639999998	26.29876806740372
VON HIPPEL-LINDAU DISEASE	1.71212586	26.154273214116813
FAMILIAL ADENOMATOUS POLYPOSIS 1; FAP1	1.6931597999999997	25.86454946972145
CATARACT 3, MULTIPLE TYPES; CTRCT3	1.6760999600000002	25.603944962323194
POLYEMBRYOMA	1.6666660000000002	25.459832678819076
NEUROFIBROMATOSIS, TYPE III, MIXED CENTRAL AND PERIPHERAL	1.6607143	25.368915070759318
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	1.6351865300000001	24.97895526305737
LYSINE-SPECIFIC METHYLTRANSFERASE 2A; KMT2A	1.632857	24.94336958241092
HYPERPLASTIC POLYPOSIS SYNDROME	1.620902	24.76074612955637
COWDEN SYNDROME 7; CWS7	1.6043	24.507135542831886
FAMILIAL COLORECTAL CANCER TYPE X	1.5937041	24.3452735734382
COMBINED IMMUNODEFICIENCY DUE TO DOCK8 DEFICIENCY	1.5811966	24.154210182674642
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	1.5811688	24.15378551249569
PTEN HAMARTOMA TUMOR SYNDROME	1.5473105999999999	23.63657084152623
ADENOCARCINOMA OF OVARY	1.5454545	23.60821723292369
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	1.5442806299999998	23.590285305478904
CHEMODECTOMA, INTRAABDOMINAL, WITH CUTANEOUS ANGIOLIPOMAS	1.5333329999999998	23.423050341767148
ANAPLASTIC THYROID CARCINOMA	1.50899583	23.05127802741264
NEUROFIBROMATOSIS, TYPE I	1.4535843899999998	22.20481809429321
PARAGANGLIOMAS 2	1.45	22.150063290597913
SQUAMOUS CELL CARCINOMA OF THE ANAL CANAL	1.4335498	21.898771586361367
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	1.4285074999999998	21.82174588696124
AICARDI SYNDROME; AIC	1.41844989	21.66810678485631
COWDEN SYNDROME	1.396846084	21.338089081257827
PEUTZ-JEGHERS SYNDROME	1.3897748	21.230068813571073
CARNEY COMPLEX, TYPE 1; CNC1	1.3878175	21.200169283309908
CRANIOLENTICULOSUTURAL DYSPLASIA	1.3794964699999999	21.07305801355614
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	1.3702079999999999	20.931168221574882
ADENOCARCINOMA OF THE ANAL CANAL	1.3621212	20.807635027217366
LYNCH SYNDROME	1.3506482999999998	20.63237608850929
NORRIE DISEASE	1.35050819	20.630235781359193
LI-FRAUMENI SYNDROME; LFS	1.3464223999999998	20.56782163853706
ATTENUATED FAMILIAL ADENOMATOUS POLYPOSIS	1.3354323	20.399937907109475
AL AMYLOIDOSIS	1.311111	20.028408021378702
PARAGANGLIOMAS 4	1.3030023000000002	19.904540284685968
MAFFUCCI SYNDROME	1.28126329	19.572457217530832
CATARACT 30, MULTIPLE TYPES	1.277778	19.519216256092154
ATELOSTEOGENESIS TYPE II	1.25765804	19.211865644089183
JUVENILE NASOPHARYNGEAL ANGIOFIBROMA	1.25	19.094882147067167
DIGEORGE SYNDROME; DGS	1.213392544	18.53567010064801
HEMANGIOBLASTOMA	1.20613497	18.424804084485114
VIPOMA	1.1612657	17.739385346345163
MONOSOMY 9Q22.3	1.1569237739999998	17.673058494136132
ZOLLINGER-ELLISON SYNDROME	1.14106023	17.43072849164428
PARATHYROID CARCINOMA	1.1379915	17.38385086149135
ACQUIRED HYPERTRICHOSIS LANUGINOSA	1.13778413	17.380683096922677
HEREDITARY BREAST AND OVARIAN CANCER SYNDROME	1.1348213999999999	17.33542471277581
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	1.1199820939999998	17.1087408734044
GASTROINTESTINAL STROMAL TUMOR	1.1156589700000001	17.042701238774676
SAGLIKER SYNDROME	1.11545293	17.039553791160607
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	1.115452454	17.03954651982949
MIDDLE EAR NEUROENDOCRINE TUMOR	1.11261476	16.99619817382994
OSTEOID OSTEOMA	1.111111	16.973226877847956
METACHONDROMATOSIS	1.1	16.803496289419108
NOONAN SYNDROME 7; NS7	1.0982708	16.77708119325214
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	1.09704555	16.758364389771586
SYSTEMIC MASTOCYTOSIS WITH ASSOCIATED HEMATOLOGIC NEOPLASM	1.0960603	16.743313803663266
FOCAL DERMAL HYPOPLASIA	1.09430024	16.71642729304585
STURGE-WEBER SYNDROME	1.0833333	16.54889735159469
RAPIDLY INVOLUTING CONGENITAL HEMANGIOMA	1.083333	16.548892768822974
NON-INVOLUTING CONGENITAL HEMANGIOMA	1.083333	16.548892768822974
MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA	1.0769231	16.450975740763383
GANGLIONEUROMA	1.0736263	16.400614134793422
BRANCHIOOTORENAL SYNDROME 1	1.0725617299999999	16.384351863843577
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	1.06378252	16.250241479608096
CATECHOLAMINE-PRODUCING TUMOR	1.0555556	16.124567825341416
THYMIC NEUROENDOCRINE TUMOR	1.05441493	16.10714305796646
OTOSCLEROSIS 7	1.05030887	16.044419272535432
MOWAT-WILSON SYNDROME; MOWS	1.04866187	16.019259855818458
DEAFNESS, AUTOSOMAL DOMINANT 1	1.04695826	15.993235670078803
KINDLER SYNDROME	1.025641	15.667595216160093
DEAFNESS, AUTOSOMAL DOMINANT 6	1.0232558	15.631159125842345
HEMIHYPERPLASIA, ISOLATED	1.0227273	15.623085809670565
N SYNDROME	1.021378854	15.602487075709218
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	1.01686623	15.533552656945995
EMANUEL SYNDROME	1.0155418339999998	15.513321308517156
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	1.01373517	15.485722879589678
LOWE OCULOCEREBRORENAL SYNDROME	1.01305321	15.47530532292647
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	1.0121646199999998	15.461731305864815
LYMPHANGIOLEIOMYOMATOSIS	1.0106728	15.438942404197109
INSULINOMATOSIS AND DIABETES MELLITUS; INSDM	1.00943396	15.420018001157848
PSEUDOAMINOPTERIN SYNDROME	1.007607704	15.39212028668555
PYOMYOSITIS	1.00520833	15.355467675680162
116100 CATARACT, MEMBRANOUS	1.00178253	15.303135477872623
BLAU SYNDROME	1.00178253	15.303135477872623
HEMIFACIAL HYPERPLASIA WITH STRABISMUS	1.00124533	15.294929261321096
EHLERS-DANLOS SYNDROME, TYPE I	1.00065189	15.285863927832017
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	1.00065189	15.285863927832017
CURRARINO SYNDROME	1.000545554	15.28423954912162
CHRONIC ACTINIC DERMATITIS	1.0	15.275905717653734
DEAFNESS, AMINOGLYCOSIDE-INDUCED	1.0	15.275905717653734
SESSILE SERRATED POLYPOSIS CANCER SYNDROME	1.0	15.275905717653734
IDIOPATHIC UVEAL EFFUSION SYNDROME	1.0	15.275905717653734
137245 GASTRIC LYMPHOMA, PRIMARY	1.0	15.275905717653734
GIGANTIFORM CEMENTOMA, FAMILIAL	1.0	15.275905717653734
MESOTHELIOMA, MALIGNANT	1.0	15.275905717653734
TERATOMA, OVARIAN	1.0	15.275905717653734
MYELOPROLIFERATIVE SYNDROME, TRANSIENT	1.0	15.275905717653734
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 1	1.0	15.275905717653734
URETER, CANCER OF	1.0	15.275905717653734
AASE-SMITH SYNDROME I	1.0	15.275905717653734
DYSTROPHIA MYOTONICA 2	1.0	15.275905717653734
POLYPOSIS, INTESTINAL, SCATTERED AND DISCRETE	1.0	15.275905717653734
ALPHA-B CRYSTALLIN-RELATED LATE-ONSET MYOPATHY	1.0	15.275905717653734
ADIPOSIS DOLOROSA	1.0	15.275905717653734
ACATALASEMIA	1.0	15.275905717653734
STRABISMUS, SUSCEPTIBILITY TO	1.0	15.275905717653734
BROWN SYNDROME	1.0	15.275905717653734
SARCOMA, SYNOVIAL	1.0	15.275905717653734
RETINOBLASTOMA; RB1	0.9988035000000001	15.257628096462561
PROTEUS SYNDROME	0.9653825599999999	14.747092968027195
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.9543561899999999	14.578655179499231
SUBEPENDYMOMA	0.9396221599999998	14.353579526378146
EPENDYMOMA	0.9396221599999998	14.353579526378146
8Q24.3 MICRODELETION SYNDROME	0.9240200540000001	14.115243226125312
ATYPICAL WERNER SYNDROME	0.9221149499999999	14.086141037038985
GRFOMA	0.9214626699999999	14.076176869257473
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.909530444	13.89390130987974
FAMILIAL PAPILLARY OR FOLLICULAR THYROID CARCINOMA	0.9020199	13.77917094784745
EXOSTOSES, MULTIPLE, TYPE I	0.89509589	13.673400423899357
EXOSTOSES, MULTIPLE, TYPE II	0.89509589	13.673400423899357
REFRACTORY ANEMIA WITH EXCESS BLASTS	0.873333	13.340952568115688
COLORECTAL CANCER	0.8530023	13.030382711741783
FAMILIAL ADENOMATOUS POLYPOSIS	0.8489899	12.96908966764027
DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA; DMSMFH	0.8421565000000001	12.864703293509258
LI-FRAUMENI SYNDROME	0.8419582000000001	12.861674081405447
KASABACH-MERRITT SYNDROME	0.818287	12.500075061981718
PARAGANGLIOMAS 3	0.816667	12.475328094719123
DUODENAL NEUROENDOCRINE TUMOR	0.8030306	12.267019733990908
SCHINZEL-GIEDION SYNDROME	0.8011776599999999	12.238714397250437
NELSON SYNDROME	0.777778	11.881263397265284
NIJMEGEN BREAKAGE SYNDROME	0.76808729	11.73322902496816
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2	0.7621951	11.64322048605766
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.750545554	11.465263119708188
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.7372113599999999	11.261571229343282
JUVENILE POLYPOSIS OF INFANCY	0.73594063	11.24215967767069
OVARIAN CANCER	0.7243902	11.06571639799233
CUSHING SYNDROME DUE TO ECTOPIC ACTH SECRETION	0.71615788	10.939960253834776
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.71532724	10.927271475509464
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.7135353339999999	10.899898488398565
PALLISTER-HALL SYNDROME	0.709530444	10.838720166348992
FRONTONASAL DYSPLASIA 1; FND1	0.7066369	10.79451866101511
LARYNGEAL NEUROENDOCRINE TUMOR	0.7052083299999999	10.77269596038404
BAZEX SYNDROME	0.7	10.693134002357613
CARNEY TRIAD	0.6967040699999999	10.642785686425626
ROTHMUND-THOMSON SYNDROME	0.690081394	10.541618312251058
BRANCHIOSKELETOGENITAL SYNDROME	0.68639558	10.48531416509425
COSTELLO SYNDROME; CSTLO	0.6801002839999999	10.389147816933527
CARCINOID SYNDROME	0.6728019700000001	10.277659460371696
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.66895653	10.218916881488802
AICARDI-GOUTIÈRES SYNDROME	0.667864444	10.202234278717231
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.6504432640000001	9.936109975546959
OVARIAN FIBROTHECOMA	0.65	9.929338716474927
PINEOBLASTOMA	0.64914631	9.916297828522822
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.64806533	9.899784879960153
RING CHROMOSOME 7 SYNDROME	0.63674913	9.72691967567804
POLYMERASE PROOFREADING-RELATED ADENOMATOUS POLYPOSIS	0.6322656	9.658429694115767
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.6319953699999998	9.654301686113683
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.6267297000000001	9.57386380765341
MONOSOMY 22	0.62562625	9.557007609489265
234800 HEMANGIOMATOSIS, CUTANEOUS, WITH ASSOCIATED FEATURES	0.6253919	9.553427700984333
NEUROFIBROMATOSIS, TYPE IV, OF RICCARDI	0.625	9.547441073533584
DIAPHANOSPONDYLODYSOSTOSIS	0.620866454	9.484297414557998
TUMOR PREDISPOSITION SYNDROME; TPDS	0.6125259000000001	9.356887898021
46,XY PARTIAL GONADAL DYSGENESIS	0.6060603	9.258120002012937
CATARACT 31, MULTIPLE TYPES	0.6055556000000001	9.250410252397238
INSULINOMA	0.6043413099999999	9.231860872843347
LHERMITTE-DUCLOS DISEASE	0.6033566699999999	9.216819605037516
LMNA-RELATED CARDIOCUTANEOUS PROGERIA SYNDROME	0.6025969999999999	9.205214957740985
CATARACT 15, MULTIPLE TYPES; CTRCT15	0.60010509	9.167148775524108
TESTICULAR GERM CELL TUMOR; TGCT	0.5958330000000001	9.101888731466778
CATARACT 33, MULTIPLE TYPES; CTRCT33	0.5888886	8.995806731801101
NEUROFIBROMATOSIS TYPE 2	0.58445509	8.928080851042825
NK-CELL ENTEROPATHY	0.5833333	8.91094449276782
NIEMANN-PICK DISEASE TYPE B	0.56731859	8.666305292712254
NEUROENDOCRINE CARCINOMA OF SALIVARY GLANDS, SENSORINEURAL HEARING LOSS, AND ENAMEL HYPOPLASIA	0.56400376	8.615668262162202
MISMATCH REPAIR CANCER SYNDROME; MMRCS	0.5630902	8.601712805734783
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.56177353	8.581599478953521
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.5615076	8.577537157346026
PPOMA	0.5593429000000001	8.544469404239022
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.55829547	8.528468962313179
ALPORT SYNDROME	0.55417768	8.46556599050808
COWDEN SYNDROME 6; CWS6	0.5520248400000001	8.432679409642889
COWDEN SYNDROME 5; CWS5	0.5520248400000001	8.432679409642889
PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, 1	0.5482951699999999	8.375705322364926
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.5454545	8.332311515269957
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.54065189	8.258947297711297
EAR EXOSTOSES	0.53855445	8.226907002022863
DERMOCHONDROCORNEAL DYSTROPHY	0.5384615	8.225487106586407
OCULOCEREBRORENAL SYNDROME OF LOWE	0.5357380399999999	8.183883788400603
JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	0.5352561	8.176521718399037
SÉZARY SYNDROME	0.53494004	8.171693615637917
MILROY DISEASE	0.53494004	8.171693615637917
CLASSIC MYCOSIS FUNGOIDES	0.53125	8.115324912503546
NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM	0.53125	8.115324912503546
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.530303	8.100858629788927
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.527220024	8.053763379083138
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.525237484	8.023478284961662
MUTYH-RELATED ATTENUATED FAMILIAL ADENOMATOUS POLYPOSIS	0.5245421	8.012855664540096
DEAFNESS-HYPOGONADISM SYNDROME	0.5232558	7.993206267015479
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.5208333	7.956200385414464
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.5208333	7.956200385414464
MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME	0.51983357	7.940928604191351
MEDULLOBLASTOMA	0.517785734	7.9096460545301355
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.51769005	7.908184394767447
SOMATOSTATINOMA	0.5176759	7.907968240701542
LYMPHOBLASTIC LEUKEMIA, ACUTE, WITH LYMPHOMATOUS FEATURES	0.515873	7.880427310283185
RHYNS SYNDROME	0.51521605	7.870391804021973
DOWN SYNDROME	0.51446118	7.8588604810728855
SPINAL ARTERIOVENOUS METAMERIC SYNDROME	0.51332659	7.841528591204694
OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES; EORVA	0.5121951	7.824244056644226
SPONDYLOPERIPHERAL DYSPLASIA	0.5105874899999999	7.799686357853466
FAMILIAL PANCREATIC CARCINOMA	0.510481	7.798059626653594
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.507790364	7.75695772479707
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.5072634540000001	7.7489086973153825
DESMOPLASTIC SMALL ROUND CELL TUMOR	0.5067175700000001	7.740569824798607
17Q24.2 MICRODELETION SYNDROME	0.50649351	7.737147105363508
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.505570684	7.723050102393709
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.50550626	7.722065967443754
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.50526139	7.718325356410673
AUTOSOMAL DOMINANT EPIDERMOLYTIC ICHTHYOSIS	0.50520833	7.717514816853294
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.5048874839999999	7.712613603607407
CRYPTOCOCCOSIS	0.50401606	7.6993018127433075
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.50296736	7.6832819704172035
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.50296736	7.6832819704172035
%229400 FRONTOFACIONASAL DYSPLASIA;;FFND;;FRONTOFACIONASAL DYSOSTOSIS	0.50178253	7.665182619045755
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.501197444	7.656244900473036
XYLT1-CDG	0.50065189	7.647911069005148
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.50065189	7.647911069005148
ANAL CANAL CARCINOMACLOACOGENIC CARCINOMA, INCLUDED	0.5	7.637952858826867
%300228 TESTICULAR GERM CELL TUMOR 1; TGCT1	0.5	7.637952858826867
PYLORIC STENOSIS, INFANTILE HYPERTROPHIC 1	0.5	7.637952858826867
CHILBLAIN LUPUS	0.5	7.637952858826867
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.5	7.637952858826867
PULMONARY FIBROSIS, IDIOPATHIC; IPF	0.5	7.637952858826867
FUNCTIONING GONADOTROPIC ADENOMA	0.5	7.637952858826867
RHABDOMYOSARCOMA 1	0.5	7.637952858826867
RHABDOMYOSARCOMA 2; RMS2	0.5	7.637952858826867
CATARACT 19, MULTIPLE TYPES; CTRCT19	0.5	7.637952858826867
LAMBERT-EATON MYASTHENIC SYNDROME	0.5	7.637952858826867
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.5	7.637952858826867
FAMILIAL HYPERALDOSTERONISM TYPE II	0.5	7.637952858826867
FAMILIAL HYPERALDOSTERONISM TYPE I	0.5	7.637952858826867
MANDIBULOACRAL DYSPLASIA	0.5	7.637952858826867
DEAFNESS, UNILATERAL, WITH DELAYED ENDOLYMPHATIC HYDROPS	0.5	7.637952858826867
DEAFNESS, UNILATERAL	0.5	7.637952858826867
MYOFIBROMATOSIS, INFANTILE, 1; IMF1	0.5	7.637952858826867
PLEOMORPHIC LIPOSARCOMA	0.5	7.637952858826867
HIS BUNDLE TACHYCARDIA	0.5	7.637952858826867
ANGIOMA, TUFTED	0.5	7.637952858826867
LUNG CANCER	0.5	7.637952858826867
%608645 DEAFNESS, AUTOSOMAL DOMINANT 31; DFNA31	0.5	7.637952858826867
FANCONI-LIKE SYNDROME	0.5	7.637952858826867
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.5	7.637952858826867
UPINGTON DISEASE	0.5	7.637952858826867
HEMANGIOMAS, CAVERNOUS, OF FACE AND SUPRAUMBILICAL MIDLINE RAPHE	0.5	7.637952858826867
REFRACTORY ANEMIA	0.5	7.637952858826867
RESTRICTIVE DERMOPATHY	0.5	7.637952858826867
NASOPHARYNGEAL CARCINOMA, SUSCEPTIBILITY TO, 3	0.5	7.637952858826867
%607107 NASOPHARYNGEAL CARCINOMA;;NPCA;;NPC;;NASOPHARYNGEAL CANCERNASOPHARYNGEAL CARCINOMA, SUSCEPTIBILITY TO, 1, INCLUDED; NPCA1, INCLUDED	0.5	7.637952858826867
MEIGE DISEASE	0.5	7.637952858826867
GENERALIZED JUVENILE POLYPOSIS/JUVENILE POLYPOSIS COLI	0.48503474	7.409344958026693
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.47834564999999996	7.307163049849791
TREACHER-COLLINS SYNDROME	0.476243584	7.275052087821505
OVARIAN FIBROMA	0.4738095	7.237869250128656
PALLISTER-HALL SYNDROME	0.470766444	7.191383813579116
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.4541394	6.937390657071836
FRONTORHINY	0.45302786	6.920410876830435
GONADOBLASTOMA	0.45	6.8741575729441795
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.45	6.8741575729441795
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.4464909	6.820552892190361
MELANOMA, CUTANEOUS MALIGNANT	0.4450757	6.798934430418738
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV; MEN4	0.444087	6.783831142435694
XERODERMA PIGMENTOSUM	0.44024811	6.725188620735251
GANGLIOCYTOMA	0.43926080000000006	6.710106566261153
RHABDOID TUMOR	0.439121	6.707970994641825
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.43845601	6.697812670098642
BLOOM SYNDROME	0.43648789	6.667747854537613
CARNEY-STRATAKIS SYNDROME	0.43333299999999997	6.619554052348045
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.43259917	6.608344134455259
OROFACIODIGITAL SYNDROME TYPE 1	0.42162600999999994	6.440719176870529
POLYCYSTIC KIDNEY DISEASE, INFANTILE SEVERE, WITH TUBEROUS SCLEROSIS	0.4136903	6.319494019107888
MULTIPLE OSTEOCHONDROMAS	0.41176289	6.290051085668626
TRICHOTHIODYSTROPHY	0.4084619640000001	6.2396264513116755
PITUITARY ADENOMA, PROLACTIN-SECRETING	0.4047616	6.183100039726673
PLEUROPULMONARY BLASTOMA	0.40384620000000004	6.169116475632733
NEUROENDOCRINE TUMOR OF STOMACH	0.4022524	6.144769737099937
MCCUNE-ALBRIGHT SYNDROME	0.40181276	6.138053837910227
MELANOSIS, NEUROCUTANEOUS; NCMS	0.39989585399999994	6.108771362584622
POLAND SYNDROME	0.39934094	6.100294548639216
PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 46,XX SEX REVERSAL	0.395833	6.04670758793603
SEGMENTAL OUTGROWTH-LIPOMATOSIS-ARTERIOVENOUS MALFORMATION-EPIDERMAL NEVUS SYNDROME	0.3913058	5.977550507571068
CRONKHITE-CANADA SYNDROME	0.39120563	5.976020320095332
BECKWITH-WIEDEMANN SYNDROME	0.39027907000000006	5.961866276893582
WHIM SYNDROME	0.3888889	5.94063017104207
CATARACT, CONGENITAL TOTAL, WITH POSTERIOR SUTURAL OPACITIES IN HETEROZYGOTES	0.3888886	5.940625588270356
DERMATOMYOSITIS	0.38832853	5.932070011755069
SOTOS SYNDROME	0.38751862400000003	5.919697964058908
ATYPICAL TERATOID RHABDOID TUMOR	0.38708697000000003	5.91310405825226
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.38453044399999997	5.874050808111528
ALAGILLE SYNDROME 1; ALGS1	0.38168047	5.830514873989764
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.37906952400000005	5.79063030905988
PUNCTATE PALMOPLANTAR KERATODERMA TYPE 1	0.3769648	5.758478743674196
ELSAHY-WATERS SYNDROME; ESWS	0.376554144	5.752205601335807
AUTOIMMUNE ENTEROPATHY AND ENDOCRINOPATHY-SUSCEPTIBILITY TO CHRONIC INFECTIONS SYNDROME	0.37565189	5.738422854298431
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.37522437	5.73189209908602
ECTOPIC ALDOSTERONE-PRODUCING TUMOR	0.3749997	5.728460061348435
UNCLASSIFIED MYELODYSPLASTIC SYNDROME	0.37333299999999997	5.702999709288821
MYELODYSPLASTIC SYNDROME ASSOCIATED WITH ISOLATED DEL(5Q) CHROMOSOME ABNORMALITY	0.37333299999999997	5.702999709288821
YELLOW NAIL SYNDROME	0.37323249999999997	5.701464480764196
GALLBLADDER NEUROENDOCRINE TUMOR	0.37187533	5.680732479801369
CRANIOLENTICULOSUTURAL DYSPLASIA	0.37102188999999997	5.667695410825694
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	0.36809239	5.622944645025828
ATELOSTEOGENESIS TYPE I	0.36781579999999997	5.618719482263382
THYMIC TUMOR	0.366667	5.601170521774942
ACITRETIN/ETRETINATE EMBRYOPATHY	0.36625969999999997	5.594948645376141
SCHWARTZ-JAMPEL SYNDROME	0.3659124399999999	5.589643934356627
GLYCOGEN STORAGE DISEASE IB	0.36523489	5.579293744437632
GLYCOGEN STORAGE DISEASE IA	0.36523489	5.579293744437632
LINEAR IGA DERMATOSIS	0.36111099999999996	5.516297589607657
INFANTILE MYOFIBROMATOSIS	0.3593029	5.488677224479567
NANCE-HORAN SYNDROME	0.35878109	5.480706104117039
OLLIER DISEASE	0.35873	5.479925658093924
BAZEX SYNDROME; BZX	0.3571425	5.455675157767148
MEDULLARY THYROID CARCINOMA	0.35621843	5.441559151570636
MASTOCYTOSIS	0.35613497	5.4402842244794405
AYME-GRIPP SYNDROME; AYGRP	0.35301900999999997	5.39268511329946
EARLOBES, THICKENED, WITH CONDUCTIVE DEAFNESS FROM INCUDOSTAPEDIALABNORMALITIES	0.35	5.346567001178807
KAPOSI SARCOMA, SUSCEPTIBILITY TO	0.34999969999999997	5.346562418407091
C SYNDROME	0.34892882	5.330203756492169
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.34834379	5.321266893370171
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.347407124	5.30695847186524
CLEFT LIP/PALATE-DEAFNESS-SACRAL LIPOMA SYNDROME	0.34731936	5.305617797275835
DUBOWITZ SYNDROME	0.34517339	5.272836161882923
PALMOPLANTAR KERATODERMA-ESOPHAGEAL CARCINOMA SYNDROME	0.3446763	5.265242661909733
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL DOMINANT	0.34414507	5.257127642515344
ILEAL NEUROENDOCRINE TUMOR	0.34157193	5.2178205984770205
JEJUNAL NEUROENDOCRINE TUMOR	0.34157193	5.2178205984770205
CRANIOPHARYNGIOMA	0.341530974	5.217194958482448
FAMILIAL ADENOMATOUS POLYPOSIS 3	0.3413545	5.214499158296832
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.34092341000000004	5.207913868101008
OTODENTAL SYNDROME	0.33958745999999995	5.187506021857508
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.33946797	5.185680703883306
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.339001564	5.178555929801157
EPISODIC ATAXIA TYPE 1	0.33868059	5.17365276123934
%109500 BASILAR IMPRESSION, PRIMARY	0.33868059	5.17365276123934
KLATSKIN TUMOR	0.33854133	5.171525438609099
BRONCHIAL NEUROENDOCRINE TUMOR	0.33854133	5.171525438609099
DEAFNESS AND MYOPIA; DFNMYP	0.33818737	5.166118379021278
CLEFT VELUM	0.33818737	5.166118379021278
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.33806401399999997	5.164234004395571
PAPILLOMA OF CHOROID PLEXUS	0.33734906	5.153312434499112
NIJMEGEN BREAKAGE SYNDROME	0.33703809	5.148562086098093
CLEIDOCRANIAL DYSPLASIA	0.33550233999999995	5.125102113892206
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.335382314	5.12326860803254
IMMUNODEFICIENCY 36; IMD36	0.33515109000000004	5.1197364520088815
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.33511553	5.119193240801561
SPINOCEREBELLAR ATAXIA TYPE 42	0.33457833	5.110987024250037
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.33398489	5.101921690760953
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.333878554	5.100297312050561
ACROMELIC FRONTONASAL DYSPLASIA	0.333878554	5.100297312050561
PARTIAL ANDROGEN INSENSITIVITY SYNDROME	0.333333	5.091963480582671
SALIVARY GLAND ADENOMA, PLEOMORPHIC	0.333333	5.091963480582671
IMMUNODEFICIENCY 16	0.333333	5.091963480582671
CHOLANGIOCARCINOMA	0.333333	5.091963480582671
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.333333	5.091963480582671
CHOROIDAL ATROPHY-ALOPECIA SYNDROME	0.333333	5.091963480582671
TRICHOEPITHELIOMAS, MULTIPLE DESMOPLASTIC	0.333333	5.091963480582671
LEYDIG CELL HYPOPLASIA	0.333333	5.091963480582671
PELVIS-SHOULDER DYSPLASIA	0.333333	5.091963480582671
FAMILIAL ATRIAL MYXOMA	0.333333	5.091963480582671
BURKITT LYMPHOMA; BL	0.333333	5.091963480582671
PAPILLOMA OF CHOROID PLEXUS	0.333333	5.091963480582671
MYOFIBROMATOSIS, INFANTILE, 2; IMF2	0.333333	5.091963480582671
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 4; EV4	0.333333	5.091963480582671
CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA	0.333333	5.091963480582671
GESTATIONAL CHORIOCARCINOMA	0.333333	5.091963480582671
COMPLETE ANDROGEN INSENSITIVITY SYNDROME	0.333333	5.091963480582671
DEAFNESS, AUTOSOMAL RECESSIVE 102; DFNB102	0.333333	5.091963480582671
PLACENTAL INSUFFICIENCY	0.333333	5.091963480582671
PAI SYNDROME	0.333333	5.091963480582671
ANGIOLIPOMATOSIS, FAMILIAL	0.333333	5.091963480582671
RARE CIRCULATORY SYSTEM DISEASE	0.3309091	5.054936212713651
PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY	0.3286003	5.019667201592732
AXONAL POLYNEUROPATHY ASSOCIATED WITH IGG/IGM/IGA MONOCLONAL GAMMOPATHY	0.326984	4.994976755181288
FAMILIAL MULTIPLE LIPOMATOSIS	0.3269231	4.994046452523084
FAMILIAL MELANOMA	0.3263406	4.98514823744255
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.32007503	4.88943598085519
PGM3-CDG	0.316736	4.838429273386773
WISKOTT-ALDRICH SYNDROME	0.315873	4.825246166752438
DIETHYLSTILBESTROL SYNDROME	0.31309655999999997	4.782833531081715
MOHR-TRANEBJAERG SYNDROME	0.3125	4.773720536766792
45,X/46,XY MIXED GONADAL DYSGENESIS	0.31099284000000005	4.750697302705373
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.309239904	4.723919617640291
SYSTEMIC MASTOCYTOSIS	0.30613497	4.676488938596754
MARFAN SYNDROME; MFS	0.29927841	4.571748774489318
WALDENSTRÖM MACROGLOBULINEMIA	0.29625945000000004	4.525631426163951
ADRENOCORTICAL CARCINOMA	0.29611743	4.523461942033929
MALAKOPLAKIA	0.291667	4.455477592950912
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.291667	4.455477592950912
SEBOCYSTOMATOSIS	0.29090910000000003	4.443899984007502
THYROID CANCER, NONMEDULLARY, 1; NMTC1	0.29090910000000003	4.443899984007502
ACUTE PANMYELOSIS WITH MYELOFIBROSIS	0.29	4.4300126581195824
FRONTOOCULAR SYNDROME	0.28882788400000003	4.41210752461343
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.2884615	4.406510677172972
FAMILIAL ADENOMATOUS POLYPOSIS 4; FAP4	0.2835497	4.3314784834690006
%223200 DISORGANIZATION, MOUSE, HOMOLOG OF;;DS	0.28180676000000004	4.304853496357474
CATARACT 1, MULTIPLE TYPES	0.28165656	4.302559055318682
ROBERTS SYNDROME	0.281564744	4.30115648275931
ESOPHAGEAL ATRESIA	0.28073019	4.288407914539018
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.28030299999999997	4.281882200375494
NEUROFIBROMATOSIS-PHEOCHROMOCYTOMA-DUODENAL CARCINOID SYNDROME	0.27777759999999996	4.243304428076131
FAMILIAL BREAST-OVARIAN CANCER-1	0.27439020000000003	4.191558825048152
ADENOCARCINOMA OF THE ESOPHAGUS	0.27399197	4.185475501114209
ROBERTS SYNDROME; RBS	0.27261583	4.164453716219918
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.27253035999999997	4.163148084558229
COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE	0.27245221000000003	4.161954272526396
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.2717391	4.15106087140008
ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	0.2712766	4.1439957650056645
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.27029226	4.128959079971549
MUCOLIPIDOSIS TYPE II	0.27021216000000003	4.127735479923566
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.26875885	4.105534853385042
FAMILIAL THROMBOCYTOSIS	0.26793563000000004	4.092959422280155
GLUCAGONOMA	0.2676759	4.088991811288109
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.26749963	4.0862991273872575
GLIOMA SUSCEPTIBILITY 3	0.2652346	4.0516987426596005
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.26349144999999996	4.025070547607872
WILLIAMS SYNDROME	0.26329121	4.02201170024697
RHABDOID TUMOR PREDISPOSITION SYNDROME 2; RTPS2	0.2625	4.0099252508841055
COACH SYNDROME	0.26123744400000004	3.9906385644648474
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.260991614	3.9868832885622756
ALPORT SYNDROME, X-LINKED; ATS	0.26093772000000004	3.9860600088995293
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.26081207	3.984140591346106
HALLERMANN-STREIFF SYNDROME	0.26067929	3.982112256584916
CATARACT 9, MULTIPLE TYPES; CTRCT9	0.26067929	3.982112256584916
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.260658314	3.9817918291865824
CUSHING SYNDROME	0.26009342	3.973162561702114
NON-FUNCTIONING PARAGANGLIOMA	0.2600627	3.9726932858784676
CATARACT, AUTOSOMAL DOMINANT, MULTIPLE TYPES 1	0.25943396	3.96308871291755
LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT	0.25943396	3.96308871291755
OTOMANDIBULAR SYNDROME	0.25915935	3.958893796448425
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.25912647	3.958391524668429
PHACE SYNDROME	0.258864214	3.9543853267385396
46,XY SEX REVERSAL 6; SRXY6	0.2588235	3.953763383513151
46,XY SEX REVERSAL 10; SRXY10	0.2588235	3.953763383513151
46,XY OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.2588235	3.953763383513151
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.25821357	3.9444461503387824
CUTANEOUS MASTOCYTOSIS	0.25805807000000003	3.942070746999687
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.25769095399999997	3.9364627175962443
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.2576657	3.9360769398732516
ALLAN-HERNDON-DUDLEY SYNDROME	0.25740741	3.9321313261854387
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.257039064	3.926504507417963
BURKITT LYMPHOMA	0.25613497	3.912693652714068
PULMONARY BLASTOMA	0.25520833	3.898538387439861
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.2551938	3.8983164285297836
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.25509360400000003	3.896785843880498
MALARIA	0.25375397	3.876321721200334
POLYARTERITIS NODOSA	0.25306863	3.8658525319757975
NOONAN SYNDROME 6; NS6	0.252701204	3.8602397670415822
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.252049314	3.850281556863302
MYH9-RELATED DISEASE	0.25150376	3.841947725395413
SPINOCEREBELLAR ATAXIA TYPE 37	0.25150376	3.841947725395413
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.251197444	3.8372684710596032
NOONAN SYNDROME 3; NS3	0.251197444	3.8372684710596032
ACUTE MONOBLASTIC LEUKEMIA	0.25066283	3.829101758000266
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.250545554	3.8273102608813225
FUMARASE DEFICIENCY; FMRD	0.250545554	3.8273102608813225
AUTOIMMUNE HEMOLYTIC ANEMIA, WARM TYPE	0.2500003	3.8189810121851484
COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 5	0.2500003	3.8189810121851484
MYOPIA 17	0.25	3.8189764294134334
LICHEN PLANOPILARIS	0.25	3.8189764294134334
127820 DYSPLASIA EPIPHYSEALIS HEMIMELICA WITH CHONDROMAS AND OSTEOCHONDROMAS;;OSTEOCHONDROMATOSIS, DOMINANT CARPOTARSAL	0.25	3.8189764294134334
OSSICULAR MALFORMATIONS, FAMILIAL	0.25	3.8189764294134334
ORAL SUBMUCOUS FIBROSIS	0.25	3.8189764294134334
PLATELET DISORDER, UNDEFINED	0.25	3.8189764294134334
%108650 SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7;;SPASTIC ATAXIA WITH CONGENITAL MIOSIS;;MIOSIS, CONGENITAL, WITH SPASTIC ATAXIA	0.25	3.8189764294134334
FRASIER SYNDROME	0.25	3.8189764294134334
FOVEAL HYPOPLASIA AND PRESENILE CATARACT SYNDROMEFOVEAL HYPOPLASIA, ISOLATED, INCLUDED	0.25	3.8189764294134334
MELANOMA, UVEAL	0.25	3.8189764294134334
LYMPHANGIOLEIOMYOMATOSIS	0.25	3.8189764294134334
MELANOMA, MALIGNANT FAMILIAL INTRAOCULAR	0.25	3.8189764294134334
JUVENILE MYELOMONOCYTIC LEUKEMIA	0.25	3.8189764294134334
DYSTONIA 6, TORSION	0.25	3.8189764294134334
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.25	3.8189764294134334
GAMMA-HEAVY CHAIN DISEASE	0.25	3.8189764294134334
ATAXIA-PANCYTOPENIA SYNDROME	0.25	3.8189764294134334
SMALL CELL CARCINOMA OF THE BLADDER	0.25	3.8189764294134334
CONGENITAL CONTRACTURAL ARACHNODACTYLY	0.25	3.8189764294134334
CARNEY-STRATAKIS SYNDROME	0.24958278	3.812603016029914
MACROGLOBULINEMIA, WALDENSTROM, SUSCEPTIBILITY TO, 1	0.247123	3.7750276486637437
BIRT-HOGG-DUBÉ SYNDROME	0.2464003	3.763987751601595
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.24629130400000002	3.7623227389819944
TRICHOHEPATOENTERIC SYNDROME 1	0.24424199000000002	3.731017611532126
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.24359010000000003	3.7210594013538447
ONDINE SYNDROME	0.24359010000000003	3.7210594013538447
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.24050455399999998	3.6739248915703606
GCGR-RELATED HYPERGLUCAGONEMIA	0.23846150000000002	3.6427153912902863
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.23745613999999998	3.6273576067179856
WATSON SYNDROME	0.23676288999999998	3.616767585079222
HENNEKAM SYNDROME	0.23643332	3.6117331048318544
EPIDERMAL NEVUS SYNDROME	0.23637939400000002	3.610909336340125
HYPERCALCEMIA, INFANTILE, 1	0.236347	3.610414488650307
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.235680244	3.6002291868576273
PRIMARY MYELOFIBROSIS	0.23562800000000003	3.5994311124393144
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.23432160999999999	3.5794748219688284
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.23376609999999998	3.570988903583614
ENCHONDROMATOSIS, MULTIPLE	0.2328501	3.5569961739462435
MULTIPLE ENCHONDROMATOSIS, MAFFUCCI TYPE	0.2328501	3.5569961739462435
CATARACT 17, MULTIPLE TYPES	0.23165656	3.5387637694359952
DERMATOFIBROSARCOMA PROTUBERANS	0.23125	3.532553197207426
7Q11.23 MICRODUPLICATION SYNDROME	0.22988127	3.5116446067745013
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.2277778	3.479512197374589
HEMIFACIAL MICROSOMIA	0.22771232000000002	3.478511931068197
OCULOCEREBROCUTANEOUS SYNDROME	0.22768686000000002	3.4781230065086253
AUTOSOMAL DOMINANT SEVERE CONGENITAL NEUTROPENIA	0.2273234	3.4725708258164865
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.22673585400000001	3.4635955285157025
CEREBROOCULONASAL SYNDROME	0.2254905	3.4445716182265995
COLORECTAL CANCER, SUSCEPTIBILITY TO, 10; CRCS10	0.22275640000000002	3.402805764403962
175500 POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES;;CRONKHITE-CANADA SYNDROME	0.22161059000000002	3.3853024788736175
CLAPO SYNDROME	0.22037036000000004	3.366356842325412
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.21941556	3.351771407546196
DESMOID TUMOR	0.21875	3.3416043757367544
AYMÉ-GRIPP SYNDROME	0.218714114	3.34105618458417
PARANEOPLASTIC PEMPHIGUS	0.21783220000000003	3.327584149469092
PAPILLORENAL SYNDROME	0.21698489	3.3146407217954663
117600 CEREBRAL SARCOMA	0.21666670000000002	3.3097800813551665
INSULIN-RESISTANCE SYNDROME TYPE B	0.21631932999999998	3.3044736899860245
DUPLICATION OF THE PITUITARY GLAND	0.215872794	3.2976524481504863
FAMILIAL PARATHYROID ADENOMA	0.214286	3.273412732613148
TETRASOMY 9P	0.213890454	3.2673704092101534
AICARDI SYNDROME	0.21330571	3.2584379149971894
300270 ADRENOMYODYSTROPHY	0.211656964	3.2332518265488304
OCULOAURICULOFRONTONASAL SYNDROME	0.21126463	3.227258569355001
MODY	0.211236	3.2268212201743043
OROFACIODIGITAL SYNDROME TYPE 6	0.21121822399999998	3.2265496756742666
TETRASOMY 5P	0.21065807400000003	3.2179928770865236
SCARF SYNDROME	0.21024338	3.211658050640847
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.20997834	3.2076093245894395
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.20997434	3.207548220966569
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.20960622	3.2019248545537864
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.20940313000000002	3.198822470861588
ADNP SYNDROME	0.20930625999999997	3.1973426938747185
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.20847326400000002	3.1846179255155365
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.20772889000000003	3.1732469384728637
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.20743829	3.168807760271313
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.207094834	3.1635611587971506
ACQUIRED IDIOPATHIC SIDEROBLASTIC ANEMIA	0.20666700000000002	3.157025606950344
ERYTHROLEUKEMIA, FAMILIAL, SUSCEPTIBILITY TO; FERLK	0.20666700000000002	3.157025606950344
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.2066369	3.156565802188243
CROUZON SYNDROME	0.2060997	3.148359585636719
KAPOSIFORM LYMPHANGIOMATOSIS	0.20591140000000002	3.145483132590085
PROTEUS SYNDROME	0.20589312	3.1452038890335663
NEUROENDOCRINE TUMOR OF THE RECTUM	0.20520833000000002	3.1347431015571745
NEUROENDOCRINE TUMOR OF THE COLON	0.20520833000000002	3.1347431015571745
NEUROENDOCRINE TUMOR OF ANAL CANAL	0.20520833000000002	3.1347431015571745
HEMIFACIAL MICROSOMIA WITH RADIAL DEFECTS	0.20485437	3.1293360419693537
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.20466795	3.1264883076254684
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.20178253000000002	3.0824109037496363
OSTEOGENIC SARCOMA	0.20168049999999998	3.0808523030892636
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.201197444	3.073473185176917
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.20065189	3.0651393537090277
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.20054555400000001	3.0635149749986357
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.20054555400000001	3.0635149749986357
RETINAL CAPILLARY MALFORMATION	0.2	3.055181143530747
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 4	0.2	3.055181143530747
TERATOMA, PINEAL	0.2	3.055181143530747
CAYLER CARDIOFACIAL SYNDROME	0.2	3.055181143530747
CURRARINO SYNDROME	0.2	3.055181143530747
INCESSANT INFANT VENTRICULAR TACHYCARDIA	0.2	3.055181143530747
OVARIAN FIBROMATA	0.2	3.055181143530747
ADRENOCORTICAL CARCINOMA WITH PURE ALDOSTERONE HYPERSECRETION	0.2	3.055181143530747
%606960 INSULINOMA TUMOR SUPPRESSOR GENE LOCUS	0.2	3.055181143530747
ACQUIRED VON WILLEBRAND SYNDROME	0.2	3.055181143530747
PACHYONYCHIA CONGENITA 2	0.2	3.055181143530747
SECONDARY NON-TRAUMATIC AVASCULAR NECROSIS	0.2	3.055181143530747
THYROID CANCER, NONMEDULLARY, 4; NMTC4	0.2	3.055181143530747
THYROID CANCER, NONMEDULLARY, 5; NMTC5	0.2	3.055181143530747
ROMANO-WARD SYNDROME	0.2	3.055181143530747
HEPATIC ADENOMAS, FAMILIAL	0.2	3.055181143530747
CAHMR SYNDROME	0.2	3.055181143530747
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.2	3.055181143530747
STEATOCYSTOMA MULTIPLEX	0.2	3.055181143530747
MYELOCYTIC LEUKEMIA-LIKE SYNDROME, FAMILIAL, CHRONIC	0.2	3.055181143530747
LEUKEMIA, ACUTE MONOCYTIC	0.2	3.055181143530747
STEATOCYSTOMA MULTIPLEX WITH NATAL TEETH	0.2	3.055181143530747
POLYNEUROPATHY ASSOCIATED WITH IGM MONOCLONAL GAMMAPATHY WITH ANTI-MAG	0.2	3.055181143530747
EPISODIC ATAXIA, TYPE 4	0.2	3.055181143530747
THYROID CANCER, NONMEDULLARY, 3; NMTC3	0.2	3.055181143530747
SOMATOMAMMOTROPINOMA	0.19962136000000003	3.0493970745898147
ACROMEGALY	0.19962136000000003	3.0493970745898147
KERATOSIS, FAMILIAL ACTINIC	0.19861109999999998	3.0339644380794972
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.1984126	3.0309321707945434
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.19551962	2.9867392810714852
GLOMUVENOUS MALFORMATION	0.19548859999999998	2.9862654224761234
DISTAL MONOSOMY 12Q	0.19415755400000004	2.9659324892742642
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.1935926	2.957302305235452
HEART DEFECT-TONGUE HAMARTOMA-POLYSYNDACTYLY SYNDROME	0.1916667	2.9278824384138225
PITUITARY GIGANTISM	0.19162887000000003	2.9273045509005247
SCHÖPF-SCHULZ-PASSARGE SYNDROME	0.19111720000000001	2.919488328221972
FAMILIAL ISOLATED HYPERPARATHYROIDISM	0.19047599999999998	2.9096934174758124
ZUNICH NEUROECTODERMAL SYNDROME	0.18937806999999998	2.8929215423112287
SMITH-LEMLI-OPITZ SYNDROME	0.188410134	2.8781354432345063
HIRSCHSPRUNG DISEASE	0.18710994999999997	2.8582739550349037
INCONTINENTIA PIGMENTI	0.18640430400000002	2.847494573268865
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.18389917000000003	2.809226382474776
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.18357449	2.804266601406368
MÉNÉTRIER DISEASE	0.18346679000000002	2.802621386360577
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.18261628400000002	2.789629136892278
CARBOXYLESTERASE 1	0.18254	2.7884638297005124
AREDYLD SYNDROME	0.18120779	2.768113115344397
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.18083035999999997	2.7623475302493823
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.18036560000000001	2.7552479003080466
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.1785713	2.7278383426788597
ACQUIRED ICHTHYOSIS	0.17698399999999997	2.703590897533228
FECHTNER SYNDROME	0.17610096	2.690101661748311
LEGIUS SYNDROME	0.17568530999999998	2.683752231536768
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.17521301	2.6765374212663207
DUBOWITZ SYNDROME	0.1749162	2.672003379690264
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.17444901000000002	2.6648666292980336
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 3	0.17424240000000002	2.661710474417709
WOLFRAM-LIKE SYNDROME	0.17410699999999998	2.6596421167835382
DIENCEPHALIC SYNDROME	0.1734126	2.6490345278531997
CARCINOMA OF GALLBLADDER AND EXTRAHEPATIC BILIARY TRACT	0.17280197	2.639706601544829
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.1727667	2.6391678203501674
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.172619	2.6369115690756697
THYMIC CARCINOMA	0.17187533000000002	2.625551336270622
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.170892304	2.61053472377662
HEREDITARY ACROKERATOTIC POIKILODERMA	0.17066734	2.6070981949227536
601095 HARROD SYNDROME	0.17035704000000002	2.602358081378566
LIG4 SYNDROME	0.170068194	2.5979456971156445
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.16996164400000002	2.596318049361429
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.16873000400000002	2.5775036328433374
VITREORETINOCHOROIDOPATHY; VRCP	0.16791233	2.5650129219115603
THYMOMA	0.166667	2.5459893782441947
TERMINAL OSSEOUS DYSPLASIA; TOD	0.166667	2.5459893782441947
ACUTE ERYTHROID LEUKEMIA	0.166667	2.5459893782441947
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	2.5459893782441947
CHOLANGIOCARCINOMA	0.166667	2.5459893782441947
DERMATOLEUKODYSTROPHY	0.166667	2.5459893782441947
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.166667	2.5459893782441947
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.166667	2.5459893782441947
CATARACT, ANTERIOR POLAR, 2	0.166667	2.5459893782441947
HYPERPARATHYROIDISM 4	0.166667	2.5459893782441947
LEUKEMIA, CHRONIC LYMPHOCYTIC; CLL	0.166667	2.5459893782441947
ANEMIA, SIDEROBLASTIC, AUTOSOMAL DOMINANT	0.166667	2.5459893782441947
CORNEA GUTTATA WITH ANTERIOR POLAR CATARACTS	0.166667	2.5459893782441947
B-CELL MALIGNANCY, LOW-GRADE	0.166667	2.5459893782441947
CATARACT, ANTERIOR POLAR, 1	0.166667	2.5459893782441947
CARCINOID TUMORS, INTESTINAL	0.166667	2.5459893782441947
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.16415475000000002	2.507612484105019
JERVELL AND LANGE-NIELSEN SYNDROME	0.16369029999999998	2.500517589694455
LINEAR NEVUS SEBACEUS SYNDROME	0.16346900000000003	2.497137031759139
POLYPOSIS, INTESTINAL, WITH MULTIPLE EXOSTOSES	0.1625	2.4823346791187317
UNILATERAL POLYMICROGYRIA	0.16242902999999997	2.481250548089949
FAMILIAL KERATOACANTHOMA	0.16233770000000003	2.479855399620757
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.16206185999999997	2.4756416937875985
SIMPSON-GOLABI-BEHMEL SYNDROME	0.16193362400000003	2.47368277274199
POTOCKI-SHAFFER SYNDROME	0.16155518400000002	2.467901758982201
LARGE CONGENITAL MELANOCYTIC NEVUS	0.16025640000000002	2.448061657050604
COMMON VARIABLE IMMUNODEFICIENCY	0.15872999999999998	2.4247445145631765
MONOSOMY 18Q	0.158438664	2.420294093295019
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.157808	2.4106601294915
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.157554004	2.4067801105428392
POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4	0.1570693	2.3993758179378695
LIPODYSTROPHY DUE TO PEPTIDIC GROWTH FACTORS DEFICIENCY	0.1567459	2.39443559002878
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.15653548	2.3912212339476717
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 2; PFBMFT2	0.15625	2.386860268383396
AFRICAN IRON OVERLOAD	0.15625	2.386860268383396
DIFFUSE CUTANEOUS MASTOCYTOSIS	0.15625	2.386860268383396
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1; PFBMFT1	0.15625	2.386860268383396
KBG SYNDROME	0.155978534	2.382713379361847
PARAGANGLIOMAS 7; PGL7	0.15555560000000002	2.3762526794530574
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.15508275999999996	2.3690296201935213
OROFACIODIGITAL SYNDROME I; OFD1	0.1544129	2.358796901989494
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.15402438999999998	2.352862059859128
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.15294284999999996	2.336340556789257
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.15294284999999996	2.336340556789257
MOSAIC TRISOMY 1	0.15280083	2.334171072659236
DESMOID DISEASE, HEREDITARY	0.1527778	2.3338192685505583
LEUKEMIA, ACUTE MYELOCYTIC, WITH POLYPOSIS COLI AND COLON CANCER	0.1524338	2.328564356983686
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.15233366999999998	2.3270347805441767
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.15233366999999998	2.3270347805441767
AXIN2-RELATED ATTENUATED FAMILIAL ADENOMATOUS POLYPOSIS	0.1523199	2.326824431322445
SMITH-MAGENIS SYNDROME; SMS	0.15090209400000001	2.305166160540521
9Q31.1Q31.3 MICRODELETION SYNDROME	0.15059994	2.300550484524309
RING CHROMOSOME 13 SYNDROME	0.15019668	2.294390322784608
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.149812814	2.288526421960395
HYDRANENCEPHALY	0.14969186399999998	2.286678801163845
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.14926725999999998	2.2801925904925064
HYDROCEPHALUS, TALL STATURE, JOINT LAXITY, AND KYPHOSCOLIOSIS	0.14820459	2.2639593437635273
CARCINOMA OF ESOPHAGUS	0.14806533	2.2618320211332867
PYODERMA GANGRENOSUM	0.1477273	2.2566683067235487
IMMUNODEFICIENCY 21; IMD21	0.1477273	2.2566683067235487
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.14719892999999998	2.248596976419511
FREE SIALIC ACID STORAGE DISEASE	0.147092594	2.246972597709119
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.14699916999999998	2.2455454614933528
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.14647624999999997	2.2375573848754775
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.14588485999999998	2.228523366993114
STEINERT MYOTONIC DYSTROPHY	0.14588485999999998	2.228523366993114
ULBRIGHT-HODES SYNDROME	0.1458333	2.227735741294312
C SYNDROME	0.14529977399999996	2.2195856484203946
MONOSOMY 13Q14	0.14529141999999998	2.2194580335040297
DISTAL TRISOMY 14Q	0.14502633999999998	2.215408696416394
NON-ACQUIRED COMBINED PITUITARY HORMONE DEFICIENCY-SENSORINEURAL HEARING LOSS-SPINE ABNORMALITIES SYNDROME	0.14501264999999997	2.2151995692671194
SARCOSINEMIA	0.14464788399999998	2.2096274382421135
AUTOIMMUNE HYPOPARATHYROIDISM	0.14463953	2.2094998233257486
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.14410232999999997	2.201293606774225
ANAUXETIC DYSPLASIA 2; ANXD2	0.14350888999999997	2.1922282732851404
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.14350888999999997	2.1922282732851404
ATELOSTEOGENESIS TYPE III	0.143402554	2.190603894574748
DYSSPONDYLOENCHONDROMATOSIS	0.14303648000000002	2.185011782665064
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.14285699999999998	2.1822700631068592
L-2-HYDROXYGLUTARIC ACIDURIA	0.14285699999999998	2.1822700631068592
CHROMOSOME 13Q14 DELETION SYNDROME	0.14285699999999998	2.1822700631068592
SPASTIC TETRAPLEGIA-RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY SYNDROME	0.14285699999999998	2.1822700631068592
PERINEURAL CYST	0.14285699999999998	2.1822700631068592
ARNOLD-CHIARI MALFORMATION TYPE I	0.14285699999999998	2.1822700631068592
NEUROBLASTOMA	0.14285699999999998	2.1822700631068592
FAMILIAL MULTIPLE NEVI FLAMMEI	0.14285699999999998	2.1822700631068592
JOUBERT SYNDROME 5	0.14285699999999998	2.1822700631068592
GASTROESOPHAGEAL REFLUX	0.14285699999999998	2.1822700631068592
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.14285699999999998	2.1822700631068592
ODONTOMATOSIS-AORTAE ESOPHAGUS STENOSIS SYNDROME	0.14285699999999998	2.1822700631068592
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 46	0.14285699999999998	2.1822700631068592
MUNGAN SYNDROME	0.14285699999999998	2.1822700631068592
ODONTOMA-DYSPHAGIA SYNDROME	0.14285699999999998	2.1822700631068592
%613065 LEUKEMIA, ACUTE LYMPHOBLASTIC; ALLLEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 1, INCLUDED;;ALL1, INCLUDED;;LEUKEMIA, ACUTE LYMPHOCYTIC, SUSCEPTIBILITY TO, 1, INCLUDED;;LEUKEMIA, B-CELL ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, INCLUDED;;LEUKEMIA, T-CELL ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, INCLUDED;;LEUKEMIA, ACUTE LYMPHOBLASTIC, B-HYPERDIPLOID, SUSCEPTIBILITY TO,INCLUDED	0.14285699999999998	2.1822700631068592
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 3	0.14285699999999998	2.1822700631068592
BLADDER CANCER	0.14285699999999998	2.1822700631068592
DEAFNESS, AUTOSOMAL RECESSIVE, 24	0.14285699999999998	2.1822700631068592
FAMILIAL ALZHEIMER-LIKE PRION DISEASE	0.14285699999999998	2.1822700631068592
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.14285699999999998	2.1822700631068592
DEAFNESS, AUTOSOMAL RECESSIVE 48	0.14285699999999998	2.1822700631068592
GLIOBLASTOMA	0.14285699999999998	2.1822700631068592
%603964 DEAFNESS, AUTOSOMAL DOMINANT 16; DFNA16	0.14285699999999998	2.1822700631068592
ALSTROM SYNDROME; ALMS	0.14280520400000002	2.181478832294308
ROTHMUND-THOMSON SYNDROME TYPE 2	0.14256844	2.177862047752973
PSEUDOACHONDROPLASIA	0.14239046000000002	2.1751432420533456
KAPOSI SARCOMA	0.14153073000000002	2.162010087630707
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.14066847	2.148838285166603
OSTEOMA OF MIDDLE EAR	0.14052279999999998	2.146613043980712
NEPHROBLASTOMA	0.14005683	2.139494930193457
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.13977016000000003	2.1351157863013777
XQ12-Q13.3 DUPLICATION SYNDROME	0.13972120000000002	2.134367877957441
OROFACIODIGITAL SYNDROME VI	0.139526394	2.1313920398682074
COLORECTAL CANCER, SUSCEPTIBILITY TO, 12; CRCS12	0.13942310000000002	2.1298141304630085
DISTAL 17P13.1 MICRODELETION SYNDROME	0.13906931	2.1244096677791595
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.138572054	2.1168136320056217
RING CHROMOSOME 12 SYNDROME	0.13809891400000002	2.1095859899743714
METACHONDROMATOSIS	0.13703700000000002	2.093364291830115
RING CHROMOSOME 22 SYNDROME	0.136998024	2.0927688981288632
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.136236	2.0811282913502738
COSTELLO SYNDROME	0.13568289	2.0726790351387825
MYXOPAPILLARY EPENDYMOMA	0.13526606	2.066311579358493
CHARGE SYNDROME	0.13303366	2.032209647434403
TRISOMY 8P	0.1330228	2.032043751098309
PROTEUS-LIKE SYNDROME	0.13198723	2.0162244814142785
DEAFNESS, AUTOSOMAL DOMINANT 39, WITH DENTINOGENESIS IMPERFECTA 1	0.1319443	2.015568686781819
GAUCHER DISEASE, TYPE I	0.1319443	2.015568686781819
MACULOPAPULAR CUTANEOUS MASTOCYTOSIS	0.13113497	2.0032054380073503
SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS	0.13113497	2.0032054380073503
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.13050625999999999	1.9936013233236043
RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD	0.13045630000000003	1.9928381390739511
HADDAD SYNDROME	0.12967219000000002	1.9808601486416815
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.129585454	1.9795351776833547
BLACKFAN-DIAMOND ANEMIA	0.12911339	1.9723239725266561
MELANOMA-ASTROCYTOMA SYNDROME	0.1287878	1.9673502903840456
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.12866691	1.9655035861418382
CHOROIDAL OSTEOMA, BILATERAL	0.1277777	1.9519200980186433
MICROPHTHALMIA, SYNDROMIC 3	0.12770120399999998	1.9507515523348655
LISSENCEPHALY, X-LINKED, 2	0.12645501000000003	1.9317148102849606
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.12511583	1.9112576228659928
CENTRAL PRECOCIOUS PUBERTY	0.125	1.9094882147067167
MASTOCYTOSIS, CUTANEOUS; MASTC	0.125	1.9094882147067167
CUTANEOUS MASTOCYTOMA	0.125	1.9094882147067167
CONGENITAL FACTOR XIII DEFICIENCY	0.125	1.9094882147067167
RENAL AGENESIS	0.125	1.9094882147067167
SAPHO SYNDROME	0.125	1.9094882147067167
BULLOUS DIFFUSE CUTANEOUS MASTOCYTOSIS	0.125	1.9094882147067167
THYROID CARCINOMA, FAMILIAL MEDULLARY	0.125	1.9094882147067167
PSEUDOXANTHOMATOUS DIFFUSE CUTANEOUS MASTOCYTOSIS	0.125	1.9094882147067167
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.125	1.9094882147067167
CHROMOSOME 14Q32 DUPLICATION SYNDROME, 700-KB	0.125	1.9094882147067167
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.12397756000000001	1.893869517664759
ISOLATED PUNCTATE PALMOPLANTAR KERATODERMA	0.12359660000000001	1.8880500086225616
TUFTED ANGIOMA	0.12305788000000001	1.8798205726943473
MARDEN-WALKER SYNDROME	0.12289959	1.8774025495782998
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.12225332400000001	1.8675302510937746
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.1217391	1.8596750137520195
PETTIGREW SYNDROME	0.121719014	1.859368181909775
STURGE-WEBER SYNDROME	0.12161563	1.857788897673061
ARIMA SYNDROME	0.12137885400000001	1.8541719298208577
OPTIC PATHWAY GLIOMA	0.12056758399999999	1.8417790457892966
CATARACT, CONGENITAL OR JUVENILECATARACT, JUVENILE, HUTTERITE TYPE, INCLUDED	0.12054495999999999	1.8414334436983406
CATARACT, POSTERIOR POLAR, 1 CTPA CATARACT, CONGENITAL TOTAL, INCLUDED	0.12054495999999999	1.8414334436983406
NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA	0.12050763	1.8408631941379008
X-LINKED ACROGIGANTISM	0.12020027	1.8361679917565223
DIAMOND-BLACKFAN ANEMIA 1	0.11962918	1.8274440747602279
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.11892522999999999	1.816690600930285
OROFACIODIGITAL SYNDROME TYPE 3	0.1188618	1.8157216502306146
COG8-CDG	0.11851840999999999	1.8104760569662295
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS;;BURTON SYNDROME	0.11722736999999998	1.7907542516485095
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.11667495	1.7823155358119636
SYSTEMIC CAPILLARY LEAK SYNDROME	0.11631932999999998	1.7768831182206513
PRIMROSE SYNDROME; PRIMS	0.1162477	1.7757889050940958
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.116170794	1.774614096288974
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.11599848399999999	1.7719819049747647
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.11599848399999999	1.7719819049747647
CHROMOSOME 16P13.3 DELETION SYNDROME	0.11584122400000002	1.7695796160416073
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.11476063999999998	1.7530727167376015
NF1-MICRODELETION SYNDROME	0.11464456999999999	1.7512996423609535
DEMENTIA, FAMILIAL DANISH	0.11262844999999999	1.7205015833254775
DEAFNESS, X-LINKED 4	0.11261476	1.7202924561762027
AUTOSOMAL DOMINANT PRIMARY MICROCEPHALY	0.11176288999999999	1.7072793703725049
MICROCEPHALY, AUTOSOMAL DOMINANT	0.11176288999999999	1.7072793703725049
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.11176288999999999	1.7072793703725049
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.1117424	1.7069663670643505
W SYNDROME	0.11165655399999999	1.7056549916621127
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.11165655399999999	1.7056549916621127
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.11165655399999999	1.7056549916621127
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.111581364	1.7045063963112024
UNCOMBABLE HAIR SYNDROME 2	0.11111099999999999	1.6973211601942237
311450 PALLISTER W SYNDROME;;W SYNDROME	0.11111099999999999	1.6973211601942237
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 17	0.11111099999999999	1.6973211601942237
ANTERIOR SEGMENT DYSGENESIS 1; ASGD1	0.11111099999999999	1.6973211601942237
OSTEOMAS OF MANDIBLE	0.11111099999999999	1.6973211601942237
MYELOMA, MULTIPLE	0.11111099999999999	1.6973211601942237
SPONDYLOCOSTAL DYSOSTOSIS 6, AUTOSOMAL RECESSIVE; SCDO6	0.11111099999999999	1.6973211601942237
TRICHO-RETINO-DENTO-DIGITAL SYNDROME	0.11111099999999999	1.6973211601942237
ANDROGEN INSENSITIVITY SYNDROME	0.11111099999999999	1.6973211601942237
191482 UNCOMBABLE HAIR, RETINAL PIGMENTARY DYSTROPHY, DENTAL ANOMALIES, ANDBRACHYDACTYLY;;BORK SYNDROME	0.11111099999999999	1.6973211601942237
RETINITIS PIGMENTOSA 74; RP74	0.11111099999999999	1.6973211601942237
FOVEAL HYPOPLASIA 2; FVH2	0.11111099999999999	1.6973211601942237
CONGENITAL MACROGLOSSIA	0.11111099999999999	1.6973211601942237
SUBCORNEAL PUSTULAR DERMATOSIS	0.11111099999999999	1.6973211601942237
WAGR 11P13 DELETION SYNDROME	0.11111099999999999	1.6973211601942237
ATELOSTEOGENESIS, TYPE II	0.11111099999999999	1.6973211601942237
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 7	0.11111099999999999	1.6973211601942237
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.11052036000000001	1.6882985992411492
POEMS SYNDROME	0.11028073000000001	1.6846380339540274
BLUE RUBBER BLEB NEVUS	0.110119	1.6821674617223115
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.11002494000000002	1.6807306100305093
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.10931498	1.6698853280072035
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.10851126	1.6576077770638107
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.10841774000000001	1.656179174361096
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.10840336	1.6559595068368762
15Q OVERGROWTH SYNDROME	0.10766500000000001	1.6446803890911892
TURNPENNY-FRY SYNDROME; TPFS	0.106798634	1.6314458637582085
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.10648395000000002	1.6266387806433544
IDIOPATHIC ANTERIOR UVEITIS	0.1055556	1.6124573935703705
NEPHRONOPHTHISIS 11; NPHP11	0.10544052400000001	1.6106995034440057
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.10542907000000001	1.6105245332199158
PITT-HOPKINS SYNDROME	0.10532445400000001	1.6089264290673577
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.1045032	1.5963810303931119
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 3	0.10389831000000001	1.58714078778356
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.10366646000000002	1.5835990690429222
NEPHRONOPHTHISIS 1	0.10364964	1.5833421283087512
NEPHRONOPHTHISIS 4	0.10364964	1.5833421283087512
CERNUNNOS-XLF DEFICIENCY	0.10364964	1.5833421283087512
PHEOCHROMOCYTOMA	0.10339536	1.579457771002866
DEXTROCARDIA	0.10317715400000001	1.57612447671984
KNOBLOCH SYNDROME	0.10302786	1.5738438756516284
GLYCOGEN STORAGE DISEASE IC; GSD1C	0.10267860000000001	1.5685086128206807
PENDRED SYNDROME	0.10267860000000001	1.5685086128206807
SAY SYNDROME	0.10267209000000001	1.5684091666744586
MALT LYMPHOMA	0.10225240000000001	1.5619980218038167
MALAN OVERGROWTH SYNDROME	0.10197789000000002	1.5578046329252637
CRANIOACROFACIAL SYNDROME	0.1018981	1.556585768408052
MELAS	0.10188405	1.5563711419327189
RUIJS-AALFS SYNDROME; RJALS	0.1015533	1.551318636116605
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.10150376000000001	1.5505618677473525
305350 EPIDERMODYSPLASIA VERRUCIFORMIS, X-LINKED; EDVX; EDV2	0.1010101	1.5430207641307754
FRYNS MICROPHTHALMIA SYNDROME	0.10093160000000001	1.5418216055319396
OCULOCUTANEOUS ALBINISM TYPE 4	0.10081233	1.539999648256995
OCULOCUTANEOUS ALBINISM	0.10081233	1.539999648256995
OCULOCUTANEOUS ALBINISM TYPE 2	0.10081233	1.539999648256995
OCULOCUTANEOUS ALBINISM TYPE 1B	0.10081233	1.539999648256995
PSEUDOPROGERIA SYNDROME	0.10065189000000001	1.5375487819436546
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.10043867000000001	1.5342916533265365
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.10043773400000003	1.5342773550787852
PAGET DISEASE OF BONE 2, EARLY-ONSET; PDB2	0.1	1.5275905717653735
CLEFT PALATE-STAPES FIXATION-OLIGODONTIA SYNDROME	0.1	1.5275905717653735
DEAFNESS, PROGRESSIVE, WITH STAPES FIXATION	0.1	1.5275905717653735
GRANULOMATOUS SLACK SKIN	0.1	1.5275905717653735
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA	0.1	1.5275905717653735
POTOCKI-SHAFFER SYNDROME	0.1	1.5275905717653735
EXOSTOSES-ANETODERMIA-BRACHYDACTYLY TYPE E SYNDROME	0.1	1.5275905717653735
LERI-WEILL DYSCHONDROSTEOSIS	0.1	1.5275905717653735
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.1	1.5275905717653735
GENOCHONDROMATOSIS TYPE 1	0.1	1.5275905717653735
MULTIPLE EXOSTOSES WITH SPASTIC TETRAPARESIS	0.1	1.5275905717653735
MEDULLARY CYSTIC KIDNEY DISEASE 1; MCKD1	0.1	1.5275905717653735
CLEFT PALATE, DEAFNESS, AND OLIGODONTIA	0.1	1.5275905717653735
SENIOR-LOKEN SYNDROME 3	0.1	1.5275905717653735
MADELUNG DEFORMITY	0.1	1.5275905717653735
EXOSTOSES WITH ANETODERMIA AND BRACHYDACTYLY, TYPE E	0.1	1.5275905717653735
PARAGANGLIOMAS 6	0.1	1.5275905717653735
UPINGTON DISEASE	0.1	1.5275905717653735
EXOSTOSES, MULTIPLE, TYPE III	0.1	1.5275905717653735
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E	0.09956699999999999	1.520976104589629
COMBINED IMMUNODEFICIENCY DUE TO ZAP70 DEFICIENCY	0.09920630000000001	1.5154660853972717
LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2	0.09920630000000001	1.5154660853972717
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO GAMMA CHAIN DEFICIENCY	0.09920630000000001	1.5154660853972717
TOWNES-BROCKS SYNDROME 1; TBS1	0.09908121400000001	1.5135552834546733
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.09905811400000002	1.5132024100325956
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.09842603000000001	1.503546754442958
OROFACIODIGITAL SYNDROME TYPE 4	0.09810512400000002	1.4986446246427287
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.09748805	1.4892182603979132
ALKAPTONURIA	0.09737915999999999	1.4875548670243175
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.09729471400000002	1.4862648778900849
SHORT STATURE-VALVULAR HEART DISEASE-CHARACTERISTIC FACIES SYNDROME	0.09728500000000001	1.4861164877419435
SYNDROMIC DIARRHEA	0.097149384	1.4840448305121383
WERNER SYNDROME; WRN	0.09697222000000001	1.481338489951576
BRANCHIOOCULOFACIAL SYNDROME	0.09653540000000001	1.4746656688159903
CLASSICAL EHLERS-DANLOS SYNDROME	0.0964775	1.4737811938749381
2Q24 MICRODELETION SYNDROME	0.09617288000000002	1.4691278474752265
MANTLE CELL LYMPHOMA	0.09611743	1.4682807985031827
THROMBOCYTHEMIA, ESSENTIAL	0.09579100000000002	1.463294284599769
MONOSOMY X	0.09550853000000001	1.4589792995117032
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.09550853000000001	1.4589792995117032
TURNER SYNDROME	0.09550853000000001	1.4589792995117032
MOSAIC MONOSOMY X	0.09550853000000001	1.4589792995117032
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.09534759000000001	1.456520795245504
HOLOPROSENCEPHALY	0.095144694	1.453421375079015
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.09459914000000001	1.4450875436111261
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.09458885000000002	1.4449303545412917
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.09455874	1.444470397020133
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.09444267	1.4426973226434847
DUANE-RADIAL RAY SYNDROME; DRRS	0.09427518000000003	1.4401387611948353
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.09416450000000001	1.4384480239500053
DISORDER OF SEX DEVELOPMENT-INTELLECTUAL DISABILITY SYNDROME	0.09387646000000001	1.4340479520670921
THYMOMA, FAMILIAL	0.0935898	1.4296689609340694
MYASTHENIA, LIMB-GIRDLE, AUTOIMMUNE	0.0935898	1.4296689609340694
VERRUCOUS HEMANGIOMA	0.0931677	1.4232210011306479
LYMPHATIC MALFORMATION 1	0.0931677	1.4232210011306479
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.09296447999999999	1.420116631570706
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.09269998400000001	1.41607621561201
GITELMAN SYNDROME	0.09221547000000001	1.4086748254291264
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.09210654400000001	1.4070108821229252
DUANE RETRACTION SYNDROME 1	0.09180788000000001	1.4024485190176679
STUVE-WIEDEMANN SYNDROME	0.09156099000000001	1.3986770506550366
MENTAL RETARDATION, X-LINKED 2	0.09156099000000001	1.3986770506550366
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.09156099000000001	1.3986770506550366
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.09145465400000001	1.397052671944644
BETA-THALASSEMIA MAJOR	0.09124328	1.3938237426494804
BALLER-GEROLD SYNDROME	0.09119176000000001	1.3930367279869071
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.0909091	1.3887188404767552
PENILE AGENESIS	0.0909091	1.3887188404767552
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.0909091	1.3887188404767552
B-CELL CLL/LYMPHOMA 2	0.0909091	1.3887188404767552
RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2	0.0909091	1.3887188404767552
PRIMARY EFFUSION LYMPHOMA	0.0909091	1.3887188404767552
GIANT AXONAL NEUROPATHY	0.0909091	1.3887188404767552
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.0909091	1.3887188404767552
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.0909091	1.3887188404767552
RENAL DYSPLASIA, DIFFUSE CYSTIC	0.0909091	1.3887188404767552
TRICHODERMODYSPLASIA-DENTAL ALTERATIONS SYNDROME	0.0909091	1.3887188404767552
NEVUS, KERATINOCYTIC, NONEPIDERMOLYTIC	0.0909091	1.3887188404767552
GOITER, MULTINODULAR 1	0.0909091	1.3887188404767552
DEAFNESS, AUTOSOMAL RECESSIVE 28	0.0909091	1.3887188404767552
PATENT DUCTUS ARTERIOSUS-BICUSPID AORTIC VALVE-HAND ANOMALIES SYNDROME	0.0909091	1.3887188404767552
LEUKONYCHIA TOTALIS	0.0909091	1.3887188404767552
YEMENITE DEAF-BLIND HYPOPIGMENTATION SYNDROME	0.0909091	1.3887188404767552
POLYPOSIS OF GASTRIC FUNDUS WITHOUT POLYPOSIS COLI	0.0909091	1.3887188404767552
ADRENOCORTICAL CARCINOMA, HEREDITARY; ADCC	0.0909091	1.3887188404767552
208080 ARTHROGRYPOSIS, DISTAL, WITH HYPOPITUITARISM, MENTAL RETARDATION,AND FACIAL ANOMALIES	0.0909091	1.3887188404767552
POLYPOSIS, GASTRIC	0.0909091	1.3887188404767552
BOHRING-OPITZ SYNDROME	0.09080120400000002	1.3870706313534436
22Q11.2 DELETION SYNDROME	0.090697504	1.3854865199305222
MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS	0.09037555000000001	1.3805683809811011
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.09023715400000001	1.3784542567334006
CAMPOMELIC DYSPLASIA	0.09019834000000002	1.3778613377288755
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.09018677	1.377684595499722
MELNICK-NEEDLES SYNDROME	0.08992622000000002	1.3737044582649878
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.08991225000000001	1.3734910538621121
NON-HISTAMINIC ANGIOEDEMA	0.08946827000000002	1.3667088572415882
NATIVE AMERICAN MYOPATHY	0.08883956000000001	1.357104742557842
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.08878462	1.356265484297714
LIPOSARCOMA	0.0883703	1.3499363710407757
ADDISON DISEASE	0.08826640000000001	1.3483492044367116
LICHEN SCLEROSUS ET ATROPHICUS; LSA	0.088141	1.3464336058597177
PALMOPLANTAR CARCINOMA, MULTIPLE SELF-HEALING; MSPC	0.088141	1.3464336058597177
CHEILITIS GLANDULARIS	0.088141	1.3464336058597177
RECOMBINANT 8 SYNDROME	0.087913504	1.3429583984125744
3C SYNDROME	0.08749810400000002	1.3366127871774613
LARYNGOTRACHEAL ANGIOMA	0.08734936000000001	1.3343405878573946
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.08733214	1.3340775367609363
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.08722847000000002	1.3324938836151874
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.08716514400000003	1.3315265216097114
DISTAL 16P11.2 MICRODELETION SYNDROME	0.08684621400000002	1.32665457699918
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.08663575999999999	1.3234397015372763
PHELAN-MCDERMID SYNDROME	0.08626283400000001	1.317742919121615
DDOST-CDG	0.08604957	1.3144851183646453
KAGAMI-OGATA SYNDROME	0.08572510400000001	1.309528606340061
WARSAW BREAKAGE SYNDROME; WABS	0.08539630400000002	1.3045058885400966
8Q12 MICRODUPLICATION SYNDROME	0.08538261400000002	1.304296761390822
CONGENITAL ENTEROVIRUS INFECTION	0.08532646	1.3034389581811527
TRISOMY 13	0.08518086000000001	1.3012147863086623
VACTERL/VATER ASSOCIATION	0.08460196	1.2923715644887126
LOEYS-DIETZ SYNDROME 5	0.08423979000000001	1.28683908971495
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.08398519000000002	1.2829498441192353
THANATOPHORIC DYSPLASIA, TYPE I	0.08387885400000002	1.2813254654088428
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.08387885400000002	1.2813254654088428
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.08387885400000002	1.2813254654088428
BLOOM SYNDROME	0.083753	1.279402931570653
OCULOSKELETODENTAL SYNDROME; OCSKD	0.08346022400000001	1.2749305129982615
THANATOPHORIC DYSPLASIA, TYPE II	0.08333330000000001	1.2729916339409542
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.08333330000000001	1.2729916339409542
SILLENCE SYNDROME	0.08333330000000001	1.2729916339409542
LYMPHOPROLIFERATIVE SYNDROME 3; LPFS3	0.08333330000000001	1.2729916339409542
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.08333330000000001	1.2729916339409542
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2	0.08333330000000001	1.2729916339409542
LARON SYNDROME	0.08333330000000001	1.2729916339409542
ECTODERMAL DYSPLASIA 14, HAIR/TOOTH TYPE WITH OR WITHOUT HYPOHIDROSIS; ECTD14	0.08333330000000001	1.2729916339409542
ENDOMETRIAL CANCER	0.08333330000000001	1.2729916339409542
IMMUNOERYTHROMYELOID HYPOPLASIA	0.08333330000000001	1.2729916339409542
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.0833333	1.2729916339409537
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.0833333	1.2729916339409537
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.08283597	1.265394467750393
HAMARTOMA, PRECALCANEAL CONGENITAL FIBROLIPOMATOUS	0.08253970000000001	1.260868675163424
CAP POLYPOSIS	0.08213143	1.2546319811360773
THYMIC EPITHELIAL NEOPLASM	0.08213143	1.2546319811360773
CARDIOFACIOCUTANEOUS SYNDROME	0.08190483400000001	1.2511705220040799
ZIMMERMANN-LABAND SYNDROME 1	0.08183355	1.2500815943409027
FRASIER SYNDROME	0.0815508	1.2457623319992361
EPIDERMODYSPLASIA VERRUCIFORMIS	0.08119660000000001	1.2403516061940432
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.08086963400000002	1.235356904405165
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.08077268400000001	1.2338759053458384
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.08062	1.231543518957244
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.08057274	1.2308215796530277
PACHYDERMOPERIOSTOSIS	0.08023807	1.2257091922865004
PIERPONT SYNDROME	0.080081134	1.2233118527467948
BECKER NEVUS SYNDROME	0.07986044	1.219940552010343
XERODERMA PIGMENTOSUM VARIANT	0.0797535	1.218306946652897
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.07968588000000001	1.2172739899082696
CHANARIN-DORFMAN SYNDROME	0.07967219	1.2170648627589946
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.07936510000000001	1.2123737848721605
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.07870563000000001	1.2022997833285394
MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF	0.0786003	1.2006907721792988
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA	0.0784615	1.1985704764656884
3Q13 MICRODELETION SYNDROME	0.0784615	1.1985704764656884
GYRATE ATROPHY OF CHOROID AND RETINA	0.07844055000000001	1.1982504462409038
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.078334824	1.1966353858329988
PETERS ANOMALY	0.07816843000000001	1.1940935667770158
POLYCYTHEMIA VERA	0.07793563	1.190537335925946
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.07778673000000001	1.1882627535645873
FIBROMATOSIS, GINGIVAL, 5; GINGF5	0.07777780000000001	1.1881263397265287
248100 MACROSOMIA ADIPOSA CONGENITA	0.0776914	1.1868065014725233
HERMANSKY-PUDLAK SYNDROME	0.07750019	1.1838855955402505
17Q23.1Q23.2 MICRODELETION SYNDROME	0.07733947	1.1814304519733092
MYELOFIBROSISMYELOFIBROSIS WITH MYELOID METAPLASIA, INCLUDED	0.07692310000000001	1.17507002310965
MYELOPROLIFERATIVE DISEASE, AUTOSOMAL RECESSIVE	0.07692310000000001	1.17507002310965
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 4	0.07692310000000001	1.17507002310965
GOOD SYNDROME	0.07692310000000001	1.17507002310965
MYASTHENIA GRAVIS; MG	0.07692310000000001	1.17507002310965
RETINITIS PIGMENTOSA 83; RP83	0.07692310000000001	1.17507002310965
ENAMEL HYPOPLASIA, CATARACTS, AND AQUEDUCTAL STENOSIS	0.07692310000000001	1.17507002310965
ETHYLMALONIC ENCEPHALOPATHY	0.07692310000000001	1.17507002310965
CHRONIC MYELOID LEUKEMIA	0.07692310000000001	1.17507002310965
EXUDATIVE VITREORETINOPATHY 4	0.07692310000000001	1.17507002310965
MEDULLOBLASTOMA	0.07692310000000001	1.17507002310965
JUVENILE XANTHOGRANULOMA	0.07692310000000001	1.17507002310965
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 3	0.07692310000000001	1.17507002310965
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.07692310000000001	1.17507002310965
GLIOMA SUSCEPTIBILITY 9; GLM9	0.07670450000000001	1.171730710119771
RAMOS-ARROYO SYNDROME	0.07638890000000001	1.1669096342752794
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.07578561	1.157693833114876
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.075720654	1.15670157138308
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.07571430000000001	1.1566045082781502
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.07566015000000001	1.155777317983539
LINEAR VERRUCOUS NEVUS SYNDROME	0.07550936	1.153473864160374
%165660 OSLAM SYNDROME;;OSTEOSARCOMA, LIMB ANOMALIES, AND MACROCYTOSIS;;OSTEOSARCOMA, LIMB ANOMALIES, AND ERYTHROID MACROCYTOSIS WITH MEGALOBLASTICMARROW	0.07549020000000001	1.153181177806824
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.07534064	1.1508965133476914
AURICULOCONDYLAR SYNDROME	0.075139964	1.1478310056918957
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE, LEROY-SPRANGERTYPE	0.07487628	1.1438029937686418
1P36 DELETION SYNDROME	0.074786794	1.142436014069592
CAMPOMELIA, CUMMING TYPE	0.07444227	1.1371730979281232
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.07440685000000001	1.1366320253476039
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.07399663000000001	1.1303655433041078
OROFACIODIGITAL SYNDROME VIII; OFD8	0.07387137400000002	1.1284521444575375
OROFACIODIGITAL SYNDROME IX; OFD9	0.07387137400000002	1.1284521444575375
NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO; NTD	0.0737813	1.1270761825259252
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.07356858999999999	1.1238268446207231
FIBROMATOSIS, GINGIVAL, WITH PROGRESSIVE DEAFNESS	0.07325580000000001	1.1190486940712985
NEVUS COMEDONICUS SYNDROME	0.07321113000000001	1.118366319362891
PENDRED SYNDROME	0.07293236000000002	1.1141078551259807
ESSENTIAL THROMBOCYTHEMIA	0.0727273	1.1109753778995182
STORAGE POOL PLATELET DISEASE	0.0727273	1.1109753778995182
ALPHA-THALASSEMIA-MYELODYSPLASTIC SYNDROME	0.0727273	1.1109753778995182
OROFACIODIGITAL SYNDROME TYPE 2	0.072718514	1.1108411637918831
GRANT SYNDROME	0.0724646	1.1069623974674907
DISTAL TRISOMY 17Q	0.072297834	1.1044148957745805
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.07208049000000001	1.1010947693222828
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.0719787	1.0995398348792829
SCIMITAR SYNDROME	0.0715198	1.0925297217454513
LIP, HAMARTOMATOUS	0.07142860000000001	1.0911365591440016
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 3	0.07142860000000001	1.0911365591440016
BASALOID FOLLICULAR HAMARTOMA SYNDROME, GENERALIZED, AUTOSOMAL DOMINANT; GBFHS	0.07142860000000001	1.0911365591440016
CONGENITAL PANFOLLICULAR NEVUS	0.07142860000000001	1.0911365591440016
49,XYYYY SYNDROME	0.07130093	1.0891862842610285
SLC35A2-CDG	0.07121794400000002	1.0879185979491437
SPONDYLO-OCULAR SYNDROME	0.07119433	1.0875578727115267
OROFACIODIGITAL SYNDROME TYPE 14	0.070902294	1.083096758309366
OROFACIODIGITAL SYNDROME XIV; OFD14	0.070902294	1.083096758309366
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.07078791400000001	1.0813495002133808
NON-DISTAL MONOSOMY 20Q	0.07053282999999999	1.0774528610792986
DEAFNESS, AUTOSOMAL DOMINANT 50	0.07021406	1.072583360613682
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	0.07019710000000001	1.0723242812527112
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.0694118	1.0603281124926374
PYRUVATE DEHYDROGENASE DEFICIENCY	0.06940346400000001	1.0602007725425753
SHWACHMAN-DIAMOND SYNDROME	0.069389224	1.0599832436451557
OCULOCUTANEOUS ALBINISM TYPE 1A	0.069264	1.0580703336275683
CHROMOSOME 2Q37 DELETION SYNDROME	0.06883262400000001	1.0514806745227097
DEAFNESS, AUTOSOMAL RECESSIVE 30; DFNB30	0.0687103	1.0496120646317033
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.0686937	1.0493584845967903
VELOCARDIOFACIAL SYNDROME	0.06852519	1.0467843417243086
ZELLWEGER SYNDROME	0.06833339000000001	1.0438544230076625
RAMON SYNDROME	0.0682946	1.0432618706248746
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.06800167	1.0387870995630024
ALEXANDER DISEASE	0.06792583	1.0376285748733756
ASPARTYLGLUCOSAMINURIA	0.06782155000000001	1.0360356034251388
PELIZAEUS-MERZBACHER DISEASE	0.06742896000000001	1.030038435599445
PERLMAN SYNDROME	0.067352104	1.0288643905896087
OROFACIODIGITAL SYNDROME IV; OFD4	0.06731859	1.0283524338853873
DISTAL MONOSOMY 7Q36	0.06729967	1.0280634137492095
OROFACIODIGITAL SYNDROME XVI; OFD16	0.067212254	1.0267280551749949
CONGENITAL HEART DEFECTS, HAMARTOMAS OF TONGUE, AND POLYSYNDACTYLY	0.0666667	1.018394223707106
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.0666667	1.018394223707106
RARE HEREDITARY HEMOCHROMATOSIS	0.0666667	1.018394223707106
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.06636420000000001	1.013773262227516
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.06628780000000001	1.0126061830306872
SMITH-MAGENIS SYNDROME	0.066120644	1.0100527237345471
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1	0.0660569	1.0090789764004808
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2	0.0660569	1.0090789764004808
CARTILAGE-HAIR HYPOPLASIA	0.06553331	1.0010806649257746
SCLERODERMA	0.06547837000000001	1.0002414066656469
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.06540245	0.9990816599035625
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.06524512	0.996678301657004
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.06521202400000001	0.9961727302813725
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.06508901	0.994293580015421
HURLER SYNDROME	0.06507196400000001	0.994033186926558
GABRIELE-DE VRIES SYNDROME	0.065063	0.9938962537077048
CZECH DYSPLASIA, METATARSAL TYPE	0.065	0.9929338716474927
CATARACT, NUCLEAR TOTAL	0.06498956	0.9927743911918004
CATARACT 2, MULTIPLE TYPES; CTRCT2	0.06498956	0.9927743911918004
CATARACT 22, MULTIPLE TYPES; CTRCT22	0.06498956	0.9927743911918004
%115665 CATARACT, CONGENITAL, VOLKMANN TYPE; CCV	0.06498956	0.9927743911918004
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.06493442	0.9919320777505289
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.06480114000000001	0.9898961050364802
OSTEOGENESIS IMPERFECTA	0.06471369	0.9885602270814713
CRI-DU-CHAT SYNDROME	0.06468859	0.9881768018479582
ASPARTYLGLUCOSAMINURIA; AGU	0.06449095	0.985157671841921
TRISOMY 12P	0.064443094	0.984426628097897
KLEEFSTRA SYNDROME	0.06426157	0.9816536845884056
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.06417109	0.9802715206390722
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.06406486	0.978648761174686
X-LINKED ENDOTHELIAL CORNEAL DYSTROPHY	0.06403018	0.9781189927643978
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.063924744	0.9765083623691513
VASCULAR EHLERS-DANLOS SYNDROME	0.06379875400000001	0.9745837510077842
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.06349145	0.9698894040771263
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.063085334	0.9636856143506956
10Q22.3Q23.3 MICRODELETION SYNDROME	0.063045554	0.9630779388212471
MONOSOMY 7 OF BONE MARROW	0.0627273	0.9582163207229811
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	0.0627273	0.9582163207229811
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0626959	0.9577366572834466
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.06268889	0.9576295731843659
RECOMBINANT CHROMOSOME 8 SYNDROME	0.062513574	0.9549514624975698
DEAFNESS, AUTOSOMAL RECESSIVE 49	0.0625	0.9547441073533584
DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 39	0.0625	0.9547441073533584
ADAMS-OLIVER SYNDROME 5; AOS5	0.0625	0.9547441073533584
DEAFNESS, AUTOSOMAL RECESSIVE 44	0.0625	0.9547441073533584
POLYPS, MULTIPLE AND RECURRENT INFLAMMATORY FIBROID, GASTROINTESTINAL	0.0625	0.9547441073533584
DEAFNESS, AUTOSOMAL RECESSIVE 71	0.0625	0.9547441073533584
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.0625	0.9547441073533584
DEAFNESS, AUTOSOMAL RECESSIVE 62	0.0625	0.9547441073533584
DEAFNESS, AUTOSOMAL RECESSIVE 104; DFNB104	0.0625	0.9547441073533584
DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 38	0.0625	0.9547441073533584
DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 40	0.0625	0.9547441073533584
DEAFNESS, AUTOSOMAL RECESSIVE 45	0.0625	0.9547441073533584
X-LINKED CENTRONUCLEAR MYOPATHY	0.0625	0.9547441073533584
DEAFNESS, AUTOSOMAL RECESSIVE 83	0.0625	0.9547441073533584
HEMANGIOMAS OF SMALL INTESTINE	0.0625	0.9547441073533584
HUMERO-RADIO-ULNAR SYNOSTOSIS	0.0625	0.9547441073533584
DEAFNESS, AUTOSOMAL RECESSIVE 85	0.0625	0.9547441073533584
APERT SYNDROME	0.062259369999999994	0.9510682661605192
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.06220229000000001	0.9501963174621557
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.062192784	0.9500511047024037
POTOCKI-LUPSKI SYNDROME	0.061840004	0.9446620706833296
CRISPONI SYNDROME	0.06179086	0.9439113515727414
KYPHOMELIC DYSPLASIA	0.06170715	0.9426326055051165
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.06169183	0.9423985786295221
GLYCEROL KINASE DEFICIENCY; GKD	0.061526264000000004	0.9398694080234731
ACQUIRED GENERALIZED LIPODYSTROPHY	0.0613275	0.9368331078994093
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.0612766	0.9360555642983808
104600 AMENORRHEA-GALACTORRHEA SYNDROME	0.0612766	0.9360555642983808
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.061138484	0.9339457173042813
KYRLE DISEASE	0.0611111	0.9335274019021091
FETAL ALCOHOL SYNDROME	0.061050773999999995	0.9326058676137857
THAUVIN-ROBINET-FAIVRE SYNDROME	0.060966893999999994	0.931324524642189
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.060915994	0.9305469810411604
BAZEX-DUPRÉ-CHRISTOL SYNDROME	0.0608465	0.9294853972492177
MENTAL RETARDATION, X-LINKED 97; MRX97	0.060580730000000006	0.9254255197866372
PAGET DISEASE OF BONE 3; PDB3	0.060340950000000004	0.921762663113658
NOONAN SYNDROME 2; NS2	0.060225244	0.9199951491666911
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.06022145	0.9199371923803984
CHROMOSOME XQ26.3 DUPLICATION SYNDROME	0.06020027	0.9196136486972986
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.060068830000000004	0.9176057836497702
MYCETOMA	0.0597381	0.9125535833517705
PMM2-CDG	0.059674243999999994	0.9115781251162639
RING CHROMOSOME Y SYNDROME	0.05947539	0.9085404501606856
OSLAM SYNDROME	0.05947539	0.9085404501606856
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.05883489	0.8987562325485284
DYSKERATOSIS CONGENITA	0.058831923999999994	0.8987109242121698
46,XY SEX REVERSAL 1; SRXY1	0.0588235	0.8985822399824045
46,XY GONADAL DYSGENESIS-MOTOR AND SENSORY NEUROPATHY SYNDROME	0.0588235	0.8985822399824045
GONADOBLASTOMA	0.0588235	0.8985822399824045
46,XY SEX REVERSAL 7	0.0588235	0.8985822399824045
HYPOKALEMIC PERIODIC PARALYSIS	0.0588235	0.8985822399824045
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.05867694	0.896343403240425
GALACTORRHEA	0.0583136	0.8907930556569728
MATERNAL PHENYLKETONURIA	0.058112524	0.8877214376388897
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.057981130000000006	0.8857142752830245
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.05787022000000001	0.8840200245798796
SECKEL SYNDROME	0.05778789	0.882762359262145
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.057632609999999994	0.8803903166223077
CUTIS LAXA	0.057587824	0.8797061699088369
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.05695214	0.8699955210586159
ZIMMERMANN-LABAND SYNDROME	0.05693593	0.8697478986269328
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.056867193999999996	0.868697893971524
NOCARDIOSIS	0.05684339	0.868334266311821
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.056690500000000005	0.865998733086649
19P13.3 MICRODUPLICATION SYNDROME	0.056372774	0.8611451806666017
RAMON SYNDROME	0.056358130000000006	0.8609214803032724
IMMUNODEFICIENCY 58; IMD58	0.056207490000000006	0.8586203178659652
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.056101154	0.8569959391555726
HOLOPROSENCEPHALY 7	0.056101154	0.8569959391555726
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.056101154	0.8569959391555726
FABRY DISEASE	0.05608428000000001	0.856738173522493
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.05602236	0.8557922894404558
PAPILLON-LEFÈVRE SYNDROME	0.055944	0.8545952694684205
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.055691109999999995	0.8507321456714829
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.055652810000000004	0.8501470784824969
EPIDERMOLYTIC PALMOPLANTAR KERATODERMA	0.055555600000000004	0.8486621076876838
SCHEIE SYNDROME	0.055555600000000004	0.8486621076876838
ACROKERATOELASTOIDOSIS OF COSTA	0.055555600000000004	0.8486621076876838
RETINAL DYSTROPHY WITH OR WITHOUT MACULAR STAPHYLOMA; RDMS	0.055555600000000004	0.8486621076876838
LIPOID PROTEINOSIS	0.055555600000000004	0.8486621076876838
PHEOCHROMOCYTOMA--ISLET CELL TUMOR SYNDROME	0.055555600000000004	0.8486621076876838
SEVERE COMBINED IMMUNODEFICIENCY DUE TO DCLRE1C DEFICIENCY	0.055555600000000004	0.8486621076876838
CATARACT, AGE-RELATED NUCLEAR	0.055555600000000004	0.8486621076876838
WHIM SYNDROME	0.055555600000000004	0.8486621076876838
AUTOSOMAL AGAMMAGLOBULINEMIA	0.055555600000000004	0.8486621076876838
VIRAL HEMORRHAGIC FEVER	0.05527142	0.8443210008008409
MAST CELL SARCOMA	0.05520833	0.843357243909114
CUSHING DISEASE	0.05511409	0.8419176425542824
WOLF-HIRSCHHORN SYNDROME	0.055041794	0.8408132556745188
KID SYNDROME	0.05501756	0.8404430593753573
DISTAL MONOSOMY 10Q	0.054999904	0.8401733479840066
PEROXISOME BIOGENESIS DISORDER 14B	0.05488846	0.8384709399472082
FETAL HYDANTOIN SYNDROME	0.054823774	0.8374828027099561
KBG SYNDROME	0.054733204	0.8360992639291082
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.054712154	0.8357777061137516
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.054706010000000006	0.8356838509490224
LIPOMATOSIS, FAMILIAL BENIGN CERVICAL	0.0545894	0.8339025275832866
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.054574814	0.8336797132224891
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.054522853999999996	0.8328859771613996
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.05436567	0.830484849197076
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.0539773	0.8245521456935109
LEPRECHAUNISM	0.05394513000000001	0.8240607198065739
SECONDARY POLYCYTHEMIA	0.05390831	0.8234982609580499
ANTLEY-BIXLER SYNDROME	0.05387693	0.8230189030366301
EAR WAX, WET/DRY	0.053802	0.8218742794212062
RABIES	0.05375397	0.8211405776695873
BENIGN FAMILIAL INFANTILE EPILEPSY	0.05375397	0.8211405776695873
SPONTANEOUS PERIODIC HYPOTHERMIA	0.05375397	0.8211405776695873
LEGIONELLOSIS	0.05375397	0.8211405776695873
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.053636550000000005	0.8193468808202203
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.05353357	0.8177737680494164
HYALINE FIBROMATOSIS SYNDROME; HFS	0.05353357	0.8177737680494164
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.053519314000000005	0.8175559947375056
RECURRENT ACUTE PANCREATITIS	0.05325797	0.8135637284336311
48,XYYY SYNDROME	0.053177154	0.812329190837153
ISOTRETINOIN-LIKE SYNDROME	0.0530914	0.8110192208182414
HEMIHYPERPLASIA-MULTIPLE LIPOMATOSIS SYNDROME	0.053030299999999995	0.8100858629788926
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.05295674	0.8089621673543022
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.052914343999999995	0.8083145300554965
TAKAYASU ARTERITIS	0.05282733	0.8069853123953805
CHIME SYNDROME	0.05276278000000001	0.8059992526813062
ACRORENAL SYNDROME	0.0526316	0.8039953593692643
RHOMBENCEPHALOSYNAPSIS	0.0526316	0.8039953593692643
CONGENITAL BILATERAL ABSENCE OF VAS DEFERENS	0.0526316	0.8039953593692643
ACROCEPHALOPOLYDACTYLY	0.0526316	0.8039953593692643
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.0526316	0.8039953593692643
ALG11-CDG	0.052452874000000003	0.8012651578439709
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.052404120000000005	0.8005203963366123
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.052381000000000004	0.8001672173964202
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.052289364	0.7987673945000773
KOOLEN-DE VRIES SYNDROME; KDVS	0.052217794	0.7976740979278647
DIASTROPHIC DWARFISM	0.05210381	0.7959328890905438
TIETZ SYNDROME	0.0520833	0.7956195802642747
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0520833	0.7956195802642747
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.051811764	0.791471621929326
COLCHICINE POISONING	0.05163506	0.7887723082853937
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.05163506	0.7887723082853937
PSEUDOXANTHOMA ELASTICUM	0.051579599999999996	0.7879251065542924
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.051548079999999996	0.787443610006072
GINGIVAL FIBROMATOSIS-PROGRESSIVE DEAFNESS SYNDROME	0.05150376	0.7867665818646656
WITTEVEEN-KOLK SYNDROME	0.051310854	0.7838197679962959
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.05131012000000001	0.7838085554814992
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.05126899	0.7831802574793321
ELLIS VAN CREVELD SYNDROME	0.051245330000000006	0.7828188295500524
MUCOLIPIDOSIS III GAMMA	0.05107880000000001	0.7802749329708916
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.050672770000000006	0.7740724569723526
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.050651890000000005	0.773753496060968
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.05064392	0.7736317470923982
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.05058387	0.7727144289540532
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.050535374	0.7719736086303698
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.050525694	0.771825737863023
ACROOSTEOLYSIS DOMINANT TYPE	0.05040008000000001	0.7699068702422057
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0502451	0.7675394103740836
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.05006505000000001	0.7647889835496201
RETINITIS PIGMENTOSA 77; RP77	0.05	0.7637952858826867
ACROMESOMELIC DYSPLASIA, GREBE TYPE	0.05	0.7637952858826867
RETINITIS PIGMENTOSA 25; RP25	0.05	0.7637952858826867
LEUKEMIA, ACUTE, ?X-LINKED	0.05	0.7637952858826867
FIBROMATOSIS, GINGIVAL, 1	0.05	0.7637952858826867
NASU-HAKOLA DISEASE	0.05	0.7637952858826867
GINGIVAL FIBROMATOSIS-FACIAL DYSMORPHISM SYNDROME	0.05	0.7637952858826867
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.05	0.7637952858826867
RETICULUM CELL SARCOMA	0.05	0.7637952858826867
RETINITIS PIGMENTOSA 10; RP10	0.05	0.7637952858826867
MICROCORNEA, MYOPIC CHORIORETINAL ATROPHY, AND TELECANTHUS; MMCAT	0.05	0.7637952858826867
RETINITIS PIGMENTOSA 72; RP72	0.05	0.7637952858826867
RETINITIS PIGMENTOSA 14	0.05	0.7637952858826867
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.05	0.7637952858826867
RETINITIS PIGMENTOSA WITH OR WITHOUT SITUS INVERSUS	0.05	0.7637952858826867
RETINITIS PIGMENTOSA 56; RP56	0.05	0.7637952858826867
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.05	0.7637952858826867
JUVENILE HYALINE FIBROMATOSIS	0.05	0.7637952858826867
PROGRESSIVE OSSEOUS HETEROPLASIA	0.05	0.7637952858826867
HEREDITARY GINGIVAL FIBROMATOSIS	0.05	0.7637952858826867
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.049996584	0.7637431033887551
CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	0.049888560000000005	0.7620929389495115
CANAVAN DISEASE	0.049682003999999995	0.7589376089680956
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.04961327	0.7578876348644984
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.04957669	0.7573288422333467
2Q37 MICRODELETION SYNDROME	0.049519964	0.756462301205607
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.049451084	0.755410096819775
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 3; EV3	0.04945050000000001	0.7554011756908361
HYPERKERATOSIS LENTICULARIS PERSTANS	0.04945050000000001	0.7554011756908361
N SYNDROME	0.049434149999999996	0.7551514146323522
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.04903763	0.7490942124971882
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.04899805	0.7484895921488834
ACUTE INTERMITTENT PORPHYRIA	0.04888261	0.7467261415928376
XP22.13P22.2 DUPLICATION SYNDROME	0.04877141	0.7450274608770344
TEMPI SYNDROME	0.0487661	0.7449463458176737
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.048708949999999994	0.7440733278059097
NIPPLES, SUPERNUMERARY	0.0483036	0.7378812394232589
138790 GOITER, MULTINODULAR, CYSTIC RENAL DISEASE, AND DIGITAL ANOMALIES;;MULTINODULAR GOITER/CYSTIC RENAL DISEASE/DIGITAL ANOMALIES;;MNG/CRD/DA	0.048272999999999996	0.7374137967082985
HUNTER-MACDONALD SYNDROME	0.048188800000000004	0.7361275654468723
VELO-FACIAL-SKELETAL SYNDROME	0.04814634	0.7354789504901007
SMITH-MCCORT DYSPLASIA 2; SMC2	0.048034179999999996	0.7337656049048086
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.047909400000000005	0.7318594773893597
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.047782583999999996	0.7299222481298697
CEREBRAL ARTERIOVENOUS MALFORMATION	0.047619	0.7274233543689531
AUTOSOMAL DOMINANT HYPOCALCEMIA	0.047619	0.7274233543689531
PERIORAL MYOCLONIA WITH ABSENCES	0.047619	0.7274233543689531
PITUITARY DEFICIENCY DUE TO RATHKE CLEFT CYSTS	0.047619	0.7274233543689531
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE I; HHC1	0.047619	0.7274233543689531
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.04760981400000001	0.7272830298990308
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.04734266	0.7232020105829368
DYSOSTOSIS, STANESCU TYPE	0.047235200000000005	0.7215604617545177
CARTILAGE-HAIR HYPOPLASIA; CHH	0.047123	0.7198465051329969
MYCOSIS FUNGOIDES	0.047123	0.7198465051329969
ACTH-DEPENDENT CUSHING SYNDROME	0.04704225	0.7186129757462963
DYSOSTEOSCLEROSIS	0.0470212	0.7182914179309396
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.04701429	0.7181858614224307
DEAFNESS, MID-TONE NEURAL	0.04695826	0.7173299524250707
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 49	0.04695826	0.7173299524250707
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.04687502999999999	0.7160585387921902
LOEYS-DIETZ SYNDROME 3; LDS3	0.046780560000000006	0.7146154239790435
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.046775354	0.7145358976138774
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.04677135	0.714474732887384
KAPUR-TORIELLO SYNDROME	0.0466369	0.7124208873636454
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.046404934	0.7088773966179441
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.04639932	0.7087916376832452
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.0462766	0.7069169785335748
PITUITARY APOPLEXY	0.04613497	0.7047534520067834
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.046106390000000004	0.7043168666213729
TOWNES-BROCKS SYNDROME	0.04609026000000001	0.7040704662621472
OCCIPITAL HORN SYNDROME	0.046014394	0.7029115443989716
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.046000054	0.7026924879109805
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.045809814000000004	0.6997863996072541
TRISOMY 20P	0.045737740000000006	0.6986854039785599
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.045725944	0.6985052093947144
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.045712254	0.6982960822454398
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.04559286	0.6964722307581861
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.04546884	0.6945777129310828
DEAFNESS, AUTOSOMAL RECESSIVE 112; DFNB112	0.0454545	0.6943586564430917
SMALL CELL CANCER OF THE LUNG	0.0454545	0.6943586564430917
X-LINKED ADRENOLEUKODYSTROPHY	0.0454545	0.6943586564430917
%606012 DEAFNESS, AUTOSOMAL DOMINANT 18; DFNA18	0.0454545	0.6943586564430917
PERRAULT SYNDROME 4	0.0454545	0.6943586564430917
POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.0454545	0.6943586564430917
DEAFNESS WITH ANHIDROTIC ECTODERMAL DYSPLASIA	0.0454545	0.6943586564430917
MERCURY POISONING	0.0454545	0.6943586564430917
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED SEVERE	0.0454545	0.6943586564430917
DEAFNESS, AUTOSOMAL DOMINANT 65; DFNA65	0.0454545	0.6943586564430917
SANDIFER SYNDROME	0.0454545	0.6943586564430917
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED SEVERE	0.0454545	0.6943586564430917
INHERITED EPIDERMOLYSIS BULLOSA	0.0454545	0.6943586564430917
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.0454545	0.6943586564430917
POROKERATOSIS	0.0454545	0.6943586564430917
PALMOPLANTAR KERATODERMA-XX SEX REVERSAL-PREDISPOSITION TO SQUAMOUS CELL CARCINOMA SYNDROME	0.0454545	0.6943586564430917
49,XXXYY SYNDROME	0.04535673999999999	0.6928652839001337
MACS SYNDROME	0.04512116000000001	0.689266586031169
SLC39A8-CDG	0.045056030000000004	0.6882716662917782
ACHONDROGENESIS TYPE 1B	0.04504045	0.6880336676806972
KYPHOMELIC DYSPLASIA	0.04504045	0.6880336676806972
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.044904240000000005	0.6859529365628956
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.04446273	0.6792084714294941
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.04444441	0.6789286168367467
CONGENITAL TRACHEAL STENOSIS	0.0442684	0.6762399046713825
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.044257279999999996	0.6760700365998021
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.04418546	0.6749729210511604
LEUKOCYTE ADHESION DEFICIENCY	0.04418546	0.6749729210511604
DOORS SYNDROME	0.044143984	0.6743393375856148
BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS	0.044110750000000004	0.6738316581349945
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0440891	0.6735009347762072
DEAFNESS, AUTOSOMAL DOMINANT 20	0.0440891	0.6735009347762072
FOCAL DERMAL HYPOPLASIA; FDH	0.04402178	0.6724725608032948
AUTOSOMAL DOMINANT OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.04400524	0.6722198973227247
NATHALIE SYNDROME	0.043986620000000004	0.6719354599582621
BRANCHIO-OCULO-FACIAL SYNDROME	0.04397182	0.6717093765536408
ACROCAPITOFEMORAL DYSPLASIA; ACFD	0.04392598	0.6710091290355436
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.04380909	0.669223528416207
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.0437736	0.6686813865222875
WILSON DISEASE	0.04366983	0.6670962057859665
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.043478300000000004	0.6641704115638644
LIPOMA OF THE CONJUNCTIVA	0.043478300000000004	0.6641704115638644
RENAL CELL CARCINOMA, NONPAPILLARY	0.043478300000000004	0.6641704115638644
FIBROCHONDROGENESIS	0.043408440000000006	0.6631032367904292
VISCERAL STEATOSIS, CONGENITAL	0.04332631	0.6618486266538381
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.04328629	0.6612372849070176
MENKES DISEASE	0.043171970000000004	0.6594909433653755
HAMAMY SYNDROME; HMMS	0.043170459999999994	0.6594678767477418
YOU-HOOVER-FONG SYNDROME; YHFS	0.043124894000000004	0.6587718148278112
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.04296736	0.6563653402964864
RENAL TUBULAR DYSGENESIS	0.04288616	0.6551249367522128
CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA	0.042756550000000004	0.6531450266121478
KNIEST DYSPLASIA	0.04272139	0.652607925767115
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.042328083999999995	0.6465998203929274
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.042318589999999996	0.6464547909440441
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.042124560000000005	0.6434908069576478
CITRULLINEMIA TYPE II	0.042100924	0.6431297456501052
WIDOW'S PEAK SYNDROME	0.04208075000000001	0.6428215695281575
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.042062880000000004	0.6425485890929828
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.04199507	0.6415127299262688
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.041922763999999994	0.640408190287448
FLYNN-AIRD SYNDROME	0.041894589999999995	0.6399778069197589
PAPILLARY TUMOR OF THE PINEAL REGION	0.04184927000000001	0.639285502872635
PINEOCYTOMA	0.04184927000000001	0.639285502872635
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.04183067000000001	0.6390013710262866
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.04178253	0.6382659889250386
ANDROGEN INSENSITIVITY SYNDROME	0.0416667	0.6364965807657629
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.041666699999999994	0.6364965807657627
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.041666699999999994	0.6364965807657627
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.041666699999999994	0.6364965807657627
PREMATURE OVARIAN FAILURE 8; POF8	0.041666699999999994	0.6364965807657627
HISTIDINEMIA	0.041666699999999994	0.6364965807657627
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.041666699999999994	0.6364965807657627
CHROMOSOME 17Q12 DELETION SYNDROME	0.041594049999999994	0.6353867862153751
MARFANOID HYPERMOBILITY SYNDROME	0.04157558	0.6351046402367703
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.04157368	0.6350756160159067
15Q26 OVERGROWTH SYNDROME	0.04151129	0.6341225522581823
SPLIT HAND/FOOT MALFORMATION 1 (SHFM1)	0.04150376	0.6340075246881284
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.041495920000000006	0.633887761587302
ACROCRANIOFACIAL DYSOSTOSIS	0.04149282	0.6338404062795772
HALLERMANN-STREIFF SYNDROME; HSS	0.04148936	0.6337875516457941
ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE	0.041428860000000005	0.632863359349876
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.041426944	0.632834090714521
9P13 MICRODELETION SYNDROME	0.04138457	0.6321867894856412
COG1-CDG	0.041295729999999996	0.6308296780216848
COFFIN-LOWRY SYNDROME	0.04122303	0.6297191196760114
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.041201804	0.6293948733012484
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.04105306	0.6271226739811818
RUBINSTEIN-TAYBI SYNDROME	0.040997224000000006	0.626269728509531
DYSTONIA, JUVENILE-ONSET	0.040891979999999994	0.624662031088182
CONGENITAL ANALBUMINEMIA	0.040661459999999996	0.6211406293021484
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.04065189	0.6209944388844307
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASEDEFICIENCY	0.04065189	0.6209944388844307
SJOGREN-LARSSON SYNDROME; SLS	0.04065189	0.6209944388844307
NON-DISTAL TRISOMY 10Q	0.04065189	0.6209944388844307
CHROMOSOME 1P36 DELETION SYNDROME	0.040608184000000005	0.6203267901491349
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.0405229	0.6190239998059105
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.040518454	0.6189560831290898
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.040510814	0.6188393752094069
ERYTHROKERATODERMIA VARIABILIS	0.04041019999999999	0.6173024052315308
NAIL-PATELLA SYNDROME	0.04033698	0.6161839034148843
OCULODENTODIGITAL DYSPLASIA	0.04014033	0.6131798965555076
FG SYNDROME TYPE 1	0.040127694000000005	0.6129868702108594
FANCONI ANEMIA	0.04008864400000001	0.6123903460925851
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.040056230000000005	0.6118951928846531
COCAINE EMBRYOFETOPATHY	0.04	0.6110362287061494
DOHLE BODIES AND LEUKEMIA	0.04	0.6110362287061494
MICROCEPHALY-GLOMERULONEPHRITIS-MARFANOID HABITUS SYNDROME	0.04	0.6110362287061494
LEUKEMIA, ACUTE MYELOID; AML	0.04	0.6110362287061494
PITUITARY ADENOMA 5, MULTIPLE TYPES; PITA5	0.04	0.6110362287061494
CEREBELLAR VERMIS APLASIA WITH ASSOCIATED FEATURES SUGGESTING SMITH-LEMLI-OPITZSYNDROME AND MECKEL SYNDROME	0.04	0.6110362287061494
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.04	0.6110362287061494
MECKEL SYNDROME, TYPE 5	0.04	0.6110362287061494
PITUITARY ADENOMA 2, GROWTH HORMONE-SECRETING; PITA2	0.04	0.6110362287061494
GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM	0.04	0.6110362287061494
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.039972900000000006	0.610622251661201
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.03996526	0.610505543741518
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.039963724	0.6104820799503358
MUCOLIPIDOSIS TYPE III	0.039899760000000006	0.6095049719170118
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.039882724	0.6092447315872057
MESOMELIC DWARFISM, REINHARDT-PFEIFFER TYPE	0.039706830000000005	0.6065577914269048
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0397012	0.6064717880777144
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.039337170000000005	0.600910900119317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.039247870000000004	0.5995467617387304
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.039247870000000004	0.5995467617387304
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.039206653999999994	0.5989171500086715
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.03911528000000001	0.5975213293996269
245800 LAURENCE-MOON SYNDROME	0.039113390000000005	0.5974924579378205
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA	0.039113390000000005	0.5974924579378205
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.039113390000000005	0.5974924579378205
8P23.1 DUPLICATION SYNDROME	0.039100004	0.5972879746638838
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.03901432	0.5959790739583724
PEROXISOME BIOGENESIS DISORDER 11B	0.039014280000000005	0.5959784629221438
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.039007054	0.5958680792274279
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.038980224	0.5954582266770233
MEIER-GORLIN SYNDROME 5; MGORS5	0.03875161	0.5919659407672875
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.03875161	0.5919659407672875
THANATOPHORIC DYSPLASIA TYPE 2	0.038742650000000003	0.5918290686520574
CHRISTIANSON SYNDROME	0.03855577	0.5889743073915423
OCULOCEREBROCUTANEOUS SYNDROME	0.038554450000000004	0.588954143195995
SPONDYLOMETAPHYSEAL DYSPLASIA, EAST AFRICAN TYPE	0.0384615	0.5875342477595391
EPISODIC ATAXIA, TYPE 1; EA1	0.0384615	0.5875342477595391
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.0384615	0.5875342477595391
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH	0.0384615	0.5875342477595391
DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	0.0384615	0.5875342477595391
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.0384615	0.5875342477595391
PANCREATIC CANCER	0.0384615	0.5875342477595391
FIBULAR APLASIA, TIBIAL CAMPOMELIA, AND OLIGOSYNDACTYLY SYNDROME	0.0384615	0.5875342477595391
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.0384615	0.5875342477595391
TROPICAL CALCIFIC PANCREATITIS	0.0384615	0.5875342477595391
CONGENITAL ERYTHROPOIETIC PORPHYRIA	0.0384615	0.5875342477595391
PHOCOMELIA, SCHINZEL TYPE	0.0384615	0.5875342477595391
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.0384615	0.5875342477595391
GERMAN SYNDROME	0.038157074	0.5828838648855366
WAGR SYNDROME	0.038148720000000004	0.5827562499691714
THANATOPHORIC DYSPLASIA TYPE 1	0.03809076	0.5818708584737762
THANATOPHORIC DYSPLASIA	0.03809076	0.5818708584737762
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0380747	0.5816255274279506
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.03804568	0.5811822206440242
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.038011144	0.5806546519641593
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.03790377	0.5790144168636321
ECTODERMAL DYSPLASIA SYNDROME	0.0378869	0.5787567123341752
300106 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED;;SEMD, X-LINKED; SEMDX	0.03784364	0.5780958766528295
3MC SYNDROME 2	0.037791134000000004	0.5772937999472184
HYPOPHOSPHATEMIC RICKETS	0.03768889	0.5757319302430226
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.03768889	0.5757319302430226
WILDERVANCK SYNDROME	0.03766026	0.5752945810623262
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.03761486	0.5746010549427447
BRANCHIOGENIC DEAFNESS SYNDROME	0.03761152000000001	0.5745500334176479
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.0375	0.5728464644120149
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.03749747	0.5728078163705493
HARLEQUIN ICHTHYOSIS	0.03749683	0.5727980397908901
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.03749683	0.5727980397908901
MUCOPOLYSACCHARIDOSIS TYPE 6	0.03743018	0.5717799006748083
MORQUIO SYNDROME A	0.03743018	0.5717799006748083
FOUNTAIN SYNDROME	0.03739066	0.5711761968808468
ODONTOCHONDRODYSPLASIA; ODCD	0.03728678	0.5695893357948969
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.037218060000000004	0.5685395755539797
AMISH INFANTILE EPILEPSY SYNDROME	0.037218060000000004	0.5685395755539797
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.03721176	0.5684433373479585
MIRAGE SYNDROME; MIRAGE	0.037082644	0.5664709735053178
EXOSTOSES OF HEEL	0.037037	0.5657737200647414
207620 APHALANGY WITH HEMIVERTEBRAE	0.037037	0.5657737200647414
PEYRONIE DISEASE	0.037037	0.5657737200647414
OVARIAN HYPERSTIMULATION SYNDROME	0.037037	0.5657737200647414
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.037037	0.5657737200647414
GENITOURINARY TRACT ANOMALIES	0.037037	0.5657737200647414
DK PHOCOMELIA SYNDROME	0.037037	0.5657737200647414
DENTIN DYSPLASIA	0.037037	0.5657737200647414
URINARY BLADDER, ATONY OF	0.037037	0.5657737200647414
ADENOMYOSIS	0.037037	0.5657737200647414
SPLENOGONADAL FUSION WITH LIMB DEFECTS AND MICROGNATHIA	0.037037	0.5657737200647414
HYPERLYSINEMIA, TYPE I	0.037037	0.5657737200647414
TESTICULAR TORSION	0.037037	0.5657737200647414
PULMONARY ARTERIAL HYPERTENSION	0.037037	0.5657737200647414
CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION; CMAVM	0.037037	0.5657737200647414
FAMILIAL SUPERNUMERARY NIPPLES	0.037037	0.5657737200647414
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.037037	0.5657737200647414
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.037037	0.5657737200647414
LÉRI-WEILL DYSCHONDROSTEOSIS	0.037037	0.5657737200647414
HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1	0.037037	0.5657737200647414
LABIA MINORA, INCOMPLETE ADHESION OF	0.037037	0.5657737200647414
CROSSED POLYSYNDACTYLY	0.03695963000000001	0.5645918232393665
RAINE SYNDROME	0.036911744	0.563860321218171
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.036911744	0.563860321218171
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.036797934	0.5621217703884447
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.03666926	0.5601561584961313
SECKEL SYNDROME 2; SCKL2	0.03655963	0.558481460952305
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.0365572	0.558444340501411
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.036510834	0.5577360578569063
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.03643797	0.5566229942626952
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.03636619000000001	0.5555264897502821
MICROHYDRANENCEPHALY; MHAC	0.03636619000000001	0.5555264897502821
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.03636619000000001	0.5555264897502821
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.03636619000000001	0.5555264897502821
DEND SYNDROME	0.03627416	0.5541206481470863
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.03627416	0.5541206481470863
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.036259854	0.5539021110398895
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.036259854	0.5539021110398895
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.036259854	0.5539021110398895
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.036259854	0.5539021110398895
THUMBS, CONGENITAL CLASPED	0.0361093	0.5516022623304739
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.035948139999999996	0.5491403973650169
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.035905309999999996	0.5484861303231297
WYBURN-MASON SYNDROME	0.035884834	0.5481733408776551
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.035714300000000004	0.5455682795720008
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.035714300000000004	0.5455682795720008
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.035714300000000004	0.5455682795720008
ALKAPTONURIA	0.035714300000000004	0.5455682795720008
SECONDARY SYRINGOMYELIA	0.035714300000000004	0.5455682795720008
OTOFACIOCERVICAL SYNDROME 2	0.035714300000000004	0.5455682795720008
OTOSCLEROSIS 4	0.035714300000000004	0.5455682795720008
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	0.035714300000000004	0.5455682795720008
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.035634373999999996	0.5443473375316115
DERMOCHONDROCORNEAL DYSTROPHY	0.0355346	0.5428231993145383
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.03550317	0.5423430775978325
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.035485593999999995	0.542074588278939
ACROCEPHALOSYNDACTYLY	0.0354377	0.5413429640504978
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.0353603	0.5401606089479513
9Q33.3Q34.11 MICRODELETION SYNDROME	0.03531458	0.5394621945385402
MAPLE SYRUP URINE DISEASE; MSUD	0.03530537	0.5393215034468806
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.035302004	0.5392700847482349
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.03526606	0.5387210075931196
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.035210224	0.5378680621214686
SUSAC SYNDROME	0.03520464	0.5377827614639414
CHROMOSOME 8Q22.1 DUPLICATION SYNDROME	0.03513469	0.5367142118589915
BRACHYDACTYLY, TYPE A6	0.03513469	0.5367142118589915
MOSAIC TRISOMY 9	0.035028354	0.5350898331485989
THREE M SYNDROME 2; 3M2	0.0349232	0.5334835105587649
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.03490792	0.5332500947193991
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.034876279999999996	0.5327667650624925
SPONDYLOCOSTAL DYSOSTOSIS 5	0.034876279999999996	0.5327667650624925
SPONDYLOCOSTAL DYSOSTOSIS, AUTOSOMAL RECESSIVE 1	0.03475939	0.530981164443156
CHST3-RELATED SKELETAL DYSPLASIA	0.03475939	0.530981164443156
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.03469252	0.5299596646278165
FANCONI ANEMIA	0.03466467	0.5295342306535799
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.03464309	0.529204576608193
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.034490534	0.5268741455355305
ISOLATED POLYCYSTIC LIVER DISEASE	0.0344828	0.5267560016807102
AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE	0.0344828	0.5267560016807102
RCAD (RENAL CYSTS AND DIABETES)	0.0344828	0.5267560016807102
ULNA METAPHYSEAL DYSPLASIA SYNDROME	0.0344828	0.5267560016807102
BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 1	0.0344828	0.5267560016807102
ANKYLOSING VERTEBRAL HYPEROSTOSIS WITH TYLOSIS	0.0344828	0.5267560016807102
CALCIFICATION OF JOINTS AND ARTERIES; CALJA	0.0344828	0.5267560016807102
OSSIFICATION OF THE POSTERIOR LONGITUDINAL LIGAMENT OF SPINE; OPLL	0.0344828	0.5267560016807102
CERVICAL VERTEBRAL BRIDGE	0.0344828	0.5267560016807102
VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX	0.0344828	0.5267560016807102
HANAC SYNDROME	0.0344828	0.5267560016807102
SPINAL INTRADURAL ARACHNOID CYSTS	0.0344828	0.5267560016807102
VACTERL ASSOCIATION WITH HYDROCEPHALUS	0.0344828	0.5267560016807102
DIAPHANOSPONDYLODYSOSTOSIS	0.0344828	0.5267560016807102
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.03446282	0.5264507890844714
HARROD SYNDROME	0.03446262	0.5264477339033279
RENPENNING SYNDROME	0.034434650000000004	0.5260204668204052
TRISOMY 18	0.034351384	0.524748503254919
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.03415532	0.521753448076293
DENT DISEASE	0.034040629999999995	0.520001454449535
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.03388835	0.5176752395268509
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.03377555	0.5159521173618995
INFANTILE SIALIC ACID STORAGE DISEASE	0.033759083999999995	0.5157005842983526
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.033672254	0.5143741774048888
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.03364981	0.5140313249769618
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.033589289999999994	0.5131068271629293
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.033578224000000004	0.5129377839902579
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.033422733999999996	0.5105625334102197
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.03337349	0.5098102867090597
MARFAN SYNDROME	0.03330974	0.5088364477195592
ALSTRÖM SYNDROME	0.033278024	0.5083519570938182
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.033235314	0.5076995231606172
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.03303959	0.5047096617899351
PETERS PLUS SYNDROME	0.03294843399999999	0.5033171713283365
PIEBALDISM	0.032767450000000004	0.5005524768079328
WT LIMB-BLOOD SYNDROME	0.03275376	0.5003433496586581
PIEBALD TRAIT-NEUROLOGIC DEFECTS SYNDROME	0.03275376	0.5003433496586581
JACOBSEN SYNDROME	0.032737524	0.5000953300534263
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.03272119	0.4998458134094341
NOONAN SYNDROME 5; NS5	0.032665284	0.49899179862438303
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.032577424	0.4976496575480299
IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	0.0325397	0.49707338928073713
X-LINKED RECESSIVE OCULAR ALBINISM	0.03249533	0.496395597344045
WAARDENBURG SYNDROME TYPE 1	0.03249533	0.496395597344045
MERRF	0.03245865	0.4958352771223213
FASCIAL DYSTROPHY, CONGENITAL	0.0323877	0.49475145161165374
MILD CANAVAN DISEASE	0.0322581	0.4927716942306459
CORTICOSTEROID-SENSITIVE ASEPTIC ABSCESS SYNDROME	0.03223533	0.4924238618574549
COFFIN-SIRIS SYNDROME 1; CSS1	0.032200254	0.49188804418850246
CORNELIA DE LANGE SYNDROME	0.032139839999999996	0.4909651656204761
BARDET-BIEDL SYNDROME 1; BBS1	0.032117863999999996	0.49062946231642496
MICROFORM HOLOPROSENCEPHALY	0.03203968	0.489435130903796
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.031972994000000005	0.4884164418551086
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.03193075	0.4877711264939719
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	0.03190189	0.4873302638549605
PERRAULT SYNDROME 3	0.03190189	0.4873302638549605
DE SANCTIS-CACCHIONE SYNDROME	0.031806759999999996	0.48587706694404
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.031806759999999996	0.48587706694404
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.031801504	0.4857967767835881
HYDROXYKYNURENINURIA	0.031795554	0.485705885144568
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.031698253999999995	0.4842195395182402
KEUTEL SYNDROME; KTLS	0.03154258	0.4818414781715503
RIN2 SYNDROME	0.031311370000000005	0.47830953601057163
TRANSALDOLASE DEFICIENCY	0.031262594	0.4775644384332873
7P22.1 MICRODUPLICATION SYNDROME	0.031262594	0.4775644384332873
DEAFNESS, AUTOSOMAL RECESSIVE 109; DFNB109	0.03125	0.4773720536766792
SYMPTOMATIC FORM OF HEMOCHROMATOSIS TYPE 1	0.03125	0.4773720536766792
XERODERMA PIGMENTOSUM, AUTOSOMAL DOMINANT, MILD	0.03125	0.4773720536766792
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 4	0.03125	0.4773720536766792
ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH	0.03125	0.4773720536766792
BUDD-CHIARI SYNDROMEMEMBRANOUS OBSTRUCTION OF INFERIOR VENA CAVA, INCLUDED	0.03125	0.4773720536766792
POROKERATOSIS 1, MULTIPLE TYPES; POROK1	0.03125	0.4773720536766792
BETA-THALASSEMIA INTERMEDIA	0.03125	0.4773720536766792
PRIMARY ERYTHROMELALGIA	0.03125	0.4773720536766792
GENERALIZED ERUPTIVE HISTIOCYTOSIS	0.03125	0.4773720536766792
TYROSINEMIA TYPE 1	0.03125	0.4773720536766792
%226500 EPIDERMOLYSIS BULLOSA DYSTROPHICA NEUROTROPHICA;;EPIDERMOLYSIS BULLOSA WITH CONGENITAL DEAFNESS;;EPIDERMOLYSIS BULLOSA PROGRESSIVA, RECESSIVE; EBR3	0.03125	0.4773720536766792
WILSON DISEASE	0.03125	0.4773720536766792
CYLINDROMATOSIS, FAMILIAL	0.03125	0.4773720536766792
WAARDENBURG SYNDROME, TYPE 2D; WS2D	0.03125	0.4773720536766792
FAMILIAL TUMORAL CALCINOSIS	0.03125	0.4773720536766792
HISTIOCYTOSIS, PROGRESSIVE MUCINOUS	0.03125	0.4773720536766792
ALPHA-1-ANTITRYPSIN DEFICIENCY; A1ATD	0.03125	0.4773720536766792
JERVELL AND LANGE-NIELSEN SYNDROME 2	0.03125	0.4773720536766792
HEPATOCELLULAR CARCINOMA	0.03125	0.4773720536766792
WAARDENBURG SYNDROME, TYPE 1; WS1	0.03125	0.4773720536766792
DEAFNESS, AUTOSOMAL RECESSIVE 108; DFNB108	0.03125	0.4773720536766792
PORPHYRIA CUTANEA TARDA	0.03125	0.4773720536766792
DEAFNESS, X-LINKED 3	0.03125	0.4773720536766792
USHER SYNDROME, TYPE IIA	0.03125	0.4773720536766792
FLOTCH SYNDROME	0.03125	0.4773720536766792
USHER SYNDROME, TYPE IF	0.03125	0.4773720536766792
TYROSINEMIA, TYPE I; TYRSN1	0.03125	0.4773720536766792
USHER SYNDROME, TYPE IE; USH1E	0.03125	0.4773720536766792
DEAFNESS-OLIGODONTIA SYNDROME	0.03125	0.4773720536766792
POROKERATOSIS PLANTARIS PALMARIS ET DISSEMINATA	0.03125	0.4773720536766792
PRIMARY BILIARY CHOLANGITIS	0.03125	0.4773720536766792
USHER SYNDROME, TYPE IC	0.03125	0.4773720536766792
USHER SYNDROME, TYPE IIC	0.03125	0.4773720536766792
PORPHYRIA CUTANEA TARDA	0.03125	0.4773720536766792
JERVELL AND LANGE-NIELSEN SYNDROME 1	0.03125	0.4773720536766792
RETINITIS PUNCTATA ALBESCENS	0.03125	0.4773720536766792
HEMOCHROMATOSIS, TYPE 1	0.03125	0.4773720536766792
AUTOIMMUNE HEPATITIS	0.03125	0.4773720536766792
DEAFNESS, AUTOSOMAL RECESSIVE 63	0.03125	0.4773720536766792
ERYTHROKERATODERMA ''EN COCARDES''	0.03125	0.4773720536766792
SMITH-FINEMAN-MYERS SYNDROME	0.0312434	0.47727123269894267
BLAU SYNDROME	0.03119433	0.4765216440053774
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.03115553	0.47592893886353244
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.03111537	0.4753154584899114
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.030962913999999998	0.4729865550078208
DISTAL TRISOMY 18Q	0.030748014	0.46970376286909704
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.03074516	0.4696601654341789
SCALP-EAR-NIPPLE SYNDROME; SENS	0.030710559999999998	0.46913161909634804
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.03039184	0.46426288242601743
FLYNN-AIRD SYNDROME	0.03038592	0.46417244906416893
BOHRING-OPITZ SYNDROME	0.030335334	0.46339970209753567
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 10; CMM10	0.030302999999999997	0.46290577096206104
ROCH-LERI MESOSOMATOUS LIPOMATOSIS	0.030302999999999997	0.46290577096206104
MULTIPLE SYMMETRIC LIPOMATOSIS	0.030302999999999997	0.46290577096206104
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 9; CMM9	0.030302999999999997	0.46290577096206104
NEUROCUTANEOUS MELANOCYTOSIS	0.030302999999999997	0.46290577096206104
EXTENSOR TENDONS OF FINGER ANOMALIES	0.030302999999999997	0.46290577096206104
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE II	0.030302999999999997	0.46290577096206104
LIPOMATOSIS, MULTIPLE	0.030302999999999997	0.46290577096206104
MELORHEOSTOSIS WITH OSTEOPOIKILOSIS	0.030302999999999997	0.46290577096206104
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.030225514	0.46172210213162296
15Q13.3 MICRODELETION SYNDROME	0.030220574000000004	0.4616466391573778
3Q29 MICRODELETION SYNDROME	0.030216954	0.4615913403786798
TRISOMY 17P	0.030109624	0.45995177741800414
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.030054434	0.4591087001814468
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.03005102	0.45905654823932673
CIRCUMVALLATE PLACENTA SYNDROME	0.029979	0.4579563775095412
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.02995977	0.45766262184259077
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.029957354	0.45762571525437695
ROSSELLI-GULIENETTI SYNDROME	0.029957354	0.45762571525437695
3MC SYNDROME 1	0.02978061	0.45492579057421595
INTERMEDIATE NEMALINE MYOPATHY	0.02967996	0.4533882706637341
POLYMYOSITIS	0.02959853	0.4521443536611456
SILVER-RUSSELL SYNDROME	0.02943766	0.44968691870834665
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.02943324	0.44961939920507454
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, KOHN TYPE	0.0294118	0.449291883786488
AREDYLD	0.0294118	0.449291883786488
EAR ANTITRAGUS, TAG AT BASE OF	0.0294118	0.449291883786488
SPONDYLOCOSTAL DYSOSTOSIS 2, AUTOSOMAL RECESSIVE; SCDO2	0.0294118	0.449291883786488
SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	0.0294118	0.449291883786488
SCHIMKE IMMUNO-OSSEOUS DYSPLASIA	0.0294118	0.449291883786488
DARWINIAN POINT OF PINNA	0.0294118	0.449291883786488
SPONDYLOCOSTAL DYSOSTOSIS-HYPOSPADIAS-INTELLECTUAL DISABILITY SYNDROME	0.0294118	0.449291883786488
OTOONYCHOPERONEAL SYNDROME	0.0294118	0.449291883786488
HAIRY EARS, Y-LINKED	0.0294118	0.449291883786488
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.0294118	0.449291883786488
EXCHONDROSIS OF PINNA, POSTERIOR	0.0294118	0.449291883786488
SPONDYLOCOSTAL DYSOSTOSIS-ANAL ATRESIA-GENITOURINARY MALFORMATION SYNDROME	0.0294118	0.449291883786488
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.0294118	0.449291883786488
DARWINIAN TUBERCLE OF PINNA	0.0294118	0.449291883786488
OSSIFIED EAR CARTILAGES	0.0294118	0.449291883786488
EAR WITHOUT HELIX	0.0294118	0.449291883786488
EAR MALFORMATION	0.0294118	0.449291883786488
SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA; SMMD	0.0294118	0.449291883786488
MUSICAL PERFECT PITCH	0.0294118	0.449291883786488
EAR FOLDING	0.0294118	0.449291883786488
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.029407354	0.44922396710966744
GAUCHER DISEASE, PERINATAL LETHAL	0.029300100000000003	0.4475855651178262
WAARDENBURG SYNDROME, TYPE IIB	0.02928156	0.44730234982582084
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.029255004000000005	0.44689668287358286
DE BARSY SYNDROME	0.029160863999999998	0.44545860910932283
ISOLATED HEMIHYPERPLASIA	0.02913756	0.4451026194024787
48,XXYY SYNDROME	0.029099273999999998	0.44451776607617255
PETERS-PLUS SYNDROME; PTRPLS	0.029070814	0.4440830137994482
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.02902313	0.4433545975112076
CEDNIK SYNDROME	0.029002933999999998	0.44304608531933376
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.0289827	0.44273699264304284
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.02893219	0.4419654066452442
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.028864404	0.4409299141002672
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.028819714	0.4402472338737453
KEPPEN-LUBINSKY SYNDROME	0.02868401	0.4381742323642368
MUCOPOLYSACCHARIDOSES, UNCLASSIFIED TYPES	0.02853357	0.4358761251080731
WAARDENBURG SYNDROME TYPE 2	0.02853076	0.4358331998130064
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0284774	0.43501807748391236
WEAVER SYNDROME	0.028467193999999998	0.434862171590158
OCULOPHARYNGODISTAL MYOPATHY	0.02846413	0.43481536621503913
JEUNE SYNDROME	0.02842969	0.4342892640221232
22Q11.2 DISTAL DELETION SYNDROME	0.02842969	0.4342892640221232
NOONAN SYNDROME 8; NS8	0.02842969	0.4342892640221232
NOONAN SYNDROME 10; NS10	0.02842969	0.4342892640221232
15Q24 RECURRENT MICRODELETION SYNDROME	0.02842969	0.4342892640221232
MENKES DISEASE	0.02842969	0.4342892640221232
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.028352500000000003	0.4331101168597775
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.028323354000000002	0.43266488531173075
OMODYSPLASIA 1; OMOD1	0.02831805	0.43258386190780435
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.02827233	0.4318854474983931
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.028224443999999998	0.4311539454771976
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.028111464	0.42942807364921703
DEAFNESS, X-LINKED 2	0.02811017	0.42940830662721846
OSTEOGENESIS IMPERFECTA, TYPE V	0.0279787	0.4273999833025185
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.02790338	0.4262494020838648
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.027810340000000003	0.4248281318158943
DWARFISM, LEVI TYPE	0.027777800000000002	0.4243310538438419
COLORECTAL CANCER, SUSCEPTIBILITY TO, 3	0.027777800000000002	0.4243310538438419
LYNCH SYNDROME I	0.027777800000000002	0.4243310538438419
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	0.4243310538438419
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	0.4243310538438419
EDINBURGH MALFORMATION SYNDROME	0.027777800000000002	0.4243310538438419
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	0.4243310538438419
PENTALOGY OF CANTRELL	0.027777800000000002	0.4243310538438419
METHANE PRODUCTION	0.027777800000000002	0.4243310538438419
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	0.4243310538438419
IMMUNODEFICIENCY 61; IMD61	0.027777800000000002	0.4243310538438419
MEESTER-LOEYS SYNDROME; MRLS	0.027777800000000002	0.4243310538438419
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	0.4243310538438419
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	0.4243310538438419
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	0.4243310538438419
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	0.4243310538438419
NASAL BONES, ABSENCE OF	0.027777800000000002	0.4243310538438419
CLEFT CHIN	0.027777800000000002	0.4243310538438419
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	0.4243310538438419
CYANIDE, INABILITY TO SMELL	0.027777800000000002	0.4243310538438419
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	0.4243310538438419
DIMPLES, FACIAL	0.027777800000000002	0.4243310538438419
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.027777800000000002	0.4243310538438419
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	0.4243310538438419
OROFACIAL CLEFT 3	0.027777800000000002	0.4243310538438419
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.027777800000000002	0.4243310538438419
MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA	0.0277778	0.4243310538438418
RENPENNING SYNDROME 1; RENS1	0.02770484	0.4232165237626819
DISTAL MONOSOMY 15Q	0.027685904	0.4229272592120124
STICKLER SYNDROME	0.02750425	0.42015232983477774
XQ21 MICRODELETION SYNDROME	0.027478554	0.4197598001614568
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.02741225	0.41874694650875355
WOODHOUSE-SAKATI SYNDROME	0.02732681	0.4174417731242372
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.02732681	0.4174417731242372
COFFIN-LOWRY SYNDROME; CLS	0.02727896	0.41671082103564755
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.027247970000000003	0.41623742071745745
POLYCYSTIC KIDNEY DISEASE 2	0.02724356	0.4161700539732425
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.027239554	0.4161088586949376
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.027158450000000004	0.4148699216376131
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.027074614	0.4135892508058678
IMMUNODEFICIENCY 55; IMD55	0.02706923	0.4135070053294839
BARDET-BIEDL SYNDROME 12; BBS12	0.027027	0.41286190383102744
BARDET-BIEDL SYNDROME 11; BBS11	0.027027	0.41286190383102744
CINCA SYNDROME; CINCA	0.02690544	0.4110049647319894
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.02679012	0.40924334728462963
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.02670151	0.40788974927898836
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.026676309999999998	0.40750479645490345
ICHTHYOSIS--CHEEK--EYEBROW SYNDROME	0.02662419	0.4067086162488993
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.026518539999999997	0.4050947168098291
OSTEOGENESIS IMPERFECTA, TYPE I	0.02651745	0.405078066072597
ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	0.02650376	0.4048689389233223
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.026422724	0.4036310406275866
XFE PROGEROID SYNDROME; XFEPS	0.02639535	0.40321287798447153
15Q24 MICRODELETION SYNDROME	0.026384614000000004	0.4030488758606868
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.026376939999999998	0.4029316485602094
2Q31.1 MICRODELETION SYNDROME	0.026342964	0.4024126343875465
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.02630173	0.40178274769118466
ACRORENAL-MANDIBULAR SYNDROME	0.02618089	0.3999368072442634
MONOSOMY 22Q13.3	0.026110004	0.3988539593915618
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.02609937	0.39869151541016035
COHEN-GIBSON SYNDROME; COGIS	0.026037034	0.39773927655134467
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.025937784000000002	0.3962231429088675
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.025864599999999998	0.3951051910248267
CONGENITAL MYASTHENIC SYNDROME	0.02581554	0.3943557550903187
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.02581554	0.3943557550903187
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.025800419999999998	0.39412478339586765
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.025750429999999998	0.39336114086904217
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.02574928	0.39334357357746697
AGNATHIA-OTOCEPHALY COMPLEX	0.02568767	0.39240242502620226
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.02565189	0.3918558531196247
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.02565189	0.3918558531196247
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.025650890000000003	0.391840577213907
CHEILITIS GLANDULARIS	0.025641000000000004	0.3916894985063595
ACNE INVERSA, FAMILIAL, 2, WITH OR WITHOUT DOWLING-DEGOS DISEASE; ACNINV2	0.025641000000000004	0.3916894985063595
RECURRENT RESPIRATORY PAPILLOMATOSIS	0.025641000000000004	0.3916894985063595
SQUAMOUS CELL CARCINOMA, HEAD AND NECK	0.025641000000000004	0.3916894985063595
ESOPHAGEAL CANCER	0.025641000000000004	0.3916894985063595
CANCER, ALOPECIA, PIGMENT DYSCRASIA, ONYCHODYSTROPHY, AND KERATODERMA; CAPOK	0.025641000000000004	0.3916894985063595
DISSEMINATED SUPERFICIAL ACTINIC POROKERATOSIS	0.025641000000000004	0.3916894985063595
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.025641000000000004	0.3916894985063595
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.025629994	0.3915213718880308
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.025615614	0.391301704363811
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.025545554	0.3902314744092322
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.025428153999999998	0.3884380830779796
PRADER-WILLI-LIKE SYNDROME	0.025400694	0.3880186067069729
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.025394914	0.38793031197192485
INTELLECTUAL DISABILITY, WOLFF TYPE	0.02531944	0.3867773782637906
BUSCHKE-OLLENDORFF SYNDROME	0.025153770000000002	0.38424661896354695
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.02503833	0.382483168407501
248110 MACROSOMIA WITH MICROPHTHALMIA, LETHAL	0.025	0.3818976429413434
COMBINED INFLAMMATORY AND IMMUNOLOGIC DEFECT	0.025	0.3818976429413434
202155 ADRENAL HYPOPLASIA, CYTOMEGALIC TYPE	0.025	0.3818976429413434
LATERALITY DEFECTS, AUTOSOMAL DOMINANT	0.025	0.3818976429413434
274210 THYMIC APLASIA WITH FETAL DEATH	0.025	0.3818976429413434
HOOFT DISEASE	0.025	0.3818976429413434
CLEFT-LIMB-HEART MALFORMATION SYNDROME	0.025	0.3818976429413434
EPIPHYSEAL DYSPLASIA, BAUMANN TYPE	0.025	0.3818976429413434
GROWTH CONTROL, Y-CHROMOSOME INFLUENCED	0.025	0.3818976429413434
CRISS-CROSS HEART	0.02496664	0.3813880387266024
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.02492624	0.38077089213560916
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.024893219999999997	0.3802664817288122
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.02484936	0.37959648050403594
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.024833924	0.37936068162337827
COCKAYNE SYNDROME	0.024817569999999997	0.3791108594612717
DEAFNESS, AUTOSOMAL DOMINANT 41; DFNA41	0.02477325	0.37843383131986535
221745 DEAFNESS, SENSORINEURAL, AUTOSOMAL-MITOCHONDRIAL TYPE	0.02475956	0.3782247041705907
DEAFNESS, AUTOSOMAL RECESSIVE 79; DFNB79	0.02475956	0.3782247041705907
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.02475956	0.3782247041705907
PALLISTER-KILLIAN SYNDROME	0.02466247	0.37674156648446366
FRYNS SYNDROME	0.024639579999999998	0.3763919010025865
DILATED CARDIOMYOPATHY WITH ATAXIA	0.024523339999999998	0.37461622972196645
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.02450113	0.3742769518559774
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.024498494	0.3742366845685057
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.024482939999999998	0.3739990831309733
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.024482939999999998	0.3739990831309733
BREAST CANCER	0.0243902	0.37258239563471807
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.024374134000000002	0.3723369729334583
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.024357654	0.3720852260072313
WEAVER SYNDROME	0.024254504	0.3705095163324553
BONE MARROW FAILURE SYNDROME 1; BMFS1	0.02424475	0.3703605151480853
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.02424396	0.3703484471825684
WOLMAN DISEASE	0.024219064000000002	0.36996813823382174
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.024194270000000004	0.3695893874274582
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.02409888	0.3681322187810512
X-LINKED AGAMMAGLOBULINEMIA	0.02403068	0.3670904020111072
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.023924743999999998	0.3654721336630018
GAPO SYNDROME	0.02390844	0.3652230752961812
MUCKLE-WELLS SYNDROME	0.02390769	0.3652116183668929
KLEEFSTRA SYNDROME	0.023894724	0.36501355097335786
BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 1; BCC1	0.0238095	0.36371167718447656
FAMILIAL MULTIPLE TRICHOEPITHELIOMA	0.0238095	0.36371167718447656
TRICHOEPITHELIOMA, MULTIPLE FAMILIAL, 1	0.0238095	0.36371167718447656
ROMBO SYNDROME	0.0238095	0.36371167718447656
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.023789304	0.36340316499260283
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.02360409	0.36057385339101333
11Q22.2Q22.3 MICRODELETION SYNDROME	0.023529984	0.3594418171219009
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.023511729999999998	0.3591629707389308
HENNEKAM-BEEMER SYNDROME	0.02342324	0.3578112058419757
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.023339604	0.35653359019137393
WHITE-SUTTON SYNDROME; WHSUS	0.023276073999999997	0.3555631119011313
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.023272854	0.35551392348472055
LIG4 SYNDROME	0.023272854	0.35551392348472055
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.023272854	0.35551392348472055
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.02325681	0.3552688368533865
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 5	0.0232558	0.3552534081886117
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 4	0.0232558	0.3552534081886117
DEAFNESS, AUTOSOMAL DOMINANT 70	0.0232558	0.3552534081886117
DEAFNESS, AUTOSOMAL RECESSIVE 111; DFNB111	0.0232558	0.3552534081886117
DEAFNESS, AUTOSOMAL DOMINANT 22; DFNA22	0.0232558	0.3552534081886117
OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALDOMINANT	0.0232558	0.3552534081886117
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.0232558	0.3552534081886117
USHER SYNDROME, TYPE IV; USH4	0.0232558	0.3552534081886117
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.0232558	0.3552534081886117
ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.0232558	0.3552534081886117
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.023245594	0.3550975022948573
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.023243749999999997	0.3550693335247139
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.02316021	0.35379318436106116
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.02316021	0.35379318436106116
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.02315953	0.3537827967451732
CK SYNDROME	0.023152604000000004	0.35367699582217277
TETRASOMY 18P	0.02307696	0.3525214652100665
X-LINKED RETINOSCHISIS	0.02305913	0.35224909581112074
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.022972104000000004	0.35091969484013624
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.022882614	0.3495526540374634
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.022829924	0.3487477665652002
PRIMARY PERITONEAL CARCINOMA	0.02280167	0.3483161611250536
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.02278036	0.3479906315742104
FEMORAL-FACIAL SYNDROME	0.02273052	0.3472292804332425
DENYS-DRASH SYNDROME	0.0227273	0.34718009201683164
WILMS TUMOR 3	0.0227273	0.34718009201683164
WILMS TUMOR 4	0.0227273	0.34718009201683164
WILMS TUMOR 6	0.0227273	0.34718009201683164
CHROMOSOME 5Q DELETION SYNDROME	0.0227273	0.34718009201683164
WILMS TUMOR 5	0.0227273	0.34718009201683164
NEPHROTIC SYNDROME, TYPE 4	0.0227273	0.34718009201683164
NEUTROPHILIA, HEREDITARY	0.0227273	0.34718009201683164
MULTIPLE TUMOR-ASSOCIATED CHROMOSOME REGION 1	0.0227273	0.34718009201683164
ALPHA-THALASSEMIA	0.0227273	0.34718009201683164
GRAY PLATELET SYNDROME	0.0227273	0.34718009201683164
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 4	0.0227273	0.34718009201683164
WILMS TUMOR 1	0.0227273	0.34718009201683164
SIMOSA CRANIOFACIAL SYNDROME	0.022715179999999998	0.34699494803953373
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.022708114	0.3468870084897328
MARDEN-WALKER SYNDROME	0.022675993999999998	0.34639634639808176
20Q11.2 MICRODUPLICATION SYNDROME	0.022616064	0.34548086136842276
POLYCYSTIC KIDNEY, CATARACT, AND CONGENITAL BLINDNESS	0.02261583	0.3454772868064848
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.02261583	0.3454772868064848
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.02261583	0.3454772868064848
MEGAEPIPHYSEAL DWARFISM	0.02255794	0.34459296462448985
NEPHROSIALIDOSIS	0.02255794	0.34459296462448985
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.02252193	0.34404287925959715
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.022474044	0.34331137723840155
DYSTONIA 28, CHILDHOOD-ONSET	0.022474044	0.34331137723840155
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.022460524	0.3431048469930989
ULNAR/FIBULA RAY DEFECT-BRACHYDACTYLY SYNDROME	0.02239099	0.3420426521649276
STICKLER SYNDROME, TYPE III	0.02233706	0.3412188225695745
CRANDALL SYNDROME	0.02233706	0.3412188225695745
19Q13.11 MICRODELETION SYNDROME	0.02221401	0.3393391223710172
CEREBROCOSTOMANDIBULAR SYNDROME	0.022172219999999996	0.3387007422710764
INDOMETHACIN EMBRYOFETOPATHY	0.022101959999999997	0.3376274571353541
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.022094184	0.33750867169249366
CAMURATI-ENGELMANN DISEASE	0.02206375	0.33704376477788256
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.02201429	0.33628821848108736
PYCNODYSOSTOSIS	0.02192849	0.3349775457705127
NEUROFIBROMATOSIS-NOONAN SYNDROME	0.02192849	0.3349775457705127
MALIGNANT PERITONEAL MESOTHELIOMA	0.02187503	0.33416089585084696
PERITONEAL CYSTIC MESOTHELIOMA	0.02187503	0.33416089585084696
HEPATOCELLULAR CARCINOMA	0.02187503	0.33416089585084696
JOUBERT SYNDROME 23; JBTS23	0.021822154	0.3333531670601203
PEHO SYNDROME	0.021822154	0.3333531670601203
AICARDI-GOUTIERES SYNDROME 7	0.021822154	0.3333531670601203
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.021822154	0.3333531670601203
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.021822154	0.3333531670601203
JOUBERT SYNDROME 30; JBTS30	0.021822154	0.3333531670601203
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.021822154	0.3333531670601203
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.021822154	0.3333531670601203
GM1 GANGLIOSIDOSIS	0.02175022	0.3322543100582266
NON-DISTAL TRISOMY 13Q	0.0217391	0.3320844419866463
ANGIOMA, HEREDITARY NEUROCUTANEOUSSPINAL ARTERIAL VENOUS MALFORMATIONS WITH CUTANEOUS HEMANGIOMAS, INCLUDED	0.0217391	0.3320844419866463
KLIPPEL-TRÉNAUNAY SYNDROME	0.0217391	0.3320844419866463
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.0217391	0.3320844419866463
HEMANGIOMA-THROMBOCYTOPENIA SYNDROME	0.0217391	0.3320844419866463
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.0217391	0.3320844419866463
LUMBAR SYNDROME	0.0217391	0.3320844419866463
X-LINKED INTELLECTUAL DISABILITY, SIDERIUS TYPE	0.02169183	0.33136234992337277
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.021676044	0.33112120447571386
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.02162906	0.3304034813214756
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.021621814	0.33029279210864554
HISTIOCYTOID CARDIOMYOPATHY	0.02154137	0.3290639371490946
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.021501464	0.32845433685552594
%211890 CAMPOMELIA, CUMMING TYPE;;CERVICAL LYMPHOCELE WITH BOWED LONG BONES;;CUMMING SYNDROME	0.021485189999999998	0.3282057367658768
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.021454654	0.32773927170888256
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.021378854	0.3265813580554844
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.021378854	0.3265813580554844
MECKEL SYNDROME 13; MKS13	0.021378854	0.3265813580554844
CHARGE SYNDROME	0.021359484	0.32628546376173345
SHUKLA-VERNON SYNDROME; SHUVER	0.021299354000000003	0.32536692355093094
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.021292274	0.3252587701384499
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.02128225	0.32510564445953616
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.0212766	0.3250193355922314
SPINOCEREBELLAR ATAXIA 12	0.0212766	0.3250193355922314
ACROPECTOROVERTEBRAL DYSPLASIA, F-FORM OF	0.0212766	0.3250193355922314
HUNTINGTON DISEASE; HD	0.0212766	0.3250193355922314
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 76	0.0212766	0.3250193355922314
FIBROSCLEROSIS, MULTIFOCAL	0.0212766	0.3250193355922314
KURU, SUSCEPTIBILITY TO	0.0212766	0.3250193355922314
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.0212766	0.3250193355922314
TIBIA, ABSENCE OR HYPOPLASIA OF, WITH POLYDACTYLY, RETROCEREBELLAR ARACHNOID CYST, AND OTHER ANOMALIES	0.0212766	0.3250193355922314
PRIMARY BASILAR INVAGINATION	0.0212766	0.3250193355922314
LEBER OPTIC ATROPHY AND DYSTONIA	0.0212766	0.3250193355922314
ISOLATED CEREBELLAR AGENESIS	0.0212766	0.3250193355922314
CENTRIFUGAL LIPODYSTROPHY	0.0212766	0.3250193355922314
JUVENILE ABSENCE EPILEPSY	0.0212766	0.3250193355922314
SERTOLI CELL-ONLY SYNDROME	0.0212766	0.3250193355922314
%164900 OPHTHALMOMANDIBULOMELIC DYSPLASIA;;OMM SYNDROME	0.0212766	0.3250193355922314
JUVENILE MYOCLONIC EPILEPSY	0.0212766	0.3250193355922314
ACROPECTORAL SYNDROME	0.0212766	0.3250193355922314
BREAST, UNILATERAL GIANT	0.0212766	0.3250193355922314
HERNIA, HIATUS	0.0212766	0.3250193355922314
ACHONDROPLASIA, SO-CALLED, AND SEVERE COMBINED IMMUNODEFICIENCY	0.0212766	0.3250193355922314
RAVINE SYNDROME	0.0212766	0.3250193355922314
NEUROFERRITINOPATHY	0.0212766	0.3250193355922314
PYLE DISEASE; PYL	0.0212766	0.3250193355922314
INFANTILE-ONSET ASCENDING HEREDITARY SPASTIC PARALYSIS	0.0212766	0.3250193355922314
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.0212766	0.3250193355922314
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.021215234000000003	0.32408191436196193
CLASSIC HODGKIN LYMPHOMA	0.02108133	0.3220364094827452
FOLLICULAR LYMPHOMA	0.02108133	0.3220364094827452
HODGKIN LYMPHOMA	0.02108133	0.3220364094827452
FELTY SYNDROME	0.02108133	0.3220364094827452
ENDOCARDIAL FIBROELASTOSIS	0.02093144	0.31974670397472604
11P15.4 MICRODUPLICATION SYNDROME	0.020902294	0.3193014724266793
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.020902294	0.3193014724266793
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.020897924000000002	0.3192347167186932
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02089104	0.31912955738373283
SHORT SYNDROME	0.0208909	0.3191274187569324
LATERAL MENINGOCELE SYNDROME	0.020860044	0.3186560654101085
AL KAISSI SYNDROME; ALKAS	0.020848854	0.3184851280251279
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0208333	0.31824752658759553
MYELINATED OPTIC NERVE FIBERS	0.0208333	0.31824752658759553
DEAFNESS, AUTOSOMAL RECESSIVE 37; DFNB37	0.0208333	0.31824752658759553
POLYCYSTIC KIDNEY DISEASE 5; PKD5	0.0208333	0.31824752658759553
SPASTIC PARAPLEGIA, SENSORINEURAL DEAFNESS, MENTAL RETARDATION, AND	0.0208333	0.31824752658759553
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1	0.0208333	0.31824752658759553
MELKERSSON-ROSENTHAL SYNDROME	0.0208333	0.31824752658759553
UNIQUE GREEN PHENOMENON	0.0208333	0.31824752658759553
DEAFNESS, AUTOSOMAL RECESSIVE 101; DFNB101	0.0208333	0.31824752658759553
POLYCYSTIC KIDNEY DISEASE 3	0.0208333	0.31824752658759553
DEAFNESS, AUTOSOMAL RECESSIVE 94; DFNB94	0.0208333	0.31824752658759553
AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY	0.0208333	0.31824752658759553
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 11	0.0208333	0.31824752658759553
PUPIL, EGG-SHAPED	0.0208333	0.31824752658759553
SETTING-SUN PHENOMENON, FAMILIAL BENIGN	0.0208333	0.31824752658759553
DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY	0.0208333	0.31824752658759553
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.0208333	0.31824752658759553
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.0208333	0.31824752658759553
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.0208333	0.31824752658759553
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.0208333	0.31824752658759553
IMINOGLYCINURIA	0.0208333	0.31824752658759553
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.0208333	0.31824752658759553
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.0208333	0.31824752658759553
MECKEL SYNDROME, TYPE 1; MKS1	0.0208333	0.31824752658759553
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5	0.0208333	0.31824752658759553
BLEPHAROCHALASIS AND DOUBLE LIP	0.0208333	0.31824752658759553
MYOCLONUS-CEREBELLAR ATAXIA-DEAFNESS SYNDROME	0.0208333	0.31824752658759553
DEAFNESS, AUTOSOMAL RECESSIVE 77; DFNB77	0.0208333	0.31824752658759553
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.0208333	0.31824752658759553
PREPAPILLARY VASCULAR LOOPS	0.0208333	0.31824752658759553
DERMOIDS OF CORNEA	0.0208333	0.31824752658759553
611426 TENTED EYEBROWS	0.0208333	0.31824752658759553
OCULAR CICATRICIAL PEMPHIGOID	0.0208333	0.31824752658759553
LARYNGOONYCHOCUTANEOUS SYNDROME	0.0208333	0.31824752658759553
MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS	0.0208333	0.31824752658759553
SEA-BLUE HISTIOCYTE DISEASE	0.0208333	0.31824752658759553
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.0208333	0.31824752658759553
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.0208333	0.31824752658759553
POLYCYSTIC KIDNEYS	0.0208333	0.31824752658759553
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.020829264	0.3181858730321191
SHORT RIB-POLYDACTYLY SYNDROME	0.020740849999999998	0.3168352691039984
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.020669680000000003	0.3157480828940731
MOEBIUS SYNDROME; MBS	0.020669680000000003	0.3157480828940731
SHPRINTZEN OMPHALOCELE SYNDROME	0.02046719	0.31265486474530535
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.02038535	0.31140468462137255
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.02038241	0.31135977345856264
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.02037166	0.3111955574720978
INTESTINAL LYMPHANGIECTASIA	0.02031634	0.3103504943677972
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.0203033	0.31015129655723905
DESBUQUOIS DYSPLASIA 2; DBQD2	0.020283124000000003	0.3098430898834797
MULTIPLE EPIPHYSEAL DYSPLASIA, BEIGHTON TYPE	0.0202581	0.3094608256188011
JOUBERT SYNDROME 2	0.020256134	0.30943079318816014
CINCA SYNDROME	0.020237284	0.3091428423653825
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.02020027	0.3085774199911492
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.020110374	0.307204177170755
WIEDEMANN-STEINER SYNDROME	0.02003146	0.30599869434695204
SYSTEMIC SCLEROSIS	0.02002387	0.305882750222555
2P15P16.1 MICRODELETION SYNDROME	0.019974293999999997	0.30512543192069663
GENITOPATELLAR SYNDROME	0.019947063999999997	0.3047094690080049
RICHIERI COSTA-DA SILVA SYNDROME	0.01993854	0.3045792571876677
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.01991379	0.30420117852115575
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.01989805	0.30396073576515986
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.019893474	0.3038908332205959
21Q22.11Q22.12 MICRODELETION SYNDROME	0.01988045	0.30369187982452917
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.01982544	0.302851552251001
CRANIOFRONTONASAL SYNDROME; CFNS	0.019802804	0.30250576684917624
MENTAL RETARDATION, X-LINKED 98; MRX98	0.019712024	0.30111902012812763
MULTIPLE CARBOXYLASE DEFICIENCY	0.019695614	0.3008683425153009
GORLIN SYNDROME	0.01969456	0.3008522417106745
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.019669034	0.30046230894132564
LOWRY-MACLEAN SYNDROME	0.01960251	0.29944609458936444
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.019588314	0.29922923783179667
LATERAL MENINGOCELE SYNDROME	0.01958472	0.2991743362266474
ALPHA-HEAVY CHAIN DISEASE	0.019522639999999997	0.29822600799969545
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.01951446	0.29810105109092505
HAREL-YOON SYNDROME; HAYOS	0.019509744	0.2980290099195606
CORNELIA DE LANGE SYNDROME 1	0.01949135	0.2977480249097901
ACRO-RENAL-MANDIBULAR SYNDROME	0.019420839999999998	0.2966709207976383
CLASSIC GALACTOSEMIA	0.01941514	0.2965838481350477
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.019413454	0.2965580929580077
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.019413454	0.2965580929580077
BAND HETEROTOPIA; BH	0.019413454	0.2965580929580077
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.01940872	0.2964857768203404
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.019381594	0.2960714026018433
TETRASOMY 12P	0.01931969	0.29512576293429765
GENITOPATELLAR SYNDROME; GTPTS	0.019295174	0.29475125882972364
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.01923023	0.29375918040879634
HEREDITARY CENTRAL DIABETES INSIPIDUS	0.019163339999999997	0.2927373750753424
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.019132654000000002	0.2922686186324906
YUNIS-VARON SYNDROME	0.019110750000000003	0.29193401519365114
CRANIOFACIAL-DEAFNESS-HAND SYNDROME	0.01907171	0.2913376438344339
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.019029964	0.29069993587434473
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.019029964	0.29069993587434473
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.018890544	0.2885701690991894
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0188679	0.28822426149011887
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.28822426149011887
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.28822426149011887
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0188679	0.28822426149011887
COPPER DEFICIENCY, FAMILIAL BENIGN	0.0188679	0.28822426149011887
KNUCKLE PADS	0.0188679	0.28822426149011887
RAYNAUD DISEASE	0.0188679	0.28822426149011887
SPINAL ARACHNOIDITIS	0.0188679	0.28822426149011887
VESICOURETERAL REFLUX 1	0.0188679	0.28822426149011887
CARPAL DISPLACEMENT	0.0188679	0.28822426149011887
TRACHEOBRONCHOMEGALY	0.0188679	0.28822426149011887
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.28822426149011887
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.28822426149011887
BEEMER LETHAL MALFORMATION SYNDROME	0.0188679	0.28822426149011887
THROMBOCYTOPENIA 3	0.0188679	0.28822426149011887
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.28822426149011887
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.28822426149011887
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.28822426149011887
PRIMARY HYPEROXALURIA TYPE 1	0.0188679	0.28822426149011887
PUBIC BONE DYSPLASIA	0.0188679	0.28822426149011887
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	0.28822426149011887
VAN DEN BOSCH SYNDROME	0.0188679	0.28822426149011887
LETTERER-SIWE DISEASE	0.0188679	0.28822426149011887
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.28822426149011887
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.28822426149011887
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.28822426149011887
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.28822426149011887
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.28822426149011887
TOE, MISSHAPEN	0.0188679	0.28822426149011887
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.28822426149011887
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.28822426149011887
MONOPHALANGY OF GREAT TOE	0.0188679	0.28822426149011887
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.28822426149011887
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.28822426149011887
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.28822426149011887
HHHH SYNDROME	0.0188679	0.28822426149011887
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0188679	0.28822426149011887
MEVALONIC ACIDURIA; MEVA	0.018837134000000002	0.28775428297480954
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.018822349999999998	0.2875284439846797
XP21 MICRODELETION SYNDROME	0.018804744	0.28725949638861475
CODAS SYNDROME	0.018772064	0.2867602797897618
MCDONOUGH SYNDROME	0.01875348	0.28647639235790495
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.018716014	0.2859040652742873
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.01864341	0.28479497341556276
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.018627084	0.2845455789788163
COFFIN-SIRIS SYNDROME 6; CSS6	0.018623014	0.2844834060425455
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.01860536	0.2842137252030061
X-LINKED INTELLECTUAL DISABILITY, MILES-CARPENTER TYPE	0.01860536	0.2842137252030061
MOMO SYNDROME	0.018563919999999998	0.28358069167006644
ATAXIA-TELANGIECTASIA	0.018563919999999998	0.28358069167006644
FRASER SYNDROME	0.01855297	0.28341342050245816
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.01851617	0.2828512671720485
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.018457584	0.28195631295967405
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.018456904	0.28194592534378604
LYSOSOMAL ACID LIPASE DEFICIENCY	0.018450514	0.28184831230625024
NEU-LAXOVA SYNDROME	0.01844923	0.2818286980433088
GALACTOSEMIA	0.018402004	0.28110727811988684
ALAGILLE SYNDROME	0.0184001	0.28107819279540047
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.018396410000000002	0.28102182470330234
ALLAN-HERNDON-DUDLEY SYNDROME	0.018396410000000002	0.28102182470330234
MENTAL RETARDATION, X-LINKED 102	0.018365390000000002	0.28054796610794075
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.018186980000000002	0.2778225917688541
MEHMO SYNDROME	0.0180993	0.2764832003555302
CURRY-JONES SYNDROME	0.018066914	0.2759884748729583
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.018045383999999998	0.27565958462285717
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.018045383999999998	0.27565958462285717
EEC SYNDROME	0.018028649999999997	0.27540395761657793
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.018017364	0.2752315537446486
LARSEN-LIKE SYNDROME	0.017978354	0.2746356406626029
JOUBERT SYNDROME 35; JBTS35	0.017934193999999997	0.2739610566661112
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.01791203	0.2736224814917852
AASE-SMITH SYNDROME	0.01791203	0.2736224814917852
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.01791135	0.2736120938758972
MICROSPORIDIOSIS	0.01790496	0.2735144808383614
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.01790496	0.2735144808383614
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.01789329	0.27333621101863637
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.01787422	0.2730448994966007
HOYERAAL-HREIDARSSON SYNDROME	0.017864144	0.2728909794705896
16P13.2 MICRODELETION SYNDROME	0.017846874000000002	0.2726271645788458
HEC SYNDROME	0.01783732	0.2724812185756193
SHORT STATURE DUE TO GHSR DEFICIENCY	0.01782585	0.27230600393703785
ALAGILLE SYNDROME 2	0.01772951	0.27083432318019907
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.017718354	0.27066390517601285
RHYNS SYNDROME; RHYNS	0.01770136	0.27040430643424707
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.01765958	0.26976607909336353
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.017655324	0.26970106483862916
RIFT VALLEY FEVER	0.01763261	0.2693540879161584
MARBURG HEMORRHAGIC FEVER	0.01763261	0.2693540879161584
CENTRAL DIABETES INSIPIDUS	0.01763261	0.2693540879161584
TRIOPIA	0.01752136	0.2676546434050694
FACIAL DYSMORPHISM-ANOREXIA-CACHEXIA-EYE AND SKIN ANOMALIES SYNDROME	0.01750815	0.2674528486905392
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.01750815	0.2674528486905392
RETT SYNDROME; RTT	0.01750815	0.2674528486905392
CROME SYNDROME	0.01749326	0.26722539045440336
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.017411784	0.2659807707601518
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.017393494	0.26570137444457587
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.017348239999999997	0.2650100786072292
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.017328534	0.2647090516091571
GALACTOSE EPIMERASE DEFICIENCY	0.017321024	0.26459432955721757
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS	0.01731859	0.26455714800270075
TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	0.01731859	0.26455714800270075
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.017310394000000003	0.2644319466794389
SOTOS SYNDROME 2	0.01725946	0.26365388369761594
FRAGILE X SYNDROME	0.01725946	0.26365388369761594
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.017249654	0.2635040881661486
16Q24.3 MICRODELETION SYNDROME	0.017248780000000002	0.2634907370245514
ALCOHOL DEPENDENCE	0.0172414	0.2633780008403551
MYOPATHY, CONGENITAL	0.0172414	0.2633780008403551
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.2633780008403551
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.2633780008403551
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.2633780008403551
JUMPING FRENCHMAN OF MAINE	0.0172414	0.2633780008403551
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.2633780008403551
DIASTEMATOMYELIA	0.0172414	0.2633780008403551
MOTION SICKNESS	0.0172414	0.2633780008403551
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.2633780008403551
PALMOMENTAL REFLEX	0.0172414	0.2633780008403551
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.2633780008403551
SICKLE CELL ANEMIA	0.0172414	0.2633780008403551
CARDIAC ARRHYTHMIA	0.0172414	0.2633780008403551
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.2633780008403551
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.2633780008403551
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.2633780008403551
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.2633780008403551
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.2633780008403551
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.2633780008403551
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.2633780008403551
RHEUMATOID ARTHRITIS	0.0172414	0.2633780008403551
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.2633780008403551
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.2633780008403551
269800 SENILE PLAQUE FORMATION	0.0172414	0.2633780008403551
TRANSSEXUALITY	0.0172414	0.2633780008403551
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.2633780008403551
CERVICAL RIB	0.0172414	0.2633780008403551
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.2633780008403551
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.2633780008403551
ERYTHERMALGIA, PRIMARY	0.0172414	0.2633780008403551
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.2633780008403551
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.2633780008403551
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.2633780008403551
MOSAIC TRISOMY 15	0.0172414	0.2633780008403551
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.2633780008403551
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.2633780008403551
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.2633780008403551
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.2633780008403551
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.2633780008403551
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.017237024	0.2633111534769346
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.017225464	0.26313456400683854
LELIS SYNDROME	0.01722023	0.26305460991631235
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.017212254	0.26293276929230835
SECKEL SYNDROME 9; SCKL9	0.017211574	0.26292238167642035
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.017137430000000002	0.26178976492289063
MEIER-GORLIN SYNDROME 7	0.017118124	0.26149484828710556
SPONDYLOOCULAR SYNDROME; SOS	0.01709608	0.2611581062214656
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.01704947	0.2604460962559658
CHROMOSOME 10Q26 DELETION SYNDROME	0.016850304	0.25740365521780356
WARBURG MICRO SYNDROME 2; WARBM2	0.01684137	0.25726718027612205
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.01682755	0.25705606725910407
POLYVALVULAR HEART DISEASE SYNDROME	0.01678812	0.25645373829665696
CYCLIC VOMITING SYNDROME	0.01671779	0.2553793838475344
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.016716924	0.25536615491318293
22Q11.2 MICRODUPLICATION SYNDROME	0.016701644	0.25513273907381717
JOUBERT SYNDROME 14	0.016676523999999998	0.25474900832218966
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.01666817	0.2546213934058244
ACQUIRED PURPURA FULMINANS	0.0166667	0.2545989378244195
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.0166667	0.2545989378244195
BROOKE-SPIEGLER SYNDROME; BSS	0.0166667	0.2545989378244195
PAGET DISEASE, EXTRAMAMMARY	0.0166667	0.2545989378244195
TRIGEMINAL NEURALGIA	0.0166667	0.2545989378244195
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0166667	0.2545989378244195
ADAMANTINOMA OF LONG BONES	0.0166667	0.2545989378244195
CHYLOUS ASCITES	0.0166667	0.2545989378244195
ICHTHYOSIS, X-LINKED	0.0166667	0.2545989378244195
SECONDARY INTESTINAL LYMPHANGIECTASIA	0.0166667	0.2545989378244195
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.0166667	0.2545989378244195
CANCER, FAMILIAL, WITH IN VITRO RADIORESISTANCE	0.0166667	0.2545989378244195
DERMATOLEUKODYSTROPHY	0.0166667	0.2545989378244195
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.0166667	0.2545989378244195
HURIEZ SYNDROME; HRZ	0.0166667	0.2545989378244195
ANTISYNTHETASE SYNDROME	0.0166667	0.2545989378244195
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.0166667	0.2545989378244195
ONCOCYTOMA	0.0166667	0.2545989378244195
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.0166667	0.2545989378244195
BUTYRYLCHOLINESTERASE DEFICIENCY	0.0166667	0.2545989378244195
PITYRIASIS RUBRA PILARIS	0.0166667	0.2545989378244195
EPIDERMOLYSIS BULLOSA SIMPLEX	0.0166667	0.2545989378244195
NASOPHARYNGEAL CARCINOMA	0.0166667	0.2545989378244195
GENITOPALATOCARDIAC SYNDROME	0.016665959999999997	0.25458763365418835
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.016619474	0.25387751790099755
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.016590104	0.25342886455007013
MENTAL RETARDATION, X-LINKED 107; MRX107	0.016559684	0.25296417149813905
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.016559684	0.25296417149813905
RENAL COLOBOMA SYNDROME	0.016461379999999998	0.25146248886247075
CHÉDIAK-HIGASHI SYNDROME	0.016418554	0.25080828292420654
17Q12 MICRODELETION SYNDROME	0.016413493999999997	0.2507309868412752
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.016413493999999997	0.2507309868412752
MCDONOUGH SYNDROME	0.016399329999999997	0.25051461891269033
SALLA DISEASE	0.016390294	0.25037658582862565
CRANIOFACIOFRONTODIGITAL SYNDROME	0.016380560000000002	0.25022789016237007
WIEACKER-WOLFF SYNDROME	0.016359904	0.2499123510538662
SCHAAF-YANG SYNDROME; SHFYNG	0.016172954	0.2470565204799508
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.016123484	0.24630082142409848
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.01609037	0.2457949750821641
FAMILIAL HYPOALDOSTERONISM	0.01607392	0.24554368643310867
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.016063973999999998	0.24539175227484086
ARTHROGRYPOSIS-LIKE HAND ANOMALY-SENSORINEURAL DEAFNESS SYNDROME	0.01604455	0.24509503308218122
MOYNAHAN SYNDROME	0.01604455	0.24509503308218122
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.01601413	0.2446303400302502
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.01601413	0.2446303400302502
DYSMORPHISM-CLEFT PALATE-LOOSE SKIN SYNDROME	0.01601413	0.2446303400302502
ADULT-ONSET NEMALINE MYOPATHY	0.01601413	0.2446303400302502
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.01601413	0.2446303400302502
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.01601413	0.2446303400302502
WEYERS ULNAR RAY/OLIGODACTYLY SYNDROME	0.01601413	0.2446303400302502
NEMALINE MYOPATHY 1; NEM1	0.01601413	0.2446303400302502
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.016002374	0.24445075648263345
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.015951904	0.24367978152106343
SIALIDOSIS TYPE 1	0.015903590000000002	0.24294174141222075
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.01589	0.24273414185351783
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.01588199	0.2426117818487194
HEREDITARY METHEMOGLOBINEMIA	0.01588199	0.2426117818487194
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.01588199	0.2426117818487194
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1	0.015872999999999998	0.24247445145631769
MIXED-TYPE AUTOIMMUNE HEMOLYTIC ANEMIA	0.015872999999999998	0.24247445145631769
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.015872999999999998	0.24247445145631769
SCHNITZLER SYNDROME	0.015872999999999998	0.24247445145631769
X-LINKED LYMPHOPROLIFERATIVE DISEASE	0.015872999999999998	0.24247445145631769
OMENN SYNDROME	0.015872999999999998	0.24247445145631769
FOLLICULAR LYMPHOMA	0.015872999999999998	0.24247445145631769
THYROID LYMPHOMA	0.015872999999999998	0.24247445145631769
AUTOIMMUNE HEMOLYTIC ANEMIA	0.015872999999999998	0.24247445145631769
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.015872999999999998	0.24247445145631769
LYMPHOMA, NON-HODGKIN, FAMILIAL	0.015872999999999998	0.24247445145631769
BARDET-BIEDL SYNDROME	0.015867939999999997	0.24239715537338635
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.015859104	0.2422621774704652
MULTIPLE EPIPHYSEAL DYSPLASIA	0.015776850000000002	0.24100567312156534
KOOLEN-DE VRIES SYNDROME	0.015751364	0.24061635138844517
HEREDITARY FRUCTOSE INTOLERANCE	0.01573754	0.24040517726780433
CRANIOFACIAL DYSSYNOSTOSIS	0.01571489	0.24005917800329946
CORNELIA DE LANGE SYNDROME 3	0.015704104	0.23989441208422885
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.015619980000000002	0.238609341791637
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.015566159999999999	0.23778719254591282
16P11.2P12.2 MICRODELETION SYNDROME	0.015564304000000001	0.23775884046490087
TEMTAMY SYNDROME	0.015514514	0.23699825311921888
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.015489483999999998	0.23661589719910597
MECKEL SYNDROME	0.01548113	0.23648828228274074
TETRAAMELIA-MULTIPLE MALFORMATIONS SYNDROME	0.01548113	0.23648828228274074
WARBURG MICRO SYNDROME 1	0.01543344	0.23575977433906584
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.015406350000000001	0.23534595005317463
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.015395614000000002	0.2351819479293899
NOONAN SYNDROME	0.01535897	0.23462217764027216
OROFACIODIGITAL SYNDROME XVII	0.01532724	0.23413747315185102
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.015326644	0.2341283687120433
WOLCOTT-RALLISON SYNDROME	0.015321089999999999	0.2340435263316874
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.01531355	0.23392834600257634
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.015219374	0.23248972230571055
BOR SYNDROME	0.015216049999999998	0.23243894519510505
VICI SYNDROME; VICIS	0.015132914	0.23116896749736227
MONOSOMY 5P	0.01510155	0.23068985399043374
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.015086344000000002	0.2304575685680911
PEDIATRIC-ONSET GRAVES DISEASE	0.015083884	0.23041998984002568
TRANSKETOLASE DEFICIENCY	0.015081534	0.2303840914615892
CHOPS SYNDROME; CHOPS	0.015073244000000001	0.23025745420318985
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.015065284	0.2301358579936773
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.015063	0.23010096782501818
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.015019614000000002	0.22943820737955212
KNIEST-LIKE DYSPLASIA, LETHAL	0.01498231	0.2288683549926607
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.01492604	0.22800877977792833
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.01492604	0.22800877977792833
OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS	0.014898439999999999	0.2275871647801211
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.014896304	0.2275545354455082
MCKUSICK-KAUFMAN SYNDROME	0.014896043999999999	0.22755056371002155
MARINESCO-SJOGREN SYNDROME; MSS	0.014844094	0.22675698040798947
OCULOFACIOCARDIODENTAL SYNDROME	0.014820844	0.226401815600054
WARBURG MICRO SYNDROME 3; WARBM3	0.014781550000000001	0.22580156416078453
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.01476957	0.22561855881028703
FRYNS SYNDROME; FRNS	0.01476957	0.22561855881028703
TYROSINE TRANSAMINASE DEFICIENCY	0.014760740000000001	0.22548367256280016
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.014760740000000001	0.22548367256280016
PYCNODYSOSTOSIS	0.014730350000000001	0.22501943778804068
SIALIDOSIS TYPE 2	0.014680304000000002	0.224254939810495
MARSHALL-SMITH SYNDROME; MRSHSS	0.01467535	0.22417926297356972
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.014668750000000001	0.2240784419958332
SAETHRE-CHOTZEN SYNDROME	0.014665609999999999	0.22403047565187975
MULIBREY NANISM	0.014540790000000001	0.22212373710020225
FRYNS-SMEETS-THIRY SYNDROME	0.014540790000000001	0.22212373710020225
CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-POLYDACTYLY SYNDROME	0.014540790000000001	0.22212373710020225
JOUBERT SYNDROME 21	0.014530643999999999	0.2219687477607909
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.014523184000000001	0.22185478950413726
8P INVERTED DUPLICATION/DELETION SYNDROME	0.01444966	0.22073164381215243
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.014434454000000001	0.2204993583898098
FEINGOLD SYNDROME 1; FGLDS1	0.014421220000000002	0.2202971970535424
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.014355344	0.21929088148848622
FORSYTHE-WAKELING SYNDROME; FWS	0.014355344	0.21929088148848622
N-ACETYLASPARTATE DEFICIENCY; NACED	0.014355344	0.21929088148848622
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.014355344	0.21929088148848622
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.014355344	0.21929088148848622
JUBERG-MARSIDI SYNDROME	0.01435075	0.2192207039776193
PAGOD SYNDROME	0.014350489999999999	0.2192167322421327
SENGERS SYNDROME	0.01432893	0.21888738371486008
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.014318974	0.21873529679753514
KAGAMI-OGATA SYNDROME	0.014296504000000002	0.2183920471960595
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.01428898	0.21827711128143984
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.014244414	0.2175963252672269
TRISOMY X	0.014244153999999998	0.21759235353174025
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.014227624000000001	0.2173398428102275
HALL-RIGGS SYNDROME	0.01419427	0.21683033025092086
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.014171194	0.21647782345058028
MUCOPOLYSACCHARIDOSIS TYPE 4	0.014134750000000001	0.21592110834260614
CONO-SPONDYLAR DYSPLASIA	0.01406481	0.21485271149671342
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.013998779999999999	0.2138440434421767
HYPERTRICHOSIS CUBITI	0.013998064000000001	0.21383310589368293
ANGELMAN SYNDROME	0.013985984	0.2136485729526136
TYPICAL NEMALINE MYOPATHY	0.013956360000000001	0.21319603952163388
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.013950894	0.21311254142098116
LASSA FEVER	0.01394173	0.21297255302098458
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.013938100000000002	0.2129171014832295
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.013909620000000001	0.21248204368839074
LARYNGOTRACHEOESOPHAGEAL CLEFT TYPE 4	0.013888900000000001	0.21216552692192095
BETHLEM MYOPATHY	0.013888900000000001	0.21216552692192095
OCULOGASTROINTESTINAL MUSCULAR DYSTROPHY	0.013888900000000001	0.21216552692192095
IDIOPATHIC BRONCHIECTASIS	0.013888900000000001	0.21216552692192095
MAJEED SYNDROME	0.013888900000000001	0.21216552692192095
MULTICENTRIC RETICULOHISTIOCYTOSIS	0.013888900000000001	0.21216552692192095
RING CHROMOSOME 10 SYNDROME	0.013888900000000001	0.21216552692192095
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.013888900000000001	0.21216552692192095
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.013888900000000001	0.21216552692192095
INFANTILE NEUROAXONAL DYSTROPHY	0.013888900000000001	0.21216552692192095
WHIPPLE DISEASE	0.013888900000000001	0.21216552692192095
PROGRESSIVE NODULAR HISTIOCYTOSIS	0.013888900000000001	0.21216552692192095
AUTOSOMAL DOMINANT CONGENITAL BENIGN SPINAL MUSCULAR ATROPHY	0.013888900000000001	0.21216552692192095
2Q32Q33 MICRODELETION SYNDROME	0.013878164000000002	0.21200152479813622
PITT-HOPKINS-LIKE SYNDROME	0.01386023	0.2117275667049958
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.01381767	0.21107742415765246
OVARIAN DYSGENESIS 4; ODG4	0.01380979	0.21095705002059736
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.01380979	0.21095705002059736
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.01380979	0.21095705002059736
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 63	0.01380979	0.21095705002059736
SECKEL SYNDROME 4	0.01380979	0.21095705002059736
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.01380979	0.21095705002059736
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.01380979	0.21095705002059736
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.01380979	0.21095705002059736
CHOREOACANTHOCYTOSIS	0.01377772	0.21046715172423222
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.013761404000000001	0.21021791004654297
RESTRICTIVE DERMOPATHY, LETHAL	0.013750950000000001	0.2100582157281706
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.013748874000000001	0.2100265029479008
ALAZAMI SYNDROME; ALAZS	0.013703454	0.20933267131020492
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.013703454	0.20933267131020492
MULTINODULAR GOITER-CYSTIC KIDNEY-POLYDACTYLY SYNDROME	0.013698599999999998	0.2092585220638514
NPHP3-RELATED MECKEL-LIKE SYNDROME	0.013698599999999998	0.2092585220638514
46,XX DISORDER OF SEX DEVELOPMENT-ANORECTAL ANOMALIES SYNDROME	0.013698599999999998	0.2092585220638514
PRUNE BELLY SYNDROME	0.013698599999999998	0.2092585220638514
INFUNDIBULOPELVIC DYSGENESIS	0.013698599999999998	0.2092585220638514
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.013698599999999998	0.2092585220638514
TRISOMY 1Q	0.013698599999999998	0.2092585220638514
CYSTIC HAMARTOMA OF LUNG AND KIDNEY	0.013698599999999998	0.2092585220638514
RENAL HYPODYSPLASIA/APLASIA 3; RHDA3	0.013698599999999998	0.2092585220638514
THOMAS SYNDROME	0.013698599999999998	0.2092585220638514
RADIO-RENAL SYNDROME	0.013698599999999998	0.2092585220638514
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.013696719999999999	0.20922980336110222
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.013690069999999999	0.2091282185880798
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.013687979999999999	0.20909629194512994
LAMB-SHAFFER SYNDROME	0.013665624000000001	0.2087547837969061
PFEIFFER SYNDROME	0.0136411	0.20838015748508631
MICROCORNEA-GLAUCOMA-ABSENT FRONTAL SINUSES SYNDROME	0.0136212	0.20807616696130504
THORACOMELIC DYSPLASIA	0.0136212	0.20807616696130504
DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	0.0136212	0.20807616696130504
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.013616864000000001	0.20800993063411333
ISOLATED COMPLEX I DEFICIENCY	0.013600014	0.20775253162277083
ABRUZZO-ERICKSON SYNDROME	0.01358897	0.20758382452002508
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.013498180000000002	0.2061969250399193
MARFANOID HABITUS WITH SITUS INVERSUS	0.013456969999999999	0.20556740496529474
NEUROGENIC ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.01345251	0.20549927442579402
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.01344043	0.20531474148472476
ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	0.01344043	0.20531474148472476
OCULOAURICULOVERTEBRAL SPECTRUM WITH RADIAL DEFECTS	0.01342028	0.20500693198451403
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.013408634000000001	0.20482902878652628
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.013392544000000001	0.2045832394635292
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.01333261	0.20366769333024734
BARDET-BIEDL SYNDROME 16; BBS16	0.013299004	0.20315433124269985
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.013290844000000001	0.20302967985204382
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.013285314	0.20294520409342517
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.013279494	0.20285629832214847
FLOATING-HARBOR SYNDROME	0.0132451	0.20233089882089544
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.013224204	0.20201169349501938
SHORT SYNDROME	0.0132056	0.20172750054504815
PARANA HARD SKIN SYNDROME	0.013158620000000001	0.20100983849443277
MEIER-GORLIN SYNDROME 8; MGORS8	0.0131579	0.20099883984231606
WEAVER-WILLIAMS SYNDROME	0.0131579	0.20099883984231606
FG SYNDROME 2; FGS2	0.0131579	0.20099883984231606
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.0131579	0.20099883984231606
ANTERIOR CUTANEOUS NERVE ENTRAPMENT SYNDROME	0.0131579	0.20099883984231606
ALG13-CDG	0.0131579	0.20099883984231606
GRANGE SYNDROME; GRNG	0.0131579	0.20099883984231606
FILIPPI SYNDROME; FLPIS	0.0131579	0.20099883984231606
TRIGLYCERIDE STORAGE DISEASE, TYPE I	0.0131579	0.20099883984231606
4Q21 MICRODELETION SYNDROME	0.01313755	0.2006879751609618
MALIGNANT ATROPHIC PAPULOSIS	0.013125830000000002	0.20050894154595092
BEHÇET DISEASE	0.013125830000000002	0.20050894154595092
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.0130836	0.1998638400474944
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.01301853	0.19886983686244666
BLEPHAROCHEILODONTIC SYNDROME 2; BCDS2	0.012989210000000001	0.19842194730680507
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.012981409999999999	0.1983027952422073
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.012969834	0.19812596135761976
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.012969834	0.19812596135761976
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.012969834	0.19812596135761976
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.012958314	0.1979499829237524
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.012955294	0.19790384968848507
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.01293708	0.19762561434174378
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.01290377	0.1971167739222887
SCALP-EAR-NIPPLE SYNDROME	0.01289363	0.19696187623831168
CRYPTOSPORIDIOSIS	0.012874029999999998	0.1966624684862457
SECONDARY SHORT BOWEL SYNDROME	0.012874029999999998	0.1966624684862457
ADENYLOSUCCINASE DEFICIENCY	0.012847933999999998	0.19626382845063778
GRANULOMATOSIS WITH POLYANGIITIS	0.01284706	0.19625047730904058
1Q41Q42 MICRODELETION SYNDROME	0.0128382	0.19611513278438214
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.0128382	0.19611513278438214
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.012832600000000001	0.1960295877123633
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.012816510000000001	0.19578379838936627
BRANCHIOOTIC SYNDROME	0.012768390000000001	0.19504872180623276
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.012740654	0.1946250292852479
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.012740654	0.1946250292852479
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.012740654	0.1946250292852479
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.012740654	0.1946250292852479
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.012740654	0.1946250292852479
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.012740654	0.1946250292852479
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.012740654	0.1946250292852479
ELEJALDE DISEASE	0.012740654	0.1946250292852479
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.012716083999999999	0.19424970028176514
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.012710174000000001	0.19415941967897385
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.012695320000000001	0.19393251137544382
EMANUEL SYNDROME	0.012685954000000001	0.19378943724249226
CHROMOSOME 5Q12 DELETION SYNDROME	0.012669774000000002	0.19354227308798064
PRADER-WILLI SYNDROME; PWS	0.012639384000000002	0.19307803831322115
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.01262855	0.19291253915067608
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.01261486	0.19270341200140137
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.01261486	0.19270341200140137
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.01260988	0.19262733799092746
NEONATAL ADRENOLEUKODYSTROPHY	0.01259092	0.19233770681852075
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.01252663	0.1913556188399328
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.012510964000000001	0.19111630650096004
OTOFACIOCERVICAL SYNDROME	0.012462074	0.19036946747042394
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.012452384	0.19022144394401988
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.012433444	0.1899321182897275
EBOLA HEMORRHAGIC FEVER	0.01242428	0.1897921298897309
LUJO HEMORRHAGIC FEVER	0.01242428	0.1897921298897309
SCRUB TYPHUS	0.01242428	0.1897921298897309
CENTRAL NEUROCYTOMA	0.01242428	0.1897921298897309
DENGUE FEVER	0.01242428	0.1897921298897309
YELLOW FEVER	0.01242428	0.1897921298897309
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.01241942	0.18971788898794315
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.01241942	0.18971788898794315
ACROOTOOCULAR SYNDROME	0.01235761	0.18877368525553495
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.012354684000000001	0.18872898795540513
CODAS SYNDROME	0.012308014	0.1880160614355622
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.0122988	0.18787530924027973
COFFIN-SIRIS SYNDROME	0.012243684000000001	0.18703336242074556
SUMMITT SYNDROME	0.01223433	0.1868904715986626
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.012196740000000001	0.186316250302736
609612 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, WITH SYNERGISTIC DIVERGENCE;;CONGENITAL FIBROSIS SYNDROME WITH SYNERGISTIC DIVERGENCE;;EXTERNAL OPHTHALMOPLEGIA WITH SYNERGISTIC DIVERGENCEEXTERNAL OPHTHALMOPLEGIA, SYNERGISTIC DIVERGENCE, JAW WINKING, ANDOCULOCUTANEOUS HYPOPIGMENTATION, INCLUDED	0.0121951	0.18629119781735903
FACIOCARDIOMELIC SYNDROME	0.0121951	0.18629119781735903
COMBINED HAMARTOMA OF THE RETINA AND RETINAL PIGMENT EPITHELIUM	0.0121951	0.18629119781735903
CATARACT 48; CTRCT48	0.0121951	0.18629119781735903
ACHROMATOPSIA	0.0121951	0.18629119781735903
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.0121951	0.18629119781735903
MENTAL RETARDATION, AUTOSOMAL DOMINANT 4; MRD4	0.0121951	0.18629119781735903
TONNE-KALSCHEUER SYNDROME; TOKAS	0.012186444000000001	0.18615896957746703
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.012182454	0.1860980187136536
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.012170529999999999	0.18591586881387626
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.012153014	0.18564829604932587
CLASSIC PHENYLKETONURIA	0.012112694	0.18503237153079005
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.012109734	0.18498715484986583
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.012096254	0.18478123564079185
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.012096254	0.18478123564079185
LARSEN SYNDROME	0.01208521	0.18461252853804608
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.0120574	0.1841877056000381
BIOTINIDASE DEFICIENCY	0.012001954	0.18334071773161711
FONTAINE PROGEROID SYNDROME; FPS	0.01199977	0.18330735515352975
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.01195799	0.18266912781264616
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.01193903	0.18237949664023945
DISTAL MONOSOMY 19P13.3	0.011928814	0.1822234379874279
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.011924299999999999	0.1821544825490184
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.0119173	0.18204755120899482
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.01188789	0.18159828682183862
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.01188789	0.18159828682183862
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.01188789	0.18159828682183862
FANCONI ANEMIA, COMPLEMENTATION GROUP O	0.01188789	0.18159828682183862
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.011859994	0.181172150155939
OCULOECTODERMAL SYNDROME; OES	0.011850784	0.18103145906427937
3Q27.3 MICRODELETION SYNDROME	0.0118411	0.18088352719330963
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.011822820000000001	0.18060428363679093
ZTTK SYNDROME; ZTTKS	0.011820394000000001	0.1805672242895199
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.011817964	0.180530103838626
BARDET-BIEDL SYNDROME 17; BBS17	0.011781554	0.1799739081114462
JOUBERT SYNDROME 7	0.011781554	0.1799739081114462
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.011781554	0.1799739081114462
JOUBERT SYNDROME 1	0.011781554	0.1799739081114462
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.011781554	0.1799739081114462
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.011762990000000001	0.1796903261977037
MUCOPOLYSACCHARIDOSIS TYPE IX	0.011762990000000001	0.1796903261977037
MARSHALL SYNDROME	0.01176246	0.17968222996767333
CAMPOMELIC DYSPLASIA	0.011715650000000001	0.17896716482102998
SHELDON-HALL SYNDROME	0.011640890000000001	0.1778251381095782
BANGSTAD SYNDROME	0.011640890000000001	0.1778251381095782
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.01160408	0.17726283202011134
TEMPLE-BARAITSER SYNDROME	0.01159287	0.17709158911701642
CATARACT-DEAFNESS-HYPOGONADISM SYNDROME	0.01158961	0.1770417896643769
8Q21.11 MICRODELETION SYNDROME	0.01158756	0.1770104740576557
SHPRINTZEN-GOLDBERG SYNDROME	0.01156418	0.17665332338197695
13Q12.3 MICRODELETION SYNDROME	0.011532990000000002	0.17617686788264336
PROPIONIC ACIDEMIA	0.011502814	0.1757159021517074
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.011480404000000001	0.17537356910457483
MYOTONIA WITH SKELETAL ABNORMALITIES AND MENTAL RETARDATION	0.01146396	0.1751223721109537
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.011441940000000001	0.17478599666705097
ADAMS-OLIVER SYNDROME	0.011431219999999999	0.1746222389577577
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.011357624	0.17349799340056127
COFS SYNDROME	0.011345590000000001	0.17331416315115505
PFAPA SYNDROME	0.0113433	0.1732791813270616
STEVENS-JOHNSON SYNDROME	0.0113433	0.1732791813270616
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.0113433	0.1732791813270616
ACUTE ADRENAL INSUFFICIENCY	0.0113433	0.1732791813270616
NODULAR NON-SUPPURATIVE PANNICULITIS	0.0113433	0.1732791813270616
TOXIC EPIDERMAL NECROLYSIS	0.0113433	0.1732791813270616
ERDHEIM-CHESTER DISEASE	0.0113433	0.1732791813270616
CASTLEMAN DISEASE	0.0113433	0.1732791813270616
PSEUDOMYXOMA PERITONEI	0.0113433	0.1732791813270616
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.0113433	0.1732791813270616
MICROTIA WITH MEATAL ATRESIA AND CONDUCTIVE DEAFNESS	0.011264630000000001	0.17207742582425378
MULTIPLE SYNOSTOSES SYNDROME	0.011264630000000001	0.17207742582425378
JOHNSON NEUROECTODERMAL SYNDROME	0.011264630000000001	0.17207742582425378
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.011264630000000001	0.17207742582425378
BARDET-BIEDL SYNDROME 6; BBS6	0.011236	0.17164007664355732
BARDET-BIEDL SYNDROME 4; BBS4	0.011236	0.17164007664355732
MECKEL SYNDROME, TYPE 10; MKS10	0.011236	0.17164007664355732
228940 FIBULOULNAR APLASIA OR HYPOPLASIA WITH RENAL ABNORMALITIES	0.011236	0.17164007664355732
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.011236	0.17164007664355732
POLYCYSTIC LIVER DISEASE 3 WITH OR WITHOUT KIDNEY CYSTS; PCLD3	0.011236	0.17164007664355732
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 3; CAKUT3	0.011236	0.17164007664355732
NEPHRONOPHTHISIS 20	0.011236	0.17164007664355732
MECKEL SYNDROME, TYPE 6; MKS6	0.011236	0.17164007664355732
BARDET-BIEDL SYNDROME 10; BBS10	0.011236	0.17164007664355732
POLYCYSTIC LIVER DISEASE 4 WITH OR WITHOUT KIDNEY CYSTS; PCLD4	0.011236	0.17164007664355732
AXIAL OSTEOMALACIA	0.011236	0.17164007664355732
GENITOPALATOCARDIAC SYNDROME	0.011236	0.17164007664355732
RENAL CYSTS AND DIABETES SYNDROME; RCAD	0.011236	0.17164007664355732
ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	0.011236	0.17164007664355732
MECKEL SYNDROME, TYPE 4; MKS4	0.011236	0.17164007664355732
CONGENITAL MEGACALYCOSIS	0.011236	0.17164007664355732
ADAMS-OLIVER SYNDROME 2; AOS2	0.011224844	0.1714696586393712
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.011219014000000001	0.1713806001090373
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.011177124	0.17074069241852477
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.011168504000000001	0.1706090141112386
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.011118254000000001	0.1698413998489265
19P13.12 MICRODELETION SYNDROME	0.011116374	0.1698126811461773
LICHEN PLANUS, FAMILIAL	0.0111111	0.1697321160194224
SPINOCEREBELLAR ATAXIA 34; SCA34	0.0111111	0.1697321160194224
EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL	0.0111111	0.1697321160194224
PRENATAL BOWING	0.0111111	0.1697321160194224
131600 EPIDERMOID CYSTS	0.0111111	0.1697321160194224
PARANA HARD-SKIN SYNDROME	0.0111111	0.1697321160194224
CALLOSITIES, HEREDITARY PAINFUL	0.0111111	0.1697321160194224
SEBACEOUS GLAND HYPERPLASIA, FAMILIAL PRESENILE	0.0111111	0.1697321160194224
KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY	0.0111111	0.1697321160194224
DERMATOSIS PAPULOSA NIGRA	0.0111111	0.1697321160194224
PILONIDAL SINUS	0.0111111	0.1697321160194224
LENTIGINES	0.0111111	0.1697321160194224
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0111111	0.1697321160194224
HYPOPLASMINOGENEMIA	0.0111111	0.1697321160194224
TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1; HFTC1	0.0111111	0.1697321160194224
PIGMENTED PURPURIC ERUPTION	0.0111111	0.1697321160194224
DERMAL RIDGES, PATTERNLESS	0.0111111	0.1697321160194224
CAROTENEMIA, FAMILIAL	0.0111111	0.1697321160194224
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.0111111	0.1697321160194224
PSEUDOATROPHODERMA COLLI	0.0111111	0.1697321160194224
NODULI CUTANEI, MULTIPLE, WITH URINARY TRACT ABNORMALITIES	0.0111111	0.1697321160194224
METAPHYSEAL MODELING ABNORMALITY, SKIN LESIONS, AND SPASTIC PARAPLEGIA	0.0111111	0.1697321160194224
ATROPHIA MACULOSA VARIOLIFORMIS CUTIS, FAMILIAL	0.0111111	0.1697321160194224
PAPILLOMATOSIS, FLORID, OF NIPPLE	0.0111111	0.1697321160194224
ACROMIAL DIMPLES	0.0111111	0.1697321160194224
PATELLA APLASIA-HYPOPLASIA	0.0111111	0.1697321160194224
SYRINGOMAS, MULTIPLE	0.0111111	0.1697321160194224
129830 ECTRODACTYLY-CLEFT PALATE SYNDROME;;ECP SYNDROME	0.0111111	0.1697321160194224
ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD	0.0111111	0.1697321160194224
LENTIGINOSIS, CENTROFACIAL NEURODYSRAPHIC	0.0111111	0.1697321160194224
URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1	0.0111111	0.1697321160194224
AMYLOIDOSIS, CUTANEOUS BULLOUS	0.0111111	0.1697321160194224
TUMORAL CALCINOSIS, NORMOPHOSPHATEMIC, FAMILIAL	0.0111111	0.1697321160194224
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.0111111	0.1697321160194224
FUTCHER LINE	0.0111111	0.1697321160194224
GLOMUVENOUS MALFORMATIONS	0.0111111	0.1697321160194224
PERIODONTITIS, AGGRESSIVE, 1	0.0111111	0.1697321160194224
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.0111111	0.1697321160194224
INSECT STINGS, HYPERSENSITIVITY TO	0.0111111	0.1697321160194224
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.0111111	0.1697321160194224
CAMOS SYNDROME	0.0111111	0.1697321160194224
TRICHILEMMAL CYST 1	0.0111111	0.1697321160194224
COMEDONES, FAMILIAL DYSKERATOTIC	0.0111111	0.1697321160194224
STICKLER SYNDROME, TYPE I	0.011108020000000001	0.16968506622981203
ADENYLOSUCCINATE LYASE DEFICIENCY	0.01109745	0.16952359990637642
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.01109745	0.16952359990637642
MUCOPOLYSACCHARIDOSIS TYPE 2	0.011089144	0.1693967182334856
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.011046544	0.16874596464991354
MAN1B1-CDG	0.011035164	0.16857212484284664
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.01102461	0.16841090293390254
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.010989	0.16786692793129687
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.010989	0.16786692793129687
DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4	0.010989	0.16786692793129687
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.010989	0.16786692793129687
ROBIN SEQUENCE-OLIGODACTYLY SYNDROME	0.010989	0.16786692793129687
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.010989	0.16786692793129687
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.01093772	0.1670835794860956
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.01093772	0.1670835794860956
BARATELA-SCOTT SYNDROME	0.010864404000000001	0.1659636111825001
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.01085385	0.16580238927355598
KLEEFSTRA SYNDROME 2; KLEFS2	0.010852594	0.16578320273597458
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.010850924000000001	0.16575769197342613
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.010850924000000001	0.16575769197342613
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.010850924000000001	0.16575769197342613
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.010850924000000001	0.16575769197342613
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.010850924000000001	0.16575769197342613
ARGININOSUCCINIC ACIDURIA	0.010850924000000001	0.16575769197342613
CITRULLINEMIA, CLASSIC	0.010850924000000001	0.16575769197342613
METHYLMALONIC ACIDURIA, CBLB TYPE	0.010850924000000001	0.16575769197342613
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.010850924000000001	0.16575769197342613
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.010850924000000001	0.16575769197342613
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.010850924000000001	0.16575769197342613
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.010850924000000001	0.16575769197342613
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.010850924000000001	0.16575769197342613
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.010850924000000001	0.16575769197342613
METHYLMALONIC ACIDURIA, CBLA TYPE	0.010850924000000001	0.16575769197342613
19P13.13 MICRODELETION SYNDROME	0.010832074	0.16546974115064836
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.010828514000000001	0.1654153589262935
DISTAL MONOSOMY 10P	0.01082208	0.16531707374890608
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.01081207	0.1651641619326724
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.01074158	0.164087363338635
LISSENCEPHALY 5; LIS5	0.01070739	0.1635650801221484
BARTH SYNDROME; BTHS	0.010691889999999999	0.16332830358352476
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.010688704	0.1632796345479083
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.010645854	0.16262506198790685
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.010631404	0.16240432515028677
FRIED SYNDROME	0.010621704	0.1622561488648255
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.01057582	0.1615552292068767
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.010523894	0.16076201252658182
BILATERAL POLYMICROGYRIA	0.010523894	0.16076201252658182
AUTOSOMAL RECESSIVE STICKLER SYNDROME	0.010517130000000001	0.16065868630030763
MICROPHTHALMIA, SYNDROMIC 1	0.01051468	0.16062126033129936
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.01048961	0.16023829337495776
ARTERIAL TORTUOSITY SYNDROME	0.01048961	0.16023829337495776
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.010484504	0.16016029460036346
CONGENITAL TOXOPLASMOSIS	0.010466364	0.15988318967064521
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.010439110000000001	0.15946686013621628
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.01043527	0.15940820065826047
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.010435264	0.15940810900282615
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.010424484000000001	0.1592434347391899
OGDEN SYNDROME	0.010368434	0.15838722022371535
RAYNAUD-CLAES SYNDROME; MRXSRC	0.010349584	0.1580992694009376
ALPHA-MANNOSIDOSIS	0.010346464000000001	0.15805160857509853
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.010305370000000001	0.15742386050553728
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.010305370000000001	0.15742386050553728
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.010305370000000001	0.15742386050553728
INFANTILE LIVER FAILURE SYNDROME 2	0.010305370000000001	0.15742386050553728
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.010305370000000001	0.15742386050553728
LYSINURIC PROTEIN INTOLERANCE	0.010305370000000001	0.15742386050553728
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.010305370000000001	0.15742386050553728
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.010305370000000001	0.15742386050553728
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.010305370000000001	0.15742386050553728
CITRULLINEMIA TYPE I	0.010305370000000001	0.15742386050553728
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.010305370000000001	0.15742386050553728
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.010305370000000001	0.15742386050553728
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.010305370000000001	0.15742386050553728
LATHOSTEROLOSIS	0.01028654	0.15713621520087384
GAUCHER DISEASE, TYPE II	0.010265464	0.15681426021196856
BLINDNESS-SCOLIOSIS-ARACHNODACTYLY SYNDROME	0.01025711	0.15668664529560328
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.01025711	0.15668664529560328
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.01025615	0.15667198042611435
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.010235074	0.15635002543720908
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.010235074	0.15635002543720908
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.010235074	0.15635002543720908
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.010235074	0.15635002543720908
CLASSIC HOMOCYSTINURIA	0.01021437	0.15603375308523076
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.01018589	0.15559869529039197
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.010156499999999999	0.1551497364213501
20Q13.33 MICRODELETION SYNDROME	0.01014315	0.15494580308001948
3M SYNDROME	0.01011276	0.15448156830525997
COLE-CARPENTER SYNDROME 2; CLCRP2	0.01011276	0.15448156830525997
BRUCK SYNDROME	0.01011276	0.15448156830525997
MUCOPOLYSACCHARIDOSIS TYPE 7	0.01011252	0.15447790208788773
TORIELLO-LACASSIE-DROSTE SYNDROME	0.01010246	0.15432422647636815
RIDDLE SYNDROME	0.010095814	0.15422270280696862
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.01008585	0.1540704936823979
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.01008585	0.1540704936823979
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.010076149999999999	0.15392231739693665
GIANT CELL ARTERITIS	0.0100627	0.15371685646503425
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, MKB TYPE	0.01002708	0.15317272870337142
DESBUQUOIS DYSPLASIA 1	0.01000961	0.152905858630484
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.01000961	0.152905858630484
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.01000961	0.152905858630484
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.01000961	0.152905858630484
VAN MALDERGEM SYNDROME 2; VMLDS2	0.01000777	0.15287775096396347
VAN MALDERGEM SYNDROME 1; VMLDS1	0.01000777	0.15287775096396347
SCLEROSTEOSIS 1; SOST1	0.00999203	0.15263730820796764
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.00999203	0.15263730820796764
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.009979514	0.1524461149720055
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.009979514	0.1524461149720055
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.009979514	0.1524461149720055
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.009979514	0.1524461149720055
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00997935	0.15244360972346777
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.00994929	0.1519844159975951
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00993895	0.15182646313247458
HYPERLYSINURIA WITH HYPERAMMONEMIA	0.00993895	0.15182646313247458
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00993895	0.15182646313247458
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.00993895	0.15182646313247458
CORNEODERMATOOSSEOUS SYNDROME	0.00992081	0.15154935820275633
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00990712	0.15134023105348166
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00990712	0.15134023105348166
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00990712	0.15134023105348166
OTOFACIOCERVICAL SYNDROME	0.0098795	0.15091831053756005
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.009873594	0.1508280910383916
CROUZON DISEASE	0.00978974	0.14954714524034346
CEREBROFACIOARTICULAR SYNDROME	0.009741854000000001	0.1488156432191479
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.009718594	0.14846032565215528
ISOLATED PLAGIOCEPHALY	0.009718594	0.14846032565215528
DUANE RETRACTION SYNDROME	0.009704904	0.1482511985028806
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.009677169999999999	0.14782753653370717
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.009672024000000001	0.14774892672288414
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.009672024000000001	0.14774892672288414
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.009672024000000001	0.14774892672288414
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.009667764	0.14768385136452694
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.009659674	0.14756026928727112
PRADER-WILLI SYNDROME	0.00960332	0.14669941089645844
ROIFMAN SYNDROME; RFMN	0.009600804000000001	0.14666097671767284
TYSHCHENKO SYNDROME	0.009600804000000001	0.14666097671767284
GALLOWAY-MOWAT SYNDROME	0.009600804000000001	0.14666097671767284
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00958929	0.14648508993923978
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.00957675	0.1462935300815404
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.009543604	0.14578719491062306
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.009543604	0.14578719491062306
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.009511294	0.14529363039688564
SSR4-CDG	0.009496984	0.14507503218606604
6Q16 MICRODELETION SYNDROME	0.009485024	0.14489233235368287
AARSKOG-SCOTT SYNDROME	0.009485024	0.14489233235368287
MEVALONIC ACIDURIA	0.009473484	0.14471604840170116
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.009456724	0.1444600242218733
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00943396	0.14411228350411662
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.00943396	0.14411228350411662
CATARACT 45	0.00943396	0.14411228350411662
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.00943396	0.14411228350411662
CATARACT 13 WITH ADULT I PHENOTYPE	0.00943396	0.14411228350411662
RETINAL DYSTROPHY AND IRIS COLOBOMA WITH OR WITHOUT CONGENITAL CATARACT	0.00943396	0.14411228350411662
CONGENITAL FIBRINOGEN DEFICIENCY	0.00943396	0.14411228350411662
EDICT SYNDROME	0.00943396	0.14411228350411662
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.00943396	0.14411228350411662
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.00943396	0.14411228350411662
HYDROCEPHALUS, ENDOCARDIAL FIBROELASTOSIS, AND CATARACTS	0.00943396	0.14411228350411662
KNOBLOCH SYNDROME 1; KNO1	0.00943396	0.14411228350411662
SUPERNUMERARY NOSTRIL	0.00943396	0.14411228350411662
SPASTIC ATAXIA-CORNEAL DYSTROPHY SYNDROME	0.00943396	0.14411228350411662
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 25	0.00943396	0.14411228350411662
PUPILLARY MEMBRANE, PERSISTENCE OF	0.00943396	0.14411228350411662
%614422 CATARACT, CONGENITAL, CERULEAN TYPE, 5; CCA5	0.00943396	0.14411228350411662
MUSCULAR HYPERTROPHY-HEPATOMEGALY-POLYHYDRAMNIOS SYNDROME	0.00943396	0.14411228350411662
CATARACT 7; CTRCT7	0.00943396	0.14411228350411662
CATARACT-HYPERTRICHOSIS-INTELLECTUAL DISABILITY SYNDROME	0.00943396	0.14411228350411662
SPINOCEREBELLAR DEGENERATION WITH MACULAR CORNEAL DYSTROPHY, CONGENITALCATARACTS, AND MYOPIA	0.00943396	0.14411228350411662
CATARACT 44; CTRCT44	0.00943396	0.14411228350411662
CATARACT, CRYSTALLINE ACULEIFORM	0.00943396	0.14411228350411662
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.00943396	0.14411228350411662
PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 2; PPKCA2	0.00943396	0.14411228350411662
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.009426714000000001	0.1440015942912865
ACRO-RENAL-OCULAR SYNDROME	0.00938599	0.14337949830684077
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.009294124	0.1419761619521828
EOSINOPHILIC GASTROENTERITIS	0.009224389999999999	0.1409109119428679
RAT-BITE FEVER	0.009224389999999999	0.1409109119428679
PANCREATOBLASTOMA	0.009224389999999999	0.1409109119428679
TSH-SECRETING PITUITARY ADENOMA	0.009224389999999999	0.1409109119428679
BETA-KETOTHIOLASE DEFICIENCY	0.009224389999999999	0.1409109119428679
HURLER SYNDROME	0.009215824000000001	0.14078005853449052
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.009208404000000002	0.14066671131406555
17P11.2 MICRODUPLICATION SYNDROME	0.009208404	0.1406667113140655
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.009194714	0.14045758416479082
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.00918994	0.14038465699089475
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.00918994	0.14038465699089475
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.00918994	0.14038465699089475
15Q14 MICRODELETION SYNDROME	0.009189934	0.14038456533546045
CONGENITAL HYDROCEPHALUS	0.00915935	0.13991736703499172
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00915452	0.13984358441037545
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.00915452	0.13984358441037545
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.009126470000000001	0.1394150952549953
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.009126470000000001	0.1394150952549953
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.009104254	0.13907572573357188
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.009100174	0.13901340003824386
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.009100174	0.13901340003824386
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.009091564	0.13888187449001485
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.00908373	0.13876220304462275
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.00908373	0.13876220304462275
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00905525	0.13832714524978396
GMS SYNDROME	0.00905525	0.13832714524978396
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00905525	0.13832714524978396
FATCO SYNDROME	0.00905525	0.13832714524978396
DISTAL MONOSOMY 17Q	0.00905525	0.13832714524978396
CORNEODERMATOOSSEOUS SYNDROME	0.00905525	0.13832714524978396
TEMPLE SYNDROME	0.00905525	0.13832714524978396
TEMPLE SYNDROME	0.00905525	0.13832714524978396
CRANIODIAPHYSEAL DYSPLASIA	0.00903983	0.13809159078361774
MARINESCO-SJÖGREN SYNDROME	0.009037894000000001	0.1380620166301484
INCONTINENTIA PIGMENTI; IP	0.00902734	0.13790079472120426
WIEDEMANN-STEINER SYNDROME; WDSTS	0.009021724	0.13781500523469392
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.00902069	0.13779920994818184
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.009020134	0.13779071654460284
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.009020134	0.13779071654460284
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.009020134	0.13779071654460284
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.009020134	0.13779071654460284
ADAMS-OLIVER SYNDROME 1; AOS1	0.009020134	0.13779071654460284
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.009020134	0.13779071654460284
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.009020134	0.13779071654460284
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.009020134	0.13779071654460284
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.009020134	0.13779071654460284
XIA-GIBBS SYNDROME	0.009020134	0.13779071654460284
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.009020134	0.13779071654460284
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.009020134	0.13779071654460284
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.009020134	0.13779071654460284
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.009020134	0.13779071654460284
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.009020134	0.13779071654460284
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.009020134	0.13779071654460284
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.009013370000000001	0.13768739031832863
JABERI-ELAHI SYNDROME; JABELS	0.008985484	0.13726140641148613
SRD5A3-CDG	0.008985484	0.13726140641148613
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.008977394	0.1371378243342303
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.008977394	0.1371378243342303
RUVALCABA SYNDROME	0.008977394	0.1371378243342303
X SMALL RINGS	0.008974094	0.13708741384536205
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.008948914	0.13670276653939156
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.008948914	0.13670276653939156
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.008948914	0.13670276653939156
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.008948914	0.13670276653939156
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.008948914	0.13670276653939156
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.008948914	0.13670276653939156
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.008948914	0.13670276653939156
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.008948914	0.13670276653939156
TRISOMY 4P	0.00893947	0.13655850088579402
FLOATING-HARBOR SYNDROME	0.008936284000000001	0.1365098318501776
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.00892486	0.1363353199032591
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.00892486	0.1363353199032591
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.008853034000000001	0.1352381126991829
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.008833134	0.13493412217540157
WILLIAMS-BEUREN SYNDROME; WBS	0.00874857	0.13364233048429394
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.00874829	0.133638053230693
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.0087346	0.1334289260814183
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.0087346	0.1334289260814183
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.00867477	0.1325149686423311
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.00867477	0.1325149686423311
DISTAL MONOSOMY 3P	0.00866285	0.13233287984617664
MESOMELIA-SYNOSTOSES SYNDROME	0.00866285	0.13233287984617664
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.008652739999999999	0.13217844043937116
QAZI-MARKOUIZOS SYNDROME	0.008652739999999999	0.13217844043937116
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.008652739999999999	0.13217844043937116
PEROXISOME BIOGENESIS DISORDER 3B	0.008628264	0.13180454737102587
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.008624434	0.13174604065212728
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.008604854	0.1314469384181756
DUPLICATION/INVERSION 15Q11	0.00858501	0.1311438033451145
MELNICK-NEEDLES SYNDROME	0.0085796	0.13106116069518198
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.0085796	0.13106116069518198
GOLDENHAR SYNDROME	0.0085796	0.13106116069518198
GORDON SYNDROME	0.0085796	0.13106116069518198
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.008565910000000001	0.13085203354590733
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.00856591	0.13085203354590727
FUCOSIDOSIS	0.008563934	0.13082184835620922
FRAGILE X MENTAL RETARDATION SYNDROME	0.0085587	0.130741894265683
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.008556514000000001	0.13070850113578422
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00854601	0.13054804302212597
WAARDENBURG SYNDROME	0.00854441	0.13052360157297774
SHASHI-PENA SYNDROME; SHAPNS	0.008538044	0.13042635515717915
PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY	0.00847458	0.12945688507671396
RADIAL RAY HYPOPLASIA WITH CHOANAL ATRESIA	0.00847458	0.12945688507671396
HYPEREKPLEXIA 2; HKPX2	0.00847458	0.12945688507671396
PROGRESSIVE BIFOCAL CHORIORETINAL ATROPHY	0.00847458	0.12945688507671396
ACHALASIA-MICROCEPHALY SYNDROME	0.00847458	0.12945688507671396
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.00847458	0.12945688507671396
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.00847458	0.12945688507671396
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.00847458	0.12945688507671396
108450 ASYMMETRIC SHORT STATURE SYNDROME	0.00847458	0.12945688507671396
PACHYGYRIA, FRONTOTEMPORAL	0.00847458	0.12945688507671396
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.00844496	0.12900441274935706
SAUL-WILSON SYNDROME; SWILS	0.008444454	0.12899668314106394
MOSAIC TRISOMY 8	0.0084398	0.128925589075854
OSTEOGENESIS IMPERFECTA, TYPE IX	0.00843184	0.12880399286634145
OMPHALOCELE	0.00840336	0.12836893507150268
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00840336	0.12836893507150268
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00840336	0.12836893507150268
HYDROLETHALUS	0.00840336	0.12836893507150268
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.00840336	0.12836893507150268
SCHISIS ASSOCIATION	0.00840336	0.12836893507150268
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00840336	0.12836893507150268
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00840336	0.12836893507150268
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.12836893507150268
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.12836893507150268
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	0.12836893507150268
EBSTEIN MALFORMATION	0.00840336	0.12836893507150268
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.12836893507150268
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.12836893507150268
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00840336	0.12836893507150268
BRONCHOPULMONARY DYSPLASIA	0.00840336	0.12836893507150268
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00840336	0.12836893507150268
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.12836893507150268
RETINOPATHY OF PREMATURITY	0.00840336	0.12836893507150268
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00840336	0.12836893507150268
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.00840336	0.12836893507150268
ATELOSTEOGENESIS, TYPE I; AO1	0.00840336	0.12836893507150268
PEMPHIGOID GESTATIONIS	0.00840336	0.12836893507150268
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.00840336	0.12836893507150268
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.00840336	0.12836893507150268
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.12836893507150268
NEMALINE MYOPATHY 10	0.00840336	0.12836893507150268
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.00840336	0.12836893507150268
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00840336	0.12836893507150268
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00840336	0.12836893507150268
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.12836893507150268
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.008361480000000001	0.12772918014004736
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.008361480000000001	0.12772918014004736
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.008357990000000001	0.12767586722909274
SEVERE CANAVAN DISEASE	0.008352314	0.12758916118823932
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.008352314	0.12758916118823932
DESANTO-SHINAWI SYNDROME	0.008345664000000001	0.12748757641521694
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.00830748	0.12690428123129405
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00830748	0.12690428123129405
HYPERTELORISM, TEEBI TYPE	0.00828758	0.1266002907075127
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.008284394	0.1265516216718963
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.008284394	0.1265516216718963
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.00827604	0.126424006755531
KABUKI SYNDROME	0.00825535	0.12610794826623276
CHROMOSOME 18Q DELETION SYNDROME	0.00825535	0.12610794826623276
DISTAL MONOSOMY 1Q	0.008239694	0.12586878868631718
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.008239694	0.12586878868631718
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.008239694	0.12586878868631718
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.008239694	0.12586878868631718
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.008239694	0.12586878868631718
CHROMOSOME 18P DELETION SYNDROME	0.008239694	0.12586878868631718
MEIER-GORLIN SYNDROME 1; MGORS1	0.00822726	0.12567884807462387
48,XXXY SYNDROME	0.008201144	0.1252799025209016
GABRIELE-DE VRIES SYNDROME; GADEVS	0.008201144	0.1252799025209016
RETINITIS PIGMENTOSA	0.008140660000000001	0.12435595463947506
CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS	0.00808271	0.12347071590313702
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.008080194	0.12343228172435139
ADRENOMYODYSTROPHY	0.0080593	0.12311310695028674
TRISOMY XQ28	0.0080593	0.12311310695028674
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.0080593	0.12311310695028674
BOWEN-CONRADI SYNDROME	0.0080593	0.12311310695028674
NANCE-HORAN SYNDROME	0.00805299	0.12301671598520833
CONGENITAL HYPOTHYROIDISM	0.008030994000000001	0.12268070716304284
MUCOPOLYSACCHARIDOSIS, TYPE II	0.00801838	0.12248801688832034
MULTIPLE SULFATASE DEFICIENCY	0.008017304000000001	0.12247158001376818
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.008010960000000001	0.12237466966789537
WOODHOUSE-SAKATI SYNDROME	0.00799727	0.12216554251862069
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00799157	0.12207846985603005
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.007952964	0.1214887282398943
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.007952964	0.1214887282398943
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.007952964	0.1214887282398943
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.007952964	0.1214887282398943
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.007952964	0.1214887282398943
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.007952964	0.1214887282398943
WEBB-DATTANI SYNDROME; WEDAS	0.007952964	0.1214887282398943
ISOLATED KLIPPEL-FEIL SYNDROME	0.007927710000000001	0.12110295051690069
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.007927710000000001	0.12110295051690069
SCLEROSTEOSIS 2; SOST2	0.007927710000000001	0.12110295051690069
WILDERVANCK SYNDROME	0.007927710000000001	0.12110295051690069
DEAFNESS-CRANIOFACIAL SYNDROME	0.007927710000000001	0.12110295051690069
DEAFNESS-CRANIOFACIAL SYNDROME	0.00791402	0.12089382336762601
CRANIOFRONTONASAL DYSPLASIA	0.00791402	0.12089382336762601
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.00791402	0.12089382336762601
MARTSOLF SYNDROME	0.0078989	0.12066285167317509
MONOSOMY 13Q34	0.007885234	0.12045409114563761
ROBINOW-SORAUF SYNDROME	0.00782428	0.11952296358852374
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.00782428	0.11952296358852374
ACHONDROPLASIA	0.00782173	0.11948401002894375
CRIGLER-NAJJAR SYNDROME	0.00780676	0.11925532972035047
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.007792564	0.11903847296278265
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.007782010000000001	0.11887725105383855
ICF SYNDROME	0.007776394000000001	0.11879146156732819
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.007776394000000001	0.11879146156732819
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.00777422	0.118758251748298
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.007740024	0.1182358768763771
KEUTEL SYNDROME	0.007740024	0.1182358768763771
CHROMOSOME 1P35 DELETION SYNDROME	0.007740024	0.1182358768763771
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.00773884	0.11821779020400741
THYROID HEMIAGENESIS	0.007728764000000001	0.11806387017799636
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.007728764000000001	0.11806387017799636
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.007728764000000001	0.11806387017799636
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.007728764000000001	0.11806387017799636
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.007728764000000001	0.11806387017799636
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.007728764000000001	0.11806387017799636
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.0077061000000000004	0.11771765705081143
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.0077061000000000004	0.11771765705081143
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.0077061000000000004	0.11771765705081143
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.00769414	0.1175349572184283
TRISOMY 5P	0.00769414	0.1175349572184283
SONODA SYNDROME	0.00769414	0.1175349572184283
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.00769414	0.1175349572184283
BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II	0.00769414	0.1175349572184283
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.00769414	0.1175349572184283
CONGENITAL HEART DEFECT-ROUND FACE-DEVELOPMENTAL DELAY SYNDROME	0.00769414	0.1175349572184283
NEURALGIC AMYOTROPHY	0.00769414	0.1175349572184283
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.00769414	0.1175349572184283
%300712 CRANIOFACIOSKELETAL SYNDROME	0.007690954	0.11748628818281184
POPOV-CHANG SYNDROME; POPCHAS	0.007690954	0.11748628818281184
12Q14 MICRODELETION SYNDROME	0.007690954	0.11748628818281184
CHYLOMICRON RETENTION DISEASE	0.0076657	0.11710051045981823
CHYLOMICRON RETENTION DISEASE	0.0076657	0.11710051045981823
WOLMAN DISEASE WITH HYPOLIPOPROTEINEMIA AND ACANTHOCYTOSIS	0.0076657	0.11710051045981823
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.0076657	0.11710051045981823
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.0076657	0.11710051045981823
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.0076657	0.11710051045981823
NEPHROPATHIC INFANTILE CYSTINOSIS	0.0076657	0.11710051045981823
SPINOCEREBELLAR ATAXIA TYPE 34	0.00765559	0.11694607105301276
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00765559	0.11694607105301276
BENCZE SYNDROME	0.00765559	0.11694607105301276
SECKEL SYNDROME 1; SCKL1	0.00765559	0.11694607105301276
8P23.1 MICRODELETION SYNDROME	0.007651104	0.11687754333996334
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.00764191	0.11673709666279525
FAMILIAL COLD URTICARIA	0.00763873	0.1166885192826131
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.007636574	0.11665558442988584
JUVENILE PAGET DISEASE	0.0076338199999999995	0.11661351458553942
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.0076338199999999995	0.11661351458553942
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.007607704	0.11621456903181718
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.007587804	0.11591057850803586
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.007587804	0.11591057850803586
TIMOTHY SYNDROME; TS	0.007587804	0.11591057850803586
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.007587804	0.11591057850803586
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.007587804	0.11591057850803586
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.007535574000000001	0.11511271795240283
OPITZ G/BBB SYNDROME	0.007513794	0.11478000872587231
COCKAYNE SYNDROME A; CSA	0.007498980000000001	0.11455371145857099
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.007495174	0.1144955713614096
COFFIN-SIRIS SYNDROME 7; CSS7	0.0074937940000000015	0.11447449061151926
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.007486754	0.11436694823526697
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.007486754	0.11436694823526697
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.007485440000000001	0.11434687569515398
NEURAMINIDASE DEFICIENCY	0.007471750000000001	0.1141377485458793
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.007467904000000001	0.1140789974124892
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.007451094	0.11382220943737542
SECKEL SYNDROME 7; SCKL7	0.00740741	0.11315489677200542
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.00740741	0.11315489677200542
14Q11.2 MICRODELETION SYNDROME	0.00740741	0.11315489677200542
GLUTAMINE DEFICIENCY, CONGENITAL	0.00740741	0.11315489677200542
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.00740741	0.11315489677200542
DPM1-CDG	0.00740741	0.11315489677200542
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.00740741	0.11315489677200542
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.00740741	0.11315489677200542
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00740741	0.11315489677200542
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.00740741	0.11315489677200542
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.00740741	0.11315489677200542
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.00740741	0.11315489677200542
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.00740741	0.11315489677200542
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.00740741	0.11315489677200542
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.00740741	0.11315489677200542
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.00740741	0.11315489677200542
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.00740741	0.11315489677200542
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.00740741	0.11315489677200542
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.00740741	0.11315489677200542
AMISH LETHAL MICROCEPHALY	0.00740741	0.11315489677200542
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.00740741	0.11315489677200542
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.00740741	0.11315489677200542
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00740741	0.11315489677200542
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.00740741	0.11315489677200542
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.00740741	0.11315489677200542
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.00740741	0.11315489677200542
NEPHROGENIC DIABETES INSIPIDUS	0.007332414000000001	0.1120092649468043
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.007310704	0.11167762503367401
PERMANENT NEONATAL DIABETES MELLITUS	0.007271334	0.11107621262556999
TRANSIENT NEONATAL DIABETES MELLITUS	0.007271334	0.11107621262556999
KRABBE DISEASE	0.007257644	0.11086708547629531
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.0072308400000000005	0.11045763009943933
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.0072308400000000005	0.11045763009943933
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.0072308400000000005	0.11045763009943933
DISTAL TRISOMY 5Q	0.0072308400000000005	0.11045763009943933
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.0072308400000000005	0.11045763009943933
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.007202953999999999	0.11003164619259682
RAPADILINO SYNDROME	0.00719447	0.10990204540848826
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.0071926640000000005	0.10987445712276218
FRANK-TER HAAR SYNDROME; FTHS	0.007183210000000001	0.10973003871010747
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.007152820000000001	0.10926580393534799
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.007152820000000001	0.10926580393534799
ATKIN-FLAITZ SYNDROME	0.007152820000000001	0.10926580393534799
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.0071454	0.10915245671492299
SHORT STATURE, BRUSSELS TYPE	0.0071454	0.10915245671492299
OSTEOGENESIS IMPERFECTA, TYPE X	0.0071454	0.10915245671492299
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.0071454	0.10915245671492299
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.0071454	0.10915245671492299
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.0071384740000000006	0.10904665579192252
RAHMAN SYNDROME	0.0071384740000000006	0.10904665579192252
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.007124504	0.1088332513890469
AL-RAQAD SYNDROME; ARS	0.007124504	0.1088332513890469
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.007124504	0.1088332513890469
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.007124504	0.1088332513890469
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.00706215	0.10788073756392831
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.00704225	0.107576747040147
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.00704225	0.107576747040147
BRACHYDACTYLY, TYPE E	0.00704225	0.107576747040147
RING CHROMOSOME 1 SYNDROME	0.00704225	0.107576747040147
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.00704225	0.107576747040147
FAMILIAL VISCERAL MYOPATHY	0.00704225	0.107576747040147
FAMILIAL PARTIAL LIPODYSTROPHY, DUNNIGAN TYPE	0.00704225	0.107576747040147
AUTOSOMAL SEMI-DOMINANT SEVERE LIPODYSTROPHIC LAMINOPATHY	0.00704225	0.107576747040147
2Q37 MONOSOMY	0.00704225	0.107576747040147
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.00704225	0.107576747040147
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00704225	0.107576747040147
ACTH-INDEPENDENT CUSHING SYNDROME	0.00704225	0.107576747040147
CHERUBISM	0.00704225	0.107576747040147
ACROMICRIC DYSPLASIA	0.00704225	0.107576747040147
JUNG SYNDROME	0.00704225	0.107576747040147
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00704225	0.107576747040147
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.00704225	0.107576747040147
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE	0.00704225	0.107576747040147
ACROMICRIC DYSPLASIA	0.00704225	0.107576747040147
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.007039064	0.10752807800453056
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.007039064	0.10752807800453056
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.007039064	0.10752807800453056
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.007039064	0.10752807800453056
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.007039064	0.10752807800453056
CREE MENTAL RETARDATION SYNDROME	0.007039064	0.10752807800453056
DISTAL LIMB DEFICIENCIES-MICROGNATHIA SYNDROME	0.0070100200000000005	0.10708440459886703
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.0070100200000000005	0.10708440459886703
ACROCRANIOFACIAL DYSOSTOSIS	0.0070100200000000005	0.10708440459886703
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.006998374	0.10690650140087923
SARCOIDOSIS	0.00699086	0.10679171824531676
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.006984684	0.10669737425160455
POSTENCEPHALITIC PARKINSONISM	0.006983420000000001	0.10667806550677744
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.006955814	0.10625635885353588
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.0069412	0.1060331167673781
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.0069412	0.1060331167673781
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00693593	0.10595261274424606
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.00693593	0.10595261274424606
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.00693593	0.10595261274424606
MICROPHTHALMIA, LENZ TYPE	0.00691923	0.10569750511876125
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.006913894	0.10561599288585184
COHEN SYNDROME	0.006913894	0.10561599288585184
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.006903684	0.1054600258884746
IMMUNODEFICIENCY 23; IMD23	0.006903684	0.1054600258884746
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.006903684	0.1054600258884746
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.00686504	0.1048697037879216
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A	0.00686504	0.1048697037879216
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00685135	0.10466057663864689
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.00685135	0.10466057663864689
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	0.00685135	0.10466057663864689
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.00685135	0.10466057663864689
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.006834864	0.10440873805698567
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.006834864	0.10440873805698567
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.006834864	0.10440873805698567
EARLY MYOCLONIC ENCEPHALOPATHY	0.006834864	0.10440873805698567
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.006834864	0.10440873805698567
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.006834864	0.10440873805698567
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.006834864	0.10440873805698567
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.006834864	0.10440873805698567
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.006834864	0.10440873805698567
GABA-TRANSAMINASE DEFICIENCY	0.006834864	0.10440873805698567
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.006834864	0.10440873805698567
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.006834864	0.10440873805698567
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.006834864	0.10440873805698567
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.006828214	0.10430715328396327
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.0068160140000000004	0.1041207872342079
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.0068160140000000004	0.1041207872342079
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.0068160140000000004	0.1041207872342079
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.0068160140000000004	0.1041207872342079
ARTERIAL TORTUOSITY SYNDROME	0.0068160140000000004	0.1041207872342079
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.0068160140000000004	0.1041207872342079
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.0068160140000000004	0.1041207872342079
JOUBERT SYNDROME WITH OCULAR DEFECT	0.0068160140000000004	0.1041207872342079
JOUBERT SYNDROME WITH RENAL DEFECT	0.0068160140000000004	0.1041207872342079
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.0068160140000000004	0.1041207872342079
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.0068160140000000004	0.1041207872342079
MENTAL RETARDATION, X-LINKED 101; MRX101	0.0068160140000000004	0.1041207872342079
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.0068160140000000004	0.1041207872342079
JOUBERT SYNDROME	0.0068160140000000004	0.1041207872342079
MEHMO SYNDROME; MEHMO	0.0068160140000000004	0.1041207872342079
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.0068160140000000004	0.1041207872342079
PSEUDOHYPOALDOSTERONISM TYPE 2	0.0067868600000000005	0.10367543347891543
COOPER-JABS SYNDROME	0.00675159	0.10313665228425377
RETICULAR DYSGENESIS	0.00672578	0.10274238115768111
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.0067120899999999995	0.10253325400840643
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00670981	0.1024984249433702
SCARF SYNDROME	0.00670981	0.1024984249433702
L1 SYNDROME	0.006680524	0.102051054768523
HEREDITARY FOLATE MALABSORPTION	0.006680524	0.102051054768523
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.006670014	0.10189050499943046
20P12.3 MICRODELETION SYNDROME	0.006661924	0.10176692292217462
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.006661924	0.10176692292217462
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.006661924	0.10176692292217462
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.006661924	0.10176692292217462
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.0066471099999999995	0.10154062565487329
OCULODENTODIGITAL DYSPLASIA; ODDD	0.0066369	0.10138465865749606
14Q12 MICRODELETION SYNDROME	0.006617	0.10108066813371475
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00657895	0.10049941992115803
ACHONDROGENESIS TYPE 2	0.00657895	0.10049941992115803
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3; HKLLS3	0.00657895	0.10049941992115803
ACHONDROGENESIS	0.00657895	0.10049941992115803
FIBROCHONDROGENESIS 1; FBCG1	0.00657895	0.10049941992115803
EMERY-NELSON SYNDROME	0.00657895	0.10049941992115803
BLEPHAROCHEILODONTIC SYNDROME 1; BCDS1	0.00657895	0.10049941992115803
OROFACIODIGITAL SYNDROME TYPE 10	0.00657895	0.10049941992115803
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00657895	0.10049941992115803
MAXILLONASAL DYSPLASIA	0.00657895	0.10049941992115803
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00657895	0.10049941992115803
OROFACIODIGITAL SYNDROME XV; OFD15	0.00657895	0.10049941992115803
LETHAL KNIEST-LIKE DYSPLASIA	0.00657895	0.10049941992115803
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.00657895	0.10049941992115803
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00657895	0.10049941992115803
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.00657895	0.10049941992115803
CLEFT LIP/PALATE-INTESTINAL MALROTATION-CARDIOPATHY SYNDROME	0.00657895	0.10049941992115803
ACHONDROGENESIS TYPE 1A	0.00657895	0.10049941992115803
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MATRILIN-3 TYPE	0.00657895	0.10049941992115803
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.00657895	0.10049941992115803
MONOSOMY 18P	0.006545034	0.0999813223028381
WRINKLY SKIN SYNDROME	0.006545034	0.0999813223028381
SECKEL SYNDROME 8; SCKL8	0.006545034	0.0999813223028381
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.006545034	0.0999813223028381
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.006540774000000001	0.0999162469444809
OTODENTAL DYSPLASIA	0.00652889	0.09973470808093228
FRANK-TER HAAR SYNDROME	0.00650093	0.09930759375706669
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.00650093	0.09930759375706669
CLARK-BARAITSER SYNDROME	0.00650093	0.09930759375706669
ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2	0.00649351	0.09919424653664169
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.00649351	0.09919424653664169
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.00649351	0.09919424653664169
X-LINKED INTELLECTUAL DISABILITY-ACROMEGALY-HYPERACTIVITY SYNDROME	0.00649351	0.09919424653664169
PARTINGTON SYNDROME	0.00649351	0.09919424653664169
TRANSALDOLASE DEFICIENCY	0.00649351	0.09919424653664169
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00649351	0.09919424653664169
3-HYDROXYISOBUTYRIC ACIDURIA	0.00649351	0.09919424653664169
MEIER-GORLIN SYNDROME 3; MGORS3	0.00649351	0.09919424653664169
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.00649351	0.09919424653664169
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.00649351	0.09919424653664169
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.00649351	0.09919424653664169
RUSSELL-SILVER SYNDROME, X-LINKED	0.00649351	0.09919424653664169
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.00649351	0.09919424653664169
PERMANENT NEONATAL DIABETES MELLITUS-PANCREATIC AND CEREBELLAR AGENESIS SYNDROME	0.00649351	0.09919424653664169
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.006458834	0.09866453922997634
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.006452820000000001	0.09857266993299038
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00645282	0.09857266993299035
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00645048	0.09853692431361105
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.0064391299999999995	0.09836354278371569
ACROCALLOSAL SYNDROME; ACLS	0.00641242	0.09795552334199716
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.00641026	0.09792252738564702
CURRY-JONES SYNDROME	0.00641026	0.09792252738564702
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.00641026	0.09792252738564702
PHAKOMATOSIS PIGMENTOVASCULARIS	0.00641026	0.09792252738564702
HEMIFACIAL HYPERPLASIA	0.00641026	0.09792252738564702
HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	0.00641026	0.09792252738564702
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.00641026	0.09792252738564702
TORTICOLLIS	0.00641026	0.09792252738564702
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.00641026	0.09792252738564702
DISTAL TRISOMY 15Q	0.00641026	0.09792252738564702
CAFFEY DISEASE	0.00641026	0.09792252738564702
PROGRESSIVE HEMIFACIAL ATROPHY	0.00641026	0.09792252738564702
FAMILIAL LAMBDOID SYNOSTOSIS	0.00641026	0.09792252738564702
TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA; TKCR	0.00641026	0.09792252738564702
SPINOCEREBELLAR ATAXIA TYPE 13	0.006404934000000001	0.09784116791179481
BRAIN-LUNG-THYROID SYNDROME	0.006391244	0.09763204076252012
OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	0.00637182	0.09733532156986041
CRANIOMETAPHYSEAL DYSPLASIA	0.00635813	0.09712619442058573
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.00635813	0.09712619442058573
BRITTLE CORNEA SYNDROME	0.00635813	0.09712619442058573
FRONTOMETAPHYSEAL DYSPLASIA	0.00635813	0.09712619442058573
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.00635813	0.09712619442058573
DEAFNESS, AUTOSOMAL DOMINANT 23; DFNA23	0.00635813	0.09712619442058573
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.00628931	0.0960749065890968
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.00628931	0.0960749065890968
TYPHOID	0.00628931	0.0960749065890968
GLYCINE ENCEPHALOPATHY; GCE	0.00628931	0.0960749065890968
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.00628931	0.0960749065890968
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.00628931	0.0960749065890968
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00628931	0.0960749065890968
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.00628931	0.0960749065890968
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.00628931	0.0960749065890968
HEMOCHROMATOSIS TYPE 2	0.00628931	0.0960749065890968
EVANS SYNDROME	0.00628931	0.0960749065890968
PSEUDO-TORCH SYNDROME 2	0.00628931	0.0960749065890968
CIRRHOSIS, FAMILIAL	0.00628931	0.0960749065890968
KUFOR-RAKEB SYNDROME	0.00628931	0.0960749065890968
HEMOCHROMATOSIS, TYPE 2A	0.00628931	0.0960749065890968
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.00628931	0.0960749065890968
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.00628931	0.0960749065890968
EISENMENGER SYNDROME	0.00628931	0.0960749065890968
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.00628931	0.0960749065890968
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.00628931	0.0960749065890968
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.00628931	0.0960749065890968
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.00628931	0.0960749065890968
POSTERIOR URETHRAL VALVE	0.00628931	0.0960749065890968
MYXEDEMA	0.00628931	0.0960749065890968
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.00628931	0.0960749065890968
ENCEPHALITIS LETHARGICA	0.00628931	0.0960749065890968
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.00628931	0.0960749065890968
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.00628931	0.0960749065890968
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.00628931	0.0960749065890968
GLYCINE ENCEPHALOPATHY	0.00628931	0.0960749065890968
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.00628931	0.0960749065890968
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.00627046	0.09578695576631903
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.00626734	0.09573929494047995
COFFIN-SIRIS SYNDROME 4; CSS4	0.0062484640000000004	0.09545094694415351
COFFIN-SIRIS SYNDROME 3; CSS3	0.0062484640000000004	0.09545094694415351
LUSCAN-LUMISH SYNDROME; LLS	0.006222574	0.09505545374512346
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.006222574	0.09505545374512346
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.006222574	0.09505545374512346
GLASS SYNDROME	0.006222574	0.09505545374512346
PAROXYSMAL COLD HEMOGLOBINURIA	0.00613497	0.09371722330063412
HYDATIDIFORM MOLE	0.00613497	0.09371722330063412
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.00613497	0.09371722330063412
JUNCTIONAL EPIDERMOLYSIS BULLOSA-PYLORIC ATRESIA SYNDROME	0.00613497	0.09371722330063412
LYME DISEASE	0.00613497	0.09371722330063412
IMMUNOGLOBULIN A VASCULITIS	0.00613497	0.09371722330063412
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.00613497	0.09371722330063412
FAMILIAL MEDITERRANEAN FEVER	0.00613497	0.09371722330063412
NIPAH VIRUS DISEASE	0.00613497	0.09371722330063412
INHALATIONAL BOTULISM	0.00613497	0.09371722330063412
LEPTOSPIROSIS	0.00613497	0.09371722330063412
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.00613497	0.09371722330063412
HUGHES-STOVIN SYNDROME	0.00613497	0.09371722330063412
INTESTINAL BOTULISM	0.00613497	0.09371722330063412
COLD AGGLUTININ DISEASE	0.00613497	0.09371722330063412
RHEUMATIC FEVER	0.00613497	0.09371722330063412
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.00613497	0.09371722330063412
MICROSCOPIC POLYANGIITIS	0.00613497	0.09371722330063412
KAWASAKI DISEASE	0.00613497	0.09371722330063412
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.00613497	0.09371722330063412
DRACUNCULIASIS	0.00613497	0.09371722330063412
FOODBORNE BOTULISM	0.00613497	0.09371722330063412
INDOLENT SYSTEMIC MASTOCYTOSIS	0.00613497	0.09371722330063412
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.00613497	0.09371722330063412
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.00613497	0.09371722330063412
PAROXYSMAL HEMICRANIA	0.00613497	0.09371722330063412
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.00613497	0.09371722330063412
CREST SYNDROME	0.00613497	0.09371722330063412
DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS	0.00613497	0.09371722330063412
PORPHYRIA	0.00613497	0.09371722330063412
AMYOTROPHIC LATERAL SCLEROSIS	0.00613497	0.09371722330063412
FAMILIAL PAROXYSMAL ATAXIA	0.00613497	0.09371722330063412
LIMITED CUTANEOUS SYSTEMIC SCLEROSIS	0.00613497	0.09371722330063412
PRIMARY PARATHYROID HYPERPLASIA	0.00613497	0.09371722330063412
HEREDITARY COPROPORPHYRIA	0.00613497	0.09371722330063412
CHOLESTERYL ESTER STORAGE DISEASE	0.00613497	0.09371722330063412
GRISCELLI SYNDROME TYPE 2	0.00613497	0.09371722330063412
BABESIOSIS	0.00613497	0.09371722330063412
BOTULISM	0.00613497	0.09371722330063412
EPISODIC ATAXIA TYPE 6	0.00613497	0.09371722330063412
PORPHYRIA VARIEGATA	0.00613497	0.09371722330063412
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.006132814	0.09368428844790687
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.006132814	0.09368428844790687
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.0061163699999999994	0.09343309145428576
SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE; SMDCF	0.0061163699999999994	0.09343309145428576
TEEBI-SHALTOUT SYNDROME; TBSH	0.0061163699999999994	0.09343309145428576
BRUCK SYNDROME 2	0.0061163699999999994	0.09343309145428576
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.0061163699999999994	0.09343309145428576
SPONDYLOPERIPHERAL DYSPLASIA-SHORT ULNA SYNDROME	0.0061163699999999994	0.09343309145428576
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.0061163699999999994	0.09343309145428576
ACROCAPITOFEMORAL DYSPLASIA	0.0061163699999999994	0.09343309145428576
ULNAR-MAMMARY SYNDROME	0.0061163699999999994	0.09343309145428576
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.0060997000000000004	0.09317844210597248
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.0060997000000000004	0.09317844210597248
MEIER-GORLIN SYNDROME 6; MGORS6	0.0060997000000000004	0.09317844210597248
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.0060997000000000004	0.09317844210597248
METAPHYSEAL DYSOSTOSIS-INTELLECTUAL DISABILITY-CONDUCTIVE DEAFNESS SYNDROME	0.0060997000000000004	0.09317844210597248
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.006079064	0.09286320851558297
SALT-AND-PEPPER SYNDROME	0.006065374	0.0926540813663083
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.006065374	0.0926540813663083
GALACTOSE EPIMERASE DEFICIENCY	0.006065374	0.0926540813663083
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.006051814000000001	0.09244694008477691
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.006051814000000001	0.09244694008477691
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.006051814000000001	0.09244694008477691
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.006018124	0.09193229482114915
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.006018124	0.09193229482114915
CATEL-MANZKE SYNDROME; CATMANS	0.006010034	0.09180871274389334
GERODERMA OSTEODYSPLASTICA	0.006010034	0.09180871274389334
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00599948	0.0916474908349492
ANE SYNDROME	0.00599948	0.0916474908349492
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.00599948	0.0916474908349492
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.00599948	0.0916474908349492
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.00599948	0.0916474908349492
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.00599948	0.0916474908349492
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00599948	0.0916474908349492
AUTOSOMAL DOMINANT BRACHYOLMIA	0.00599948	0.0916474908349492
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.00599948	0.0916474908349492
SPONDYLOMETAPHYSEAL DYSPLASIA, SCHMIDT TYPE	0.00599948	0.0916474908349492
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00599522	0.09158241547659202
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.005977724	0.09131514823015595
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.005977724	0.09131514823015595
HELSMOORTEL-VAN DER AA SYNDROME	0.005976344	0.09129406748026558
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.005976344	0.09129406748026558
MICRO SYNDROME	0.005947334	0.09085091345539645
MEND SYNDROME; MEND	0.005947334	0.09085091345539645
MEND SYNDROME	0.005947334	0.09085091345539645
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.005893144	0.0900231121245568
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.005893144	0.0900231121245568
HYPEREKPLEXIA 4; HKPX4	0.005893144	0.0900231121245568
ACRODERMATITIS ENTEROPATHICA	0.005860219999999999	0.08952016820470875
GROWTH HORMONE INSENSITIVITY SYNDROME	0.005859380000000001	0.08950733644390595
DENTINOGENESIS IMPERFECTA-SHORT STATURE-HEARING LOSS-INTELLECTUAL DISABILITY SYNDROME	0.005845690000000001	0.08929820929463125
3MC SYNDROME 3	0.00581898	0.08889018985291272
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.0058069440000000005	0.08870632905169505
CHROMOSOME 19P13.13 DELETION SYNDROME	0.0058069440000000005	0.08870632905169505
2Q23.1 MICRODUPLICATION SYNDROME	0.0058069440000000005	0.08870632905169505
GALACTOSEMIA	0.00579859	0.08857871413532976
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.005753884	0.08789578949431633
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.005753884	0.08789578949431633
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.0057530440000000006	0.08788295773351351
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.0057530440000000006	0.08788295773351351
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.0057530440000000006	0.08788295773351351
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.0057530440000000006	0.08788295773351351
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.0057530440000000006	0.08788295773351351
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.0057530440000000006	0.08788295773351351
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.0057530440000000006	0.08788295773351351
MYHRE SYNDROME	0.005742754	0.08772576866367884
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.005739354	0.08767383058423883
1Q21.1 MICRODELETION SYNDROME	0.005729064000000001	0.08751664151440418
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.005712644	0.0872658111425203
ABLEPHARON MACROSTOMIA SYNDROME	0.005712644	0.0872658111425203
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.005712644	0.0872658111425203
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.005712644	0.0872658111425203
MICROTRIPLICATION 11Q24.1	0.00570291	0.08711711547626465
SIFRIM-HITZ-WEISS SYNDROME	0.00570291	0.08711711547626465
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.005698954	0.0870566839932456
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.005698954	0.0870566839932456
FOUNTAIN SYNDROME	0.00568922	0.08690798832698997
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00568922	0.08690798832698997
HURLER-SCHEIE SYNDROME	0.00568922	0.08690798832698997
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.005668564000000001	0.08659244921848613
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00558726	0.085350456980018
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.005570684	0.08509724356684217
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.005570684	0.08509724356684217
MENTAL RETARDATION, X-LINKED 72	0.005570684	0.08509724356684217
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.005570684	0.08509724356684217
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.005570684	0.08509724356684217
AU-KLINE SYNDROME; AUKS	0.005570684	0.08509724356684217
TEMTAMY SYNDROME; TEMTYS	0.005570684	0.08509724356684217
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.005570684	0.08509724356684217
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.005570684	0.08509724356684217
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.00553351	0.08452937704769412
PLAGUE	0.00553351	0.08452937704769412
KRABBE DISEASE	0.00553351	0.08452937704769412
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00553351	0.08452937704769412
SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.00551982	0.08432024989841942
DIAMOND-BLACKFAN ANEMIA 10	0.005506260000000001	0.08411310861688806
ALOPECIA ANTIBODY DEFICIENCY	0.005506260000000001	0.08411310861688806
FRONTONASAL DYSPLASIA	0.005506260000000001	0.08411310861688806
PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA	0.005506260000000001	0.08411310861688806
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.005506260000000001	0.08411310861688806
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.005506260000000001	0.08411310861688806
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.005506260000000001	0.08411310861688806
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.005506260000000001	0.08411310861688806
GORLIN-CHAUDHRY-MOSS SYNDROME	0.005506260000000001	0.08411310861688806
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.005480924	0.08372607826962557
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.005480924	0.08372607826962557
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.005480924	0.08372607826962557
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.005480924	0.08372607826962557
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.005480924	0.08372607826962557
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.005480924	0.08372607826962557
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.005480924	0.08372607826962557
6Q TERMINAL DELETION SYNDROME	0.005480924	0.08372607826962557
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.005480924	0.08372607826962557
CHROMOSOME 16P13.2 DELETION SYNDROME	0.005480924	0.08372607826962557
PENOSCROTAL TRANSPOSITION	0.00546448	0.08347488127600447
NEONATAL MARFAN SYNDROME	0.00546448	0.08347488127600447
SPINOCEREBELLAR ATAXIA 43; SCA43	0.00546448	0.08347488127600447
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00546448	0.08347488127600447
AMISH NEMALINE MYOPATHY	0.00546448	0.08347488127600447
LOEYS-DIETZ SYNDROME	0.00546448	0.08347488127600447
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.00546448	0.08347488127600447
%605967 ACROPECTORAL SYNDROME; ACRPS;;ACRP SYNDROME;;SYNDACTYLY, PREAXIAL POLYDACTYLY, AND STERNAL DEFORMITY	0.00546448	0.08347488127600447
SPINOCEREBELLAR ATAXIA TYPE 43	0.00546448	0.08347488127600447
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.00546448	0.08347488127600447
DYSMORPHISM-PECTUS CARINATUM-JOINT LAXITY SYNDROME	0.00546448	0.08347488127600447
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.00546448	0.08347488127600447
AORTIC ANEURYSM, FAMILIAL THORACIC 9; AAT9	0.00546448	0.08347488127600447
%609052 SPONDYLOMETAPHYSEAL DYSPLASIA, TYPE A4	0.00546448	0.08347488127600447
ELLIS-VAN CREVELD SYNDROME	0.00546448	0.08347488127600447
OSTEOGENESIS IMPERFECTA, TYPE XIX; OI19	0.00546448	0.08347488127600447
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.005440524	0.08310893167863237
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.005440524	0.08310893167863237
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.005440524	0.08310893167863237
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.005440524	0.08310893167863237
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.005440524	0.08310893167863237
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.005440524	0.08310893167863237
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00543217	0.08298131676226708
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.00543217	0.08298131676226708
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.0054101340000000005	0.08264469690387287
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.005399924	0.08248872990649563
ZECHI-CEIDE SYNDROME	0.005399924	0.08248872990649563
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.005399924	0.08248872990649563
OROFACIODIGITAL SYNDROME XI; OFD11	0.00534759	0.08168928065666793
CERVICAL HYPERTRICHOSIS WITH UNDERLYING KYPHOSCOLIOSIS	0.00534759	0.08168928065666793
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.00534759	0.08168928065666793
PARKINSON-DEMENTIA SYNDROMESUPRANUCLEAR PALSY, PROGRESSIVE ATYPICAL, INCLUDED	0.00534759	0.08168928065666793
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.00534759	0.08168928065666793
MYOPATHIC EHLERS-DANLOS SYNDROME	0.00534759	0.08168928065666793
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00534759	0.08168928065666793
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.00534759	0.08168928065666793
MENTAL RETARDATION, X-LINKED 19	0.00534759	0.08168928065666793
SCHOLTE SYNDROME; SHLTS	0.00534759	0.08168928065666793
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1; CMT2B1	0.00534759	0.08168928065666793
NEMALINE MYOPATHY 4	0.00534759	0.08168928065666793
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.00534759	0.08168928065666793
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00534759	0.08168928065666793
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.00534759	0.08168928065666793
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B; CMT1B	0.00534759	0.08168928065666793
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A	0.00534759	0.08168928065666793
SPONDYLOMETAPHYSEAL DYSPLASIA, ALGERIAN TYPE	0.00534759	0.08168928065666793
SPINAL MUSCULAR ATROPHY, RYUKYUAN TYPE	0.00534759	0.08168928065666793
PRIMARY DYSTONIA, DYT4 TYPE	0.00534759	0.08168928065666793
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.00534759	0.08168928065666793
CHARCOT-MARIE-TOOTH DISEASE TYPE 1A	0.00534759	0.08168928065666793
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.00534759	0.08168928065666793
SPONDYLOEPIPHYSEAL DYSPLASIA, STANESCU TYPE	0.00534759	0.08168928065666793
GERODERMA OSTEODYSPLASTICUM; GO	0.00534759	0.08168928065666793
227250 FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION	0.00534759	0.08168928065666793
CENTRAL CORE DISEASE	0.00534759	0.08168928065666793
CARPENTER SYNDROME	0.00534759	0.08168928065666793
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.00534759	0.08168928065666793
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.00534759	0.08168928065666793
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K	0.00534759	0.08168928065666793
KYPHOSCOLIOSIS-LATERAL TONGUE ATROPHY-HEREDITARY SPASTIC PARAPLEGIA SYNDROME	0.00534759	0.08168928065666793
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.005324454	0.0813358573019843
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.005324454	0.0813358573019843
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.005324454	0.0813358573019843
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.005324454	0.0813358573019843
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00526139	0.08037249758380619
SPINOCEREBELLAR ATAXIA TYPE 25	0.00526139	0.08037249758380619
NAVAJO NEUROHEPATOPATHY	0.005213504000000001	0.07964099556261062
NIEMANN-PICK DISEASE, TYPE A	0.005213504000000001	0.07964099556261062
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.005213504000000001	0.07964099556261062
FOCAL MYOSITIS	0.00520833	0.07956195802642747
ATYPICAL MYCOBACTERIOSIS, FAMILIAL	0.00520833	0.07956195802642747
PLEURAL MESOTHELIOMA	0.00520833	0.07956195802642747
PEMPHIGUS VULGARIS	0.00520833	0.07956195802642747
SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA	0.00520833	0.07956195802642747
VARIANT ABETA2M AMYLOIDOSIS	0.00520833	0.07956195802642747
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.00520833	0.07956195802642747
CHRONIC NONBACTERIAL OSTEOMYELITIS/CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.00520833	0.07956195802642747
REACTIVE ARTHRITIS	0.00520833	0.07956195802642747
TUBERCULOSIS	0.00520833	0.07956195802642747
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.00520833	0.07956195802642747
YAO SYNDROME	0.00520833	0.07956195802642747
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.00520833	0.07956195802642747
WILD TYPE ATTR AMYLOIDOSIS	0.00520833	0.07956195802642747
OROMANDIBULAR DYSTONIA	0.00520833	0.07956195802642747
ATTRV30M AMYLOIDOSIS	0.00520833	0.07956195802642747
KIKUCHI-FUJIMOTO DISEASE	0.00520833	0.07956195802642747
EOSINOPHILIC FASCIITIS	0.00520833	0.07956195802642747
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS	0.00520833	0.07956195802642747
OSTEOSARCOMA	0.00520833	0.07956195802642747
HUNTINGTON DISEASE-LIKE 1	0.00520833	0.07956195802642747
ACUTE MYELOMONOCYTIC LEUKEMIA	0.00520833	0.07956195802642747
THYROTOXIC PERIODIC PARALYSIS	0.00520833	0.07956195802642747
JUVENILE HUNTINGTON DISEASE	0.00520833	0.07956195802642747
MU-HEAVY CHAIN DISEASE	0.00520833	0.07956195802642747
THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1; TTPP1	0.00520833	0.07956195802642747
THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2; TTPP2	0.00520833	0.07956195802642747
INFLAMMATORY BOWEL DISEASE 11	0.00520833	0.07956195802642747
CHRONIC GRAFT VERSUS HOST DISEASE	0.00520833	0.07956195802642747
BULLOUS PEMPHIGOID	0.00520833	0.07956195802642747
ISAAC SYNDROME	0.00520833	0.07956195802642747
JUVENILE DERMATOMYOSITIS	0.00520833	0.07956195802642747
CONGENITAL ENTEROCYTE HEPARAN SULFATE DEFICIENCY	0.00520833	0.07956195802642747
CHRONIC HICCUP	0.00520833	0.07956195802642747
ACQUIRED CENTRAL DIABETES INSIPIDUS	0.00520833	0.07956195802642747
INSULIN AUTOIMMUNE SYNDROME	0.00520833	0.07956195802642747
PERRY SYNDROME	0.00520833	0.07956195802642747
PARKINSON DISEASE 4, AUTOSOMAL DOMINANT LEWY BODY	0.00520833	0.07956195802642747
LEISHMANIASIS	0.00520833	0.07956195802642747
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00520833	0.07956195802642747
MULTIPLE MYELOMA	0.00520833	0.07956195802642747
PERRY SYNDROME	0.00520833	0.07956195802642747
ACUTE PROMYELOCYTIC LEUKEMIA	0.00520833	0.07956195802642747
AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS	0.00520833	0.07956195802642747
CRYPTOGENIC ORGANIZING PNEUMONIA	0.00520833	0.07956195802642747
HUNTINGTON DISEASE-LIKE 2	0.00520833	0.07956195802642747
HUNTINGTON DISEASE-LIKE 2	0.00520833	0.07956195802642747
FAMILIAL GESTATIONAL HYPERTHYROIDISM	0.00520833	0.07956195802642747
BUDD-CHIARI SYNDROME	0.00520833	0.07956195802642747
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.00520749	0.07954912626562465
BETA-MANNOSIDOSIS	0.00520749	0.07954912626562465
PROLIDASE DEFICIENCY	0.00520749	0.07954912626562465
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.0051938	0.07933999911634997
OSTEOPENIA-MYOPIA-HEARING LOSS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.0051938	0.07933999911634997
LAURENCE-MOON SYNDROME	0.0051835100000000005	0.07918281004651531
CONGENITAL RUBELLA SYNDROME	0.0051835100000000005	0.07918281004651531
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.00516709	0.07893197967463142
AXENFELD-RIEGER SYNDROME	0.00516709	0.07893197967463142
OSTEOPETROSIS AND RELATED DISORDERS	0.00516709	0.07893197967463142
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.00516709	0.07893197967463142
HARDIKAR SYNDROME	0.00516709	0.07893197967463142
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.00516709	0.07893197967463142
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.00516709	0.07893197967463142
OSTEOGENESIS IMPERFECTA, TYPE IV	0.005136700000000001	0.07846774489987195
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.0051367	0.07846774489987193
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.005123010000000001	0.07825861775059727
ECTODERMAL DYSPLASIA-SENSORINEURAL DEAFNESS SYNDROME	0.005123010000000001	0.07825861775059727
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.005123010000000001	0.07825861775059727
GALACTOSIALIDOSIS	0.00505102	0.07715890529798336
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.00505102	0.07715890529798336
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 2	0.00505102	0.07715890529798336
SCHEIE SYNDROME	0.0050373300000000005	0.0769497781487087
FRONTOMETAPHYSEAL DYSPLASIA	0.0050373300000000005	0.0769497781487087
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.005030364000000001	0.07684336618947951
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.00502513	0.07676341209895331
CAP MYOPATHY	0.00502513	0.07676341209895331
MENTAL RETARDATION, X-LINKED 93	0.00502513	0.07676341209895331
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.00502513	0.07676341209895331
612917 GIACHETI SYNDROME;;MARFANOID HABITUS AND SPECIFIC LANGUAGE AND LEARNING DISABILITIES	0.00502513	0.07676341209895331
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.00502513	0.07676341209895331
GAMMA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R5	0.00502513	0.07676341209895331
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.00502513	0.07676341209895331
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.00502513	0.07676341209895331
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.00502513	0.07676341209895331
17Q21.31 RECURRENT MICRODELETION SYNDROME	0.00502513	0.07676341209895331
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.00502513	0.07676341209895331
SOTOS SYNDROME 3	0.00502513	0.07676341209895331
CDAGS SYNDROME	0.0050166740000000005	0.07663423904020483
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.00493537	0.0753922468017367
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.00493537	0.0753922468017367
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.00493537	0.0753922468017367
GAPO SYNDROME; GAPOS	0.00489497	0.07477510021074349
HOLMES-GANG SYNDROME	0.004887484	0.07466074478054113
SAY-BARBER-MILLER SYNDROME	0.004887484	0.07466074478054113
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.004887484	0.07466074478054113
WILSON-TURNER SYNDROME	0.004887484	0.07466074478054113
URBAN-ROGERS-MEYER SYNDROME	0.00486458	0.074310865435984
MASA SYNDROME	0.00486458	0.074310865435984
CLEFT LIP/PALATE	0.00485437	0.07415489843860676
ISOLATED CLEFT LIP	0.00485437	0.07415489843860676
MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT	0.00485437	0.07415489843860676
BLEPHARO-CHEILO-ODONTIC SYNDROME	0.00485437	0.07415489843860676
TREACHER COLLINS SYNDROME 3; TCS3	0.00485437	0.07415489843860676
%608572 BURN-MCKEOWN SYNDROME	0.00485437	0.07415489843860676
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE SYNDROME	0.00485437	0.07415489843860676
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00485437	0.07415489843860676
MARSHALL-SMITH SYNDROME	0.00485437	0.07415489843860676
PIGMENTED VILLONODULAR SYNOVITIS	0.00485437	0.07415489843860676
CARDIOSPONDYLOCARPOFACIAL SYNDROME	0.00485437	0.07415489843860676
ATRESIA OF EXTERNAL AUDITORY CANAL AND CONDUCTION DEAFNESS	0.00485437	0.07415489843860676
FAMILIAL EXPANSILE OSTEOLYSIS	0.00485437	0.07415489843860676
DEAFNESS-EAR MALFORMATION-FACIAL PALSY SYNDROME	0.00485437	0.07415489843860676
124490 DEAFNESS, CONDUCTIVE STAPEDIAL, WITH EAR MALFORMATION AND FACIAL PALSY	0.00485437	0.07415489843860676
PHAVER SYNDROME	0.00485437	0.07415489843860676
PHOCOMELIA-ECTRODACTYLY-DEAFNESS-SINUS ARRHYTHMIA SYNDROME	0.00485437	0.07415489843860676
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.00485437	0.07415489843860676
PRIMARY CILIARY DYSKINESIA	0.00485437	0.07415489843860676
SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.00485437	0.07415489843860676
TREACHER COLLINS SYNDROME 2; TCS2	0.00485437	0.07415489843860676
DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	0.00485437	0.07415489843860676
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00485437	0.07415489843860676
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.00485437	0.07415489843860676
DIAMOND-BLACKFAN ANEMIA 14 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA14	0.00485437	0.07415489843860676
NEPHROSIS-DEAFNESS-URINARY TRACT-DIGITAL MALFORMATIONS SYNDROME	0.00485437	0.07415489843860676
DEAFNESS, CONDUCTIVE, WITH PTOSIS AND SKELETAL ANOMALIES	0.00485437	0.07415489843860676
OTOSCLEROSIS	0.00485437	0.07415489843860676
CILIARY DYSKINESIA, PRIMARY, 33	0.00485437	0.07415489843860676
CILIARY DYSKINESIA, PRIMARY, 38; CILD38	0.00485437	0.07415489843860676
RICHARDS-RUNDLE SYNDROME; RRNS	0.004812094	0.07350909424848723
MUENKE SYNDROME	0.004812094	0.07350909424848723
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.0047789	0.07300202583409543
PITT-HOPKINS SYNDROME	0.0047789	0.07300202583409543
16P12.1P12.3 TRIPLICATION SYNDROME	0.0047789	0.07300202583409543
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.0047789	0.07300202583409543
MUCOLIPIDOSIS TYPE IV	0.0047789	0.07300202583409543
PELGER-HUET ANOMALY; PHA	0.004758244	0.07268648672559157
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.004758244	0.07268648672559157
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.004758244	0.07268648672559157
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.00474989	0.07255887180922628
SPONASTRIME DYSPLASIA	0.00474989	0.07255887180922628
METATROPIC DYSPLASIA	0.00474989	0.07255887180922628
FAMILIAL THYROID DYSHORMONOGENESIS	0.004731014	0.07227052381289986
ATHYREOSIS	0.004731014	0.07227052381289986
THYROID ECTOPIA	0.004731014	0.07227052381289986
COFFIN-SIRIS SYNDROME 5	0.004731014	0.07227052381289986
THYROID HYPOPLASIA	0.004731014	0.07227052381289986
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.004731014	0.07227052381289986
PERMANENT CONGENITAL HYPOTHYROIDISM	0.004731014	0.07227052381289986
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.004731014	0.07227052381289986
OGDEN SYNDROME; OGDNS	0.004731014	0.07227052381289986
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.004731014	0.07227052381289986
PRIMARY CONGENITAL HYPOTHYROIDISM	0.004731014	0.07227052381289986
COFFIN-SIRIS SYNDROME 2; CSS2	0.004731014	0.07227052381289986
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.004731014	0.07227052381289986
RABSON-MENDENHALL SYNDROME	0.004731014	0.07227052381289986
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.004731014	0.07227052381289986
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.004667950000000001	0.07130716409472175
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.004667950000000001	0.07130716409472175
ATRESIA OF SMALL INTESTINE	0.004667950000000001	0.07130716409472175
LYSINURIC PROTEIN INTOLERANCE; LPI	0.004667950000000001	0.07130716409472175
LESCH-NYHAN SYNDROME; LNS	0.004667950000000001	0.07130716409472175
CYSTINOSIS	0.004667950000000001	0.07130716409472175
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.004561614	0.06968278538432932
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.004561614	0.06968278538432932
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.004561614	0.06968278538432932
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.004561614	0.06968278538432932
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.00453162	0.06922459986823401
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.004497424	0.06870222499631312
YUNIS-VARON SYNDROME	0.004497424	0.06870222499631312
SANDHOFF DISEASE	0.0044848100000000005	0.06850953472159065
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.0044848100000000005	0.06850953472159065
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.0044848100000000005	0.06850953472159065
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.0044848100000000005	0.06850953472159065
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.0044848100000000005	0.06850953472159065
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.0044848100000000005	0.06850953472159065
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.0044848100000000005	0.06850953472159065
CLEIDOCRANIAL DYSPLASIA; CCD	0.0044848100000000005	0.06850953472159065
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.0044848100000000005	0.06850953472159065
INFANTILE REFSUM DISEASE	0.0044837340000000005	0.06849309784703846
VICI SYNDROME	0.004483734	0.06849309784703844
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.00447112	0.06830040757231595
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.00447112	0.06830040757231595
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.00447112	0.06830040757231595
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.00434193	0.06632691331265227
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.00434193	0.06632691331265227
KENNERKNECHT SYNDROME	0.00434193	0.06632691331265227
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00434193	0.06632691331265227
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.00434193	0.06632691331265227
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00434193	0.06632691331265227
ISOLATED AGAMMAGLOBULINEMIA	0.00434193	0.06632691331265227
RODRIGUES BLINDNESS	0.00434193	0.06632691331265227
DIAMOND-BLACKFAN ANEMIA 4	0.00434193	0.06632691331265227
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.00434193	0.06632691331265227
SPINOCEREBELLAR ATAXIA 47; SCA47	0.00434193	0.06632691331265227
HAIRY ELBOWS	0.00434193	0.06632691331265227
SHORT STATURE-WEBBED NECK-HEART DISEASE SYNDROME	0.00434193	0.06632691331265227
MICROSPHEROPHAKIA-METAPHYSEAL DYSPLASIA	0.00430153	0.06570976672165905
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.004235594	0.06470253460225985
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.004235594	0.06470253460225985
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.004235594	0.06470253460225985
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.004235594	0.06470253460225985
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.004235594	0.06470253460225985
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.004235594	0.06470253460225985
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.004235594	0.06470253460225985
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.004235594	0.06470253460225985
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.004235594	0.06470253460225985
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.004235594	0.06470253460225985
HOLOPROSENCEPHALY 5; HPE5	0.004235594	0.06470253460225985
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.004235594	0.06470253460225985
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.004235594	0.06470253460225985
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.004235594	0.06470253460225985
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.004235594	0.06470253460225985
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.004235594	0.06470253460225985
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.004235594	0.06470253460225985
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.004235594	0.06470253460225985
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.004235594	0.06470253460225985
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.004235594	0.06470253460225985
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.004235594	0.06470253460225985
MENTAL RETARDATION, X-LINKED 91; MRX91	0.004235594	0.06470253460225985
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.004235594	0.06470253460225985
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.004235594	0.06470253460225985
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.004235594	0.06470253460225985
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.004235594	0.06470253460225985
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.004235594	0.06470253460225985
ROIFMAN-CHITAYAT SYNDROME	0.004235594	0.06470253460225985
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.004225304	0.06454534553242519
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.004225304	0.06454534553242519
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.004225304	0.06454534553242519
DISTAL TRISOMY 6P	0.004225304	0.06454534553242519
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.004225304	0.06454534553242519
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00421269	0.0643526552577027
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.00421269	0.0643526552577027
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.00421269	0.0643526552577027
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00421269	0.0643526552577027
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.00421269	0.0643526552577027
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.00421269	0.0643526552577027
JOUBERT SYNDROME 10	0.004195194	0.06408538801126663
2P21 MICRODELETION SYNDROME	0.004195194	0.06408538801126663
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.004195194	0.06408538801126663
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.004195194	0.06408538801126663
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.004195194	0.06408538801126663
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.004195194	0.06408538801126663
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.004195194	0.06408538801126663
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.004195194	0.06408538801126663
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.004195194	0.06408538801126663
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.004195194	0.06408538801126663
COG4-CDG	0.004195194	0.06408538801126663
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.004195194	0.06408538801126663
HEART AND BRAIN MALFORMATION SYNDROME	0.004195194	0.06408538801126663
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.004195194	0.06408538801126663
RING CHROMOSOME 14 SYNDROME	0.004195194	0.06408538801126663
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.004195194	0.06408538801126663
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.004195194	0.06408538801126663
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.004195194	0.06408538801126663
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.004195194	0.06408538801126663
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.004195194	0.06408538801126663
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.004195194	0.06408538801126663
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.004195194	0.06408538801126663
MUCOLIPIDOSIS III ALPHA/BETA	0.00418546	0.063936692345011
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00418546	0.063936692345011
IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN	0.00418546	0.063936692345011
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00418546	0.063936692345011
CARPENTER-WAZIRI SYNDROME	0.00418546	0.063936692345011
PRIMARY IMMUNODEFICIENCY SYNDROME DUE TO LAMTOR2 DEFICIENCY	0.00418546	0.063936692345011
ATKIN-FLAITZ SYNDROME	0.00418546	0.063936692345011
2Q23.1 MICRODELETION SYNDROME	0.00418546	0.063936692345011
CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.00418546	0.063936692345011
COLE-CARPENTER SYNDROME	0.004164804	0.06362115323650715
FARBER DISEASE	0.004164804	0.06362115323650715
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.004164804	0.06362115323650715
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.004164804	0.06362115323650715
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.004164804	0.06362115323650715
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.004164803999999999	0.06362115323650713
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.004079124	0.06231231363461857
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.004079124	0.06231231363461857
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.004079124	0.06231231363461857
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.004079124	0.06231231363461857
SIALURIA	0.004079124	0.06231231363461857
PERIPHERAL HYPOTHYROIDISM	0.004079124	0.06231231363461857
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.004079124	0.06231231363461857
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.004079124	0.06231231363461857
MENTAL RETARDATION, X-LINKED 103	0.004079124	0.06231231363461857
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.004079124	0.06231231363461857
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.00401606	0.061348953916440456
AA AMYLOIDOSIS	0.00401606	0.061348953916440456
EPISODIC ATAXIA, TYPE 3	0.00401606	0.061348953916440456
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.00401606	0.061348953916440456
ALPHA-METHYLACETOACETIC ACIDURIA	0.00401606	0.061348953916440456
ESOPHAGITIS, EOSINOPHILIC, 2; EOE2	0.00401606	0.061348953916440456
ENTERIC ANENDOCRINOSIS	0.00401606	0.061348953916440456
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.00401606	0.061348953916440456
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.00401606	0.061348953916440456
PORPHYRIA, ACUTE HEPATIC	0.00401606	0.061348953916440456
INHALATIONAL ANTHRAX	0.00401606	0.061348953916440456
HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA	0.00401606	0.061348953916440456
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IB; CDG1B	0.00401606	0.061348953916440456
HELLP SYNDROME	0.00401606	0.061348953916440456
PROLACTINOMA	0.00401606	0.061348953916440456
EPISODIC ATAXIA, TYPE 6	0.00401606	0.061348953916440456
GRAFT VERSUS HOST DISEASE	0.00401606	0.061348953916440456
SUCCINYL-COA:3-OXOACID COA TRANSFERASE DEFICIENCY	0.00401606	0.061348953916440456
NEUROLEPTIC MALIGNANT SYNDROME	0.00401606	0.061348953916440456
VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE	0.00401606	0.061348953916440456
CONGENITAL SHORT BOWEL SYNDROME	0.00401606	0.061348953916440456
LIVER FAILURE, INFANTILE, TRANSIENT	0.00401606	0.061348953916440456
GITELMAN SYNDROME	0.00401606	0.061348953916440456
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.00401606	0.061348953916440456
HEREDITARY ANGIOEDEMA TYPE 1	0.00401606	0.061348953916440456
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE-2 DEFICIENCY	0.00401606	0.061348953916440456
118301 CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM	0.00401606	0.061348953916440456
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.00401606	0.061348953916440456
HYPER-IGD SYNDROME	0.00401606	0.061348953916440456
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.00401606	0.061348953916440456
RELAPSING FEVER	0.00401606	0.061348953916440456
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00401606	0.061348953916440456
ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY	0.00401606	0.061348953916440456
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.00401606	0.061348953916440456
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.00401606	0.061348953916440456
CAROLI DISEASE, ISOLATED	0.00401606	0.061348953916440456
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.00401606	0.061348953916440456
ACQUIRED METHEMOGLOBINEMIA	0.00401606	0.061348953916440456
NON-FUNCTIONING PITUITARY ADENOMA	0.00401606	0.061348953916440456
HYPOADRENOCORTICISM, FAMILIAL	0.00401606	0.061348953916440456
5-@OXOPROLINASE DEFICIENCY; OPLAHD	0.00401606	0.061348953916440456
ANGIOEDEMA, HEREDITARY, TYPE I; HAE1	0.00401606	0.061348953916440456
PEDIATRIC HEPATOCELLULAR CARCINOMA	0.00401606	0.061348953916440456
DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7	0.00401606	0.061348953916440456
PORPHYRIA VARIEGATA	0.00401606	0.061348953916440456
VISCERAL MYOPATHY; VSCM	0.00401606	0.061348953916440456
ACID PHOSPHATASE DEFICIENCY	0.00401606	0.061348953916440456
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.00401606	0.061348953916440456
VALINEMIA	0.00401606	0.061348953916440456
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.00401606	0.061348953916440456
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00401606	0.061348953916440456
LYSOSOMAL ACID LIPASE DEFICIENCY	0.00401606	0.061348953916440456
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.00401606	0.061348953916440456
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.00401606	0.061348953916440456
LATE-ONSET FAMILIAL HYPOALDOSTERONISM	0.00401606	0.061348953916440456
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.00401606	0.061348953916440456
CONGENITAL PANCREATIC CYST	0.00401606	0.061348953916440456
HYPERLIPOPROTEINEMIA, TYPE I	0.00401606	0.061348953916440456
MEDIUM CHAIN 3-KETOACYL-COA THIOLASE DEFICIENCY	0.00401606	0.061348953916440456
BENIGN OCCIPITAL EPILEPSY	0.00401606	0.061348953916440456
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.00401606	0.061348953916440456
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.00401606	0.061348953916440456
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	0.00401606	0.061348953916440456
CONGENITAL SUCRASE-ISOMALTASE DEFICIENCY	0.00401606	0.061348953916440456
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.00401606	0.061348953916440456
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.00401606	0.061348953916440456
HYPOPHOSPHATASIA, INFANTILE	0.00401606	0.061348953916440456
%241150 HYPOKALEMIC ALKALOSIS, FAMILIAL, WITH SPECIFIC RENAL TUBULOPATHY;;HYPOKALEMIA, FAMILIAL;;GULLNER SYNDROME	0.00401606	0.061348953916440456
ESOPHAGITIS, EOSINOPHILIC, 1; EOE1	0.00401606	0.061348953916440456
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.00401606	0.061348953916440456
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.00401606	0.061348953916440456
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.00401606	0.061348953916440456
ANGIOEDEMA, HEREDITARY, TYPE III	0.00401606	0.061348953916440456
OPTIC ATROPHY 11; OPA11	0.003960224	0.060496008444789535
KABUKI SYNDROME 1	0.003960224	0.060496008444789535
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.003960224	0.060496008444789535
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.00395187	0.060368393528424255
SPASTIC PARAPARESIS AND DEAFNESS	0.00395187	0.060368393528424255
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.00395187	0.060368393528424255
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.003946534	0.06028688129551485
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.00393818	0.06015926637914958
NATHALIE SYNDROME	0.00393818	0.06015926637914958
NAIL-PATELLA SYNDROME	0.00393818	0.06015926637914958
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00393818	0.06015926637914958
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.0039381799999999995	0.06015926637914957
VOGT-KOYANAGI-HARADA DISEASE	0.0039381799999999995	0.06015926637914957
LEBER CONGENITAL AMAUROSIS	0.0038455340000000003	0.058744014818031834
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.0038455340000000003	0.058744014818031834
3Q29 MICRODUPLICATION SYNDROME	0.0038455340000000003	0.058744014818031834
LATHOSTEROLOSIS	0.0038455340000000003	0.058744014818031834
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.0038455340000000003	0.058744014818031834
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.0038455340000000003	0.058744014818031834
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.0038455340000000003	0.058744014818031834
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.0038455340000000003	0.058744014818031834
OTOPALATODIGITAL SYNDROME TYPE 2	0.0038455340000000003	0.058744014818031834
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.003831844	0.058534887668757155
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.003831844	0.058534887668757155
USHER SYNDROME TYPE 1	0.003831844	0.058534887668757155
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.003831844	0.058534887668757155
MENTAL RETARDATION, X-LINKED 14	0.00369004	0.056368703134370986
LICHTENSTEIN SYNDROME	0.00369004	0.056368703134370986
ZECHI-CEIDE SYNDROME	0.00369004	0.056368703134370986
HYDROCEPHALUS, CONGENITAL, 3, WITH BRAIN ANOMALIES; HYC3	0.00369004	0.056368703134370986
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 33	0.00369004	0.056368703134370986
VERVERI-BRADY SYNDROME; VERBRAS	0.00369004	0.056368703134370986
ISOLATED BILIARY ATRESIA	0.00369004	0.056368703134370986
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.00369004	0.056368703134370986
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.00369004	0.056368703134370986
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00369004	0.056368703134370986
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.00369004	0.056368703134370986
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.00369004	0.056368703134370986
FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS; FDLAB	0.00369004	0.056368703134370986
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.00369004	0.056368703134370986
HIRSCHSPRUNG DISEASE WITH HYPOPLASTIC NAILS AND DYSMORPHIC FACIALFEATURES	0.00369004	0.056368703134370986
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00369004	0.056368703134370986
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.00369004	0.056368703134370986
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.00369004	0.056368703134370986
MENTAL RETARDATION, X-LINKED 100	0.00369004	0.056368703134370986
EPILEPSY-TELANGIECTASIA	0.00369004	0.056368703134370986
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00369004	0.056368703134370986
UROFACIAL SYNDROME	0.00369004	0.056368703134370986
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.00369004	0.056368703134370986
LARON SYNDROME	0.00369004	0.056368703134370986
FOCAL FACIAL DERMAL DYSPLASIA TYPE I	0.00369004	0.056368703134370986
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.00369004	0.056368703134370986
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO JAK3 DEFICIENCY	0.00369004	0.056368703134370986
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00369004	0.056368703134370986
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.00369004	0.056368703134370986
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.00369004	0.056368703134370986
IRIDOGONIODYSGENESIS, TYPE 2	0.00369004	0.056368703134370986
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.00369004	0.056368703134370986
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.00369004	0.056368703134370986
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00369004	0.056368703134370986
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.0036797500000000003	0.056211514064536325
HIDROTIC ECTODERMAL DYSPLASIA	0.0036797500000000003	0.056211514064536325
DYSEQUILIBRIUM SYNDROME	0.0036797500000000003	0.056211514064536325
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00364964	0.05575155654337777
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 9; MRT9	0.00364964	0.05575155654337777
ACHALASIA-MICROCEPHALY SYNDROME	0.00364964	0.05575155654337777
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.00364964	0.05575155654337777
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.00364964	0.05575155654337777
OSTEODYSPLASTY, PRECOCIOUS, OF DANKS, MAYNE, AND KOZLOWSKI	0.00364964	0.05575155654337777
ERYTHRODERMA, CONGENITAL, WITH PALMOPLANTAR KERATODERMA, HYPOTRICHOSIS, AND HYPER-IGE; EPKHE	0.00364964	0.05575155654337777
MILLER-DIEKER SYNDROME	0.00364964	0.05575155654337777
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00364964	0.05575155654337777
ACETYL-COA CARBOXYLASE DEFICIENCY	0.00364964	0.05575155654337777
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.00364964	0.05575155654337777
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00364964	0.05575155654337777
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00364964	0.05575155654337777
MENTAL AND GROWTH RETARDATION WITH AMBLYOPIA	0.00364964	0.05575155654337777
T-SUBSTANCE ANOMALY	0.00364964	0.05575155654337777
IMMUNODEFICIENCY, COMMON VARIABLE, 11; CVID11	0.00364964	0.05575155654337777
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.00364964	0.05575155654337777
LYSINE MALABSORPTION SYNDROME	0.00364964	0.05575155654337777
GLYCOGEN STORAGE DISEASE IXA	0.00364964	0.05575155654337777
AROMATASE DEFICIENCY	0.00364964	0.05575155654337777
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00364964	0.05575155654337777
FAMILIAL DYSAUTONOMIA	0.00364964	0.05575155654337777
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.00364964	0.05575155654337777
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.00364964	0.05575155654337777
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.00364964	0.05575155654337777
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.00364964	0.05575155654337777
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.00364964	0.05575155654337777
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.00364964	0.05575155654337777
DIARRHEA 2, WITH MICROVILLOUS ATROPHY	0.00364964	0.05575155654337777
EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE; EBSDM	0.00364964	0.05575155654337777
ROWLEY-ROSENBERG SYNDROME	0.00364964	0.05575155654337777
SERKAL SYNDROME	0.00364964	0.05575155654337777
CITRULLINE TRANSPORT DEFECT	0.00364964	0.05575155654337777
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 3	0.00364964	0.05575155654337777
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.00364964	0.05575155654337777
HEREDITARY SPHEROCYTOSIS	0.00364964	0.05575155654337777
FORMIMINOTRANSFERASE DEFICIENCY	0.00364964	0.05575155654337777
GLYCOGEN STORAGE DISEASE IXC	0.00364964	0.05575155654337777
SEVERE CONGENITAL HYPOCHROMIC ANEMIA WITH RINGED SIDEROBLASTS	0.00364964	0.05575155654337777
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.00364964	0.05575155654337777
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00364964	0.05575155654337777
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 4	0.00364964	0.05575155654337777
HYPOTONIA-CYSTINURIA SYNDROME	0.00364964	0.05575155654337777
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.00364964	0.05575155654337777
DIAMOND-BLACKFAN ANEMIA 9	0.00364964	0.05575155654337777
SUDDEN INFANT DEATH-DYSGENESIS OF THE TESTES SYNDROME	0.00364964	0.05575155654337777
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00364964	0.05575155654337777
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.00364964	0.05575155654337777
COLOBOMA, OCULAR	0.00364964	0.05575155654337777
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00364964	0.05575155654337777
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00364964	0.05575155654337777
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00364964	0.05575155654337777
MAJEED SYNDROME	0.00364964	0.05575155654337777
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.00364964	0.05575155654337777
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.00364964	0.05575155654337777
EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE K14	0.00364964	0.05575155654337777
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2	0.00364964	0.05575155654337777
JUNCTIONAL EPIDERMOLYSIS BULLOSA, NON-HERLITZ TYPE	0.00364964	0.05575155654337777
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.00364964	0.05575155654337777
CONGENITAL PULMONARY LYMPHANGIECTASIA	0.00364964	0.05575155654337777
INTERLEUKIN 1, DEFECTIVE T-CELL RESPONSE TO	0.00364964	0.05575155654337777
LEUKOMELANODERMA, INFANTILISM, MENTAL RETARDATION, HYPODONTIA, HYPOTRICHOSIS	0.00364964	0.05575155654337777
THREONINEMIA	0.00364964	0.05575155654337777
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.00364964	0.05575155654337777
HURLER-SCHEIE SYNDROME	0.00361925	0.055287321768618274
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.00361925	0.055287321768618274
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.00361925	0.055287321768618274
RUVALCABA SYNDROME	0.00361925	0.055287321768618274
OSTEOPOROSIS-OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME	0.00361925	0.055287321768618274
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.00361925	0.055287321768618274
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.00361925	0.055287321768618274
SJÖGREN-LARSSON SYNDROME	0.00361925	0.055287321768618274
SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE; SCDO3	0.00361925	0.055287321768618274
PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY OF CHILDHOOD	0.00361925	0.055287321768618274
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.0035734140000000005	0.054587135354143904
1Q21.1 MICRODUPLICATION SYNDROME	0.0035734140000000005	0.054587135354143904
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.0035734140000000005	0.054587135354143904
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.0035734140000000005	0.054587135354143904
MIETENS SYNDROME	0.0035734140000000005	0.054587135354143904
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.0035734140000000005	0.054587135354143904
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.0035734140000000005	0.054587135354143904
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.0035734140000000005	0.054587135354143904
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.00353357	0.05397848216672971
300064 MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM;;MENTAL RETARDATION, X-LINKED, HYDE-FORSTER TYPE	0.00353357	0.05397848216672971
CAMPTODACTYLY-FIBROUS TISSUE HYPERPLASIA-SKELETAL DYSPLASIA SYNDROME	0.00353357	0.05397848216672971
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00353357	0.05397848216672971
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.00353357	0.05397848216672971
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.00353357	0.05397848216672971
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00353357	0.05397848216672971
MENTAL RETARDATION, X-LINKED, SYNDROMIC 11; MRXS11	0.00353357	0.05397848216672971
268650 RUDIGER SYNDROME	0.00353357	0.05397848216672971
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.00353357	0.05397848216672971
HYPER-IGE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.00353357	0.05397848216672971
INFANTILE SYSTEMIC HYALINOSIS	0.00353357	0.05397848216672971
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.00353357	0.05397848216672971
CENTRAL CONGENITAL HYPOTHYROIDISM	0.00353357	0.05397848216672971
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.00353357	0.05397848216672971
SANDHOFF DISEASE	0.00353357	0.05397848216672971
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.00353357	0.05397848216672971
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.00353357	0.05397848216672971
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.00353357	0.05397848216672971
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.00353357	0.05397848216672971
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.00353357	0.05397848216672971
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.003512914	0.05366294305822584
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.003512914	0.05366294305822584
TRISOMY 9P	0.003512914	0.05366294305822584
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.003512914	0.05366294305822584
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.003512914	0.05366294305822584
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.003512914	0.05366294305822584
GAUCHER DISEASE	0.0034146700000000003	0.052162176976900676
PELVISCAPULAR DYSPLASIA	0.0034146700000000003	0.052162176976900676
FREEMAN-SHELDON SYNDROME	0.0034146700000000003	0.052162176976900676
STIFF SKIN SYNDROME	0.00340098	0.05195304982762599
COG5-CDG	0.00340098	0.05195304982762599
JOHANSON-BLIZZARD SYNDROME; JBS	0.00340098	0.05195304982762599
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00340098	0.05195304982762599
CHAR SYNDROME	0.0033083340000000004	0.050537798266508255
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.0033083340000000004	0.050537798266508255
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.0033083340000000004	0.050537798266508255
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.0033083340000000004	0.050537798266508255
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.0033083340000000004	0.050537798266508255
DISTAL MONOSOMY 6P	0.0033083340000000004	0.050537798266508255
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.00329998	0.050410183350142974
%300719 DEAFNESS, CATARACT, RETINITIS PIGMENTOSA, AND SPERM ABNORMALITIES	0.00329998	0.050410183350142974
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.00329998	0.050410183350142974
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.00329998	0.050410183350142974
OPTIC ATROPHY 3, AUTOSOMAL DOMINANT	0.00329998	0.050410183350142974
AGEL AMYLOIDOSIS	0.00329998	0.050410183350142974
MUCOPOLYSACCHARIDOSIS TYPE 3	0.00329998	0.050410183350142974
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.00329998	0.050410183350142974
CENANI-LENZ SYNDROME	0.00329998	0.050410183350142974
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.0032946440000000002	0.05032867111723357
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.0032946440000000002	0.05032867111723357
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.0032946440000000002	0.05032867111723357
LEIGH SYNDROME; LS	0.0032946440000000002	0.05032867111723357
CRANIOSYNOSTOSIS 6; CRS6	0.0032946440000000002	0.05032867111723357
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.0032946440000000002	0.05032867111723357
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.0032946440000000002	0.05032867111723357
HYPERTRYPTOPHANEMIA; HYPTRP	0.0032946440000000002	0.05032867111723357
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.0032946440000000002	0.05032867111723357
PONTINE TEGMENTAL CAP DYSPLASIA	0.0032946440000000002	0.05032867111723357
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.00328629	0.05020105620086829
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00328629	0.05020105620086829
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.00328629	0.05020105620086829
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.00328629	0.05020105620086829
REFSUM DISEASE	0.00328629	0.05020105620086829
USHER SYNDROME TYPE 2	0.00328629	0.05020105620086829
USHER SYNDROME TYPE 3	0.00328629	0.05020105620086829
REFSUM DISEASE	0.00328629	0.05020105620086829
STICKLER SYNDROME, TYPE II	0.00328629	0.05020105620086829
USHER SYNDROME	0.00328629	0.05020105620086829
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.00328629	0.05020105620086829
STICKLER SYNDROME TYPE 2	0.00328629	0.05020105620086829
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.00328629	0.05020105620086829
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.00328629	0.05020105620086829
STICKLER SYNDROME TYPE 1	0.00328629	0.05020105620086829
RELAPSING POLYCHONDRITIS	0.00328629	0.05020105620086829
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00328629	0.05020105620086829
WOOLLY HAIR	0.0030278600000000003	0.04625330388625504
MORNING GLORY DISC ANOMALY	0.0030278600000000003	0.04625330388625504
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.0030278600000000003	0.04625330388625504
MUSCLE-EYE-BRAIN DISEASE	0.0030278600000000003	0.04625330388625504
LEBER CONGENITAL AMAUROSIS 16	0.0030278600000000003	0.04625330388625504
183800 SPLIT-HAND WITH CONGENITAL NYSTAGMUS, FUNDAL CHANGES, AND CATARACTS;;NYSTAGMUS-SPLIT HAND SYNDROME;;KARSCH-NEUGEBAUER SYNDROME; KNS	0.0030278600000000003	0.04625330388625504
PRIMARY CUTIS VERTICIS GYRATA	0.0030278600000000003	0.04625330388625504
MICROPHTHALMIA, ISOLATED, WITH CATARACT 1	0.0030278600000000003	0.04625330388625504
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.0030278600000000003	0.04625330388625504
FOVEAL HYPOPLASIA-PRESENILE CATARACT SYNDROME	0.0030278600000000003	0.04625330388625504
GROENOUW TYPE I CORNEAL DYSTROPHY	0.0030278600000000003	0.04625330388625504
CATARACT-INTELLECTUAL DISABILITY-ANAL ATRESIA-URINARY DEFECTS SYNDROME	0.0030278600000000003	0.04625330388625504
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.0030278600000000003	0.04625330388625504
COATS DISEASE	0.0030278600000000003	0.04625330388625504
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.00302121	0.04615171911323263
DEAFNESS, AUTOSOMAL RECESSIVE 20; DFNB20	0.00302121	0.04615171911323263
COWCHOCK SYNDROME; COWCK	0.00302121	0.04615171911323263
DEAFNESS, AUTOSOMAL RECESSIVE 29	0.00302121	0.04615171911323263
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.002979974	0.04552180186505946
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.002979974	0.04552180186505946
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.002979974	0.04552180186505946
SENIOR-LOKEN SYNDROME	0.002979974	0.04552180186505946
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.002979974	0.04552180186505946
OCULO-PALATO-CEREBRAL SYNDROME	0.002979974	0.04552180186505946
RHIZOMELIC SYNDROME, URBACH TYPE	0.00296736	0.045329111590336986
OROFACIODIGITAL SYNDROME III	0.00296736	0.045329111590336986
CHARCOT-MARIE-TOOTH DISEASE/HEREDITARY MOTOR AND SENSORY NEUROPATHY	0.00296736	0.045329111590336986
HOLT-ORAM SYNDROME	0.00296736	0.045329111590336986
OSTEOMESOPYKNOSIS	0.00296736	0.045329111590336986
BETHLEM MYOPATHY 2; BTHLM2	0.00296736	0.045329111590336986
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00296736	0.045329111590336986
METATROPIC DYSPLASIA	0.00296736	0.045329111590336986
%112350 WEISMANN-NETTER SYNDROME; WNS;;BOWING OF LEGS, ANTERIOR, WITH DWARFISM;;TOXOPACHYOSTEOSE DIAPHYSAIRE TIBIO-PERONIERE	0.00296736	0.045329111590336986
EHLERS-DANLOS SYNDROME, TYPE VI	0.00296736	0.045329111590336986
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.00296736	0.045329111590336986
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.00296736	0.045329111590336986
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.00296736	0.045329111590336986
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.00296736	0.045329111590336986
MENTAL RETARDATION, X-LINKED 82	0.00296736	0.045329111590336986
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00296736	0.045329111590336986
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.00296736	0.045329111590336986
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.00296736	0.045329111590336986
HIP DYSPLASIA, BEUKES TYPE	0.00296736	0.045329111590336986
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.00296736	0.045329111590336986
MYOPATHY, MYOFIBRILLAR, 7; MFM7	0.00296736	0.045329111590336986
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00296736	0.045329111590336986
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00296736	0.045329111590336986
FAMILIAL SCHEUERMANN DISEASE	0.00296736	0.045329111590336986
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.00296736	0.045329111590336986
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3B	0.00296736	0.045329111590336986
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.00296736	0.045329111590336986
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00296736	0.045329111590336986
SCHEUERMANN DISEASE	0.00296736	0.045329111590336986
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	0.00296736	0.045329111590336986
SPONDYLOENCHONDRODYSPLASIA	0.00296736	0.045329111590336986
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.00296736	0.045329111590336986
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.00296736	0.045329111590336986
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00296736	0.045329111590336986
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.00296736	0.045329111590336986
FETAL AKINESIA DEFORMATION SEQUENCE 4; FADS4	0.00296736	0.045329111590336986
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1	0.00296736	0.045329111590336986
SPONDYLOMETAPHYSEAL DYSPLASIA, 'CORNER FRACTURE' TYPE	0.00296736	0.045329111590336986
IDIOPATHIC JUVENILE OSTEOPOROSIS	0.00296736	0.045329111590336986
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.00296736	0.045329111590336986
WEISMANN-NETTER SYNDROME	0.00296736	0.045329111590336986
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.00296736	0.045329111590336986
PSEUDOACHONDROPLASIA	0.00296736	0.045329111590336986
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.00296736	0.045329111590336986
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.00296736	0.045329111590336986
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.00296736	0.045329111590336986
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.00296736	0.045329111590336986
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.00296736	0.045329111590336986
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00296736	0.045329111590336986
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.00296736	0.045329111590336986
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.00296736	0.045329111590336986
RETT SYNDROME, CONGENITAL VARIANT	0.00296736	0.045329111590336986
HEART DEFECTS-LIMB SHORTENING SYNDROME	0.00296736	0.045329111590336986
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.00296736	0.045329111590336986
GAUCHER DISEASE TYPE 1	0.00296736	0.045329111590336986
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.00296736	0.045329111590336986
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.0027627800000000003	0.04220396679861938
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.0027627800000000003	0.04220396679861938
EXTERNAL AUDITORY CANAL ATRESIA-VERTICAL TALUS-HYPERTELORISM SYNDROME	0.0027627800000000003	0.04220396679861938
6P22 MICRODELETION SYNDROME	0.0027627800000000003	0.04220396679861938
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.0027627800000000003	0.04220396679861938
IVIC SYNDROME	0.0027627800000000003	0.04220396679861938
IVIC SYNDROME	0.0027627800000000003	0.04220396679861938
MOEBIUS SYNDROME	0.0027627800000000003	0.04220396679861938
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00274909	0.0419948396493447
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.00274909	0.0419948396493447
FETAL IODINE SYNDROME	0.00274909	0.0419948396493447
AUTOSOMAL DOMINANT OPTIC ATROPHY PLUS SYNDROME	0.00274909	0.0419948396493447
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.00274909	0.0419948396493447
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00274909	0.0419948396493447
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00274909	0.0419948396493447
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00274909	0.0419948396493447
PROXIMAL SYMPHALANGISM	0.00274909	0.0419948396493447
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00274909	0.0419948396493447
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.0027148940000000002	0.04147246477742381
RFT1-CDG	0.002714894	0.04147246477742381
NARP SYNDROME	0.002714894	0.04147246477742381
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.002714894	0.04147246477742381
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.002714894	0.04147246477742381
14Q22Q23 MICRODELETION SYNDROME	0.002714894	0.04147246477742381
PELIZAEUS-MERZBACHER DISEASE	0.002714894	0.04147246477742381
LYMPHEDEMA, HEREDITARY, III	0.002714894	0.04147246477742381
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.0027012040000000005	0.04126333762814914
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.0027012040000000005	0.04126333762814914
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.0027012040000000005	0.04126333762814914
16P13.11 MICRODELETION SYNDROME	0.0027012040000000005	0.04126333762814914
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.0027012040000000005	0.04126333762814914
BARAITSER-WINTER SYNDROME 1; BRWS1	0.0027012040000000005	0.04126333762814914
6Q25 MICRODELETION SYNDROME	0.0027012040000000005	0.04126333762814914
NOONAN SYNDROME 11; NS11	0.002701204	0.041263337628149134
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.002701204	0.041263337628149134
STEEL SYNDROME; STLS	0.002701204	0.041263337628149134
HADZISELIMOVIC SYNDROME	0.002442774	0.03731558531353588
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.002442774	0.03731558531353588
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.002442774	0.03731558531353588
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.002442774	0.03731558531353588
PENTASOMY X	0.002442774	0.03731558531353588
TOLUENE EMBRYOPATHY	0.002442774	0.03731558531353588
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.002442774	0.03731558531353588
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.002442774	0.03731558531353588
49,XXXXY SYNDROME	0.002442774	0.03731558531353588
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.002442774	0.03731558531353588
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.002442774	0.03731558531353588
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.002442774	0.03731558531353588
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.002442774	0.03731558531353588
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.002442774	0.03731558531353588
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.002442774	0.03731558531353588
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.002442774	0.03731558531353588
1Q44 MICRODELETION SYNDROME	0.002442774	0.03731558531353588
HARTNUP DISEASE	0.002442774	0.03731558531353588
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.002442774	0.03731558531353588
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.002442774	0.03731558531353588
HYPERGONADOTROPIC HYPOGONADISM-CATARACT SYNDROME	0.00243442	0.0371879703971706
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.00243442	0.0371879703971706
WEILL-MARCHESANI SYNDROME	0.00243442	0.0371879703971706
DAHLBERG-BORER-NEWCOMER SYNDROME	0.00243442	0.0371879703971706
MICROCEPHALIC OSTEODYSPLASTIC DYSPLASIA, SAUL-WILSON TYPE	0.00243442	0.0371879703971706
WEILL-MARCHESANI SYNDROME 1; WMS1	0.00243442	0.0371879703971706
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00243442	0.0371879703971706
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.00243442	0.0371879703971706
FRONTOFACIONASAL DYSPLASIA	0.00243442	0.0371879703971706
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.00243442	0.0371879703971706
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.00243442	0.0371879703971706
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.00243442	0.0371879703971706
ROTHMUND-THOMSON SYNDROME TYPE 1	0.00243442	0.0371879703971706
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.0023280840000000002	0.035563591686778175
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.0023280840000000002	0.035563591686778175
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.0023280840000000002	0.035563591686778175
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.0023280840000000002	0.035563591686778175
PEROXISOME BIOGENESIS DISORDER 10B	0.0023280840000000002	0.035563591686778175
WALKER-WARBURG SYNDROME	0.0023280840000000002	0.035563591686778175
PELLAGRA-LIKE SYNDROME	0.0023280840000000002	0.035563591686778175
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.0023280840000000002	0.035563591686778175
ALDH18A1-RELATED DE BARSY SYNDROME	0.0023280840000000002	0.035563591686778175
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.0023280840000000002	0.035563591686778175
CONGENITAL VARICELLA SYNDROME	0.0023280840000000002	0.035563591686778175
LISSENCEPHALY 8; LIS8	0.0023280840000000002	0.035563591686778175
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.0023280840000000002	0.035563591686778175
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.0023280840000000002	0.035563591686778175
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.0023280840000000002	0.035563591686778175
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.0023280840000000002	0.035563591686778175
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00216934	0.033138633309534954
THALIDOMIDE EMBRYOPATHY	0.00216934	0.033138633309534954
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.00216934	0.033138633309534954
CHARGE-LIKE SYNDROME, X-LINKED	0.00216934	0.033138633309534954
CONGENITAL NON-BULLOUS ICHTHYOSIFORM ERYTHRODERMA	0.00216934	0.033138633309534954
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00216934	0.033138633309534954
MAYER-ROKITANSKY-KÜSTER-HAUSER SYNDROME TYPE 2	0.00216934	0.033138633309534954
46,XX GONADAL DYSGENESIS	0.00216934	0.033138633309534954
COXOAURICULAR SYNDROME	0.00216934	0.033138633309534954
OHDO SYNDROME	0.00216934	0.033138633309534954
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.00216934	0.033138633309534954
ALBERS-SCHÖNBERG OSTEOPETROSIS	0.00216934	0.033138633309534954
DYSCHROMATOSIS UNIVERSALIS HEREDITARIA	0.00216934	0.033138633309534954
H SYNDROME	0.00216934	0.033138633309534954
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.00216934	0.033138633309534954
FETAL METHYLMERCURY SYNDROME	0.00216934	0.033138633309534954
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00216934	0.033138633309534954
ACRODYSOSTOSIS	0.00216934	0.033138633309534954
CAT-EYE SYNDROME	0.00216934	0.033138633309534954
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.00216934	0.033138633309534954
X-LINKED HYPOPHOSPHATEMIA	0.00216934	0.033138633309534954
DYSOSTEOSCLEROSIS	0.00216934	0.033138633309534954
BARAITSER-WINTER SYNDROME 2; BRWS2	0.00216934	0.033138633309534954
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.00216934	0.033138633309534954
COXOAURICULAR SYNDROME	0.00216934	0.033138633309534954
DEAFNESS, CONGENITAL, WITH VITILIGO AND ACHALASIA	0.00216934	0.033138633309534954
STICKLER SYNDROME, TYPE V; STL5	0.0021556500000000003	0.032929506160260275
KEIPERT SYNDROME	0.0021556500000000003	0.032929506160260275
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.0021556500000000003	0.032929506160260275
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.0021556500000000003	0.032929506160260275
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.0021556500000000003	0.032929506160260275
KALLMANN SYNDROME-HEART DISEASE SYNDROME	0.0021556500000000003	0.032929506160260275
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.0021556500000000003	0.032929506160260275
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.0021556500000000003	0.032929506160260275
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.0021556500000000003	0.032929506160260275
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.0021556500000000003	0.032929506160260275
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.0021556500000000003	0.032929506160260275
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.0021556500000000003	0.032929506160260275
GEMIGNANI SYNDROME	0.0021556500000000003	0.032929506160260275
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.0021556500000000003	0.032929506160260275
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.0021556500000000003	0.032929506160260275
TRIPLE A SYNDROME	0.0021556500000000003	0.032929506160260275
JOHANSON-BLIZZARD SYNDROME	0.0021556500000000003	0.032929506160260275
NEUTRAL LIPID STORAGE MYOPATHY	0.0021556500000000003	0.032929506160260275
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.0021556500000000003	0.032929506160260275
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.0021556500000000003	0.032929506160260275
NASODIGITOACOUSTIC SYNDROME	0.0021556500000000003	0.032929506160260275
FEINGOLD SYNDROME	0.0021556500000000003	0.032929506160260275
AUTOSOMAL RECESSIVE HYPOPHOSPHATEMIC RICKETS	0.0021556500000000003	0.032929506160260275
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.0021556500000000003	0.032929506160260275
KEARNS-SAYRE SYNDROME; KSS	0.0021556500000000003	0.032929506160260275
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.0021556500000000003	0.032929506160260275
DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	0.0021556500000000003	0.032929506160260275
ERMINE PHENOTYPE	0.0021556500000000003	0.032929506160260275
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.0020630040000000002	0.031514254599142526
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.0020630040000000002	0.031514254599142526
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.0020630040000000002	0.031514254599142526
20Q11.2 MICRODELETION SYNDROME	0.0020630040000000002	0.031514254599142526
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.0020630040000000002	0.031514254599142526
TARP SYNDROME	0.0020630040000000002	0.031514254599142526
SWEENEY-COX SYNDROME; SWCOS	0.0020630040000000002	0.031514254599142526
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.0020630040000000002	0.031514254599142526
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.0020630040000000002	0.031514254599142526
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.0020630040000000002	0.031514254599142526
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.0020630040000000002	0.031514254599142526
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.0020630040000000002	0.031514254599142526
BRESEK SYNDROME	0.0020630040000000002	0.031514254599142526
HSD10 DISEASE	0.0020630040000000002	0.031514254599142526
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.0020630040000000002	0.031514254599142526
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.0020630040000000002	0.031514254599142526
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.0020630040000000002	0.031514254599142526
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.0020630040000000002	0.031514254599142526
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.0020630040000000002	0.031514254599142526
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.0020630040000000002	0.031514254599142526
HYDROXYKYNURENINURIA	0.0020630040000000002	0.031514254599142526
EAR-PATELLA-SHORT STATURE SYNDROME	0.0020630040000000002	0.031514254599142526
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.0020630040000000002	0.031514254599142526
TAY-SACHS DISEASE	0.0020630040000000002	0.031514254599142526
PEROXISOME BIOGENESIS DISORDER 6B	0.002049314	0.03130512744986784
EAST SYNDROME	0.002049314	0.03130512744986784
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.002049314	0.03130512744986784
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.002049314	0.03130512744986784
INFANTILE LIVER FAILURE SYNDROME 1	0.002049314	0.03130512744986784
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.002049314	0.03130512744986784
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.002049314	0.03130512744986784
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.002049314	0.03130512744986784
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.002049314	0.03130512744986784
PEROXISOME BIOGENESIS DISORDER 5B	0.002049314	0.03130512744986784
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.002049314	0.03130512744986784
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.002049314	0.03130512744986784
WAARDENBURG-SHAH SYNDROME	0.002049314	0.03130512744986784
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.002049314	0.03130512744986784
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.002049314	0.03130512744986784
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.002049314	0.03130512744986784
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.002049314	0.03130512744986784
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.002049314	0.03130512744986784
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.002049314	0.03130512744986784
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.002049314	0.03130512744986784
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.002049314	0.03130512744986784
DONNAI-BARROW SYNDROME	0.002049314	0.03130512744986784
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00189722	0.028981753845647017
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00189722	0.028981753845647017
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00189722	0.028981753845647017
MULTIMINICORE MYOPATHY	0.00189722	0.028981753845647017
CEREBROFACIOTHORACIC DYSPLASIA	0.00189722	0.028981753845647017
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00189722	0.028981753845647017
PROGEROID SYNDROME, PETTY TYPE	0.00189722	0.028981753845647017
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.00189722	0.028981753845647017
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.00189722	0.028981753845647017
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.00189722	0.028981753845647017
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00189722	0.028981753845647017
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00189722	0.028981753845647017
MÜLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.00189722	0.028981753845647017
MOWAT-WILSON SYNDROME	0.00189722	0.028981753845647017
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.00189722	0.028981753845647017
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.00189722	0.028981753845647017
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.00189722	0.028981753845647017
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00189722	0.028981753845647017
SECKEL SYNDROME 5; SCKL5	0.00189722	0.028981753845647017
ODONTOCHONDRODYSPLASIA	0.00189722	0.028981753845647017
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001790884	0.02735737513525459
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.001790884	0.02735737513525459
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.001790884	0.02735737513525459
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.001790884	0.02735737513525459
TETRASOMY X	0.001790884	0.02735737513525459
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.001790884	0.02735737513525459
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.001790884	0.02735737513525459
SCHINDLER DISEASE, TYPE I	0.001790884	0.02735737513525459
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.001790884	0.02735737513525459
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.001790884	0.02735737513525459
CONGENITAL DISORDER OF GLYCOSYLATION	0.001790884	0.02735737513525459
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.001790884	0.02735737513525459
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.001790884	0.02735737513525459
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.001790884	0.02735737513525459
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.001790884	0.02735737513525459
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.001790884	0.02735737513525459
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.001790884	0.02735737513525459
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001790884	0.02735737513525459
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.001790884	0.02735737513525459
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.001790884	0.02735737513525459
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.001790884	0.02735737513525459
CHAR SYNDROME	0.001790884	0.02735737513525459
MENTAL RETARDATION, X-LINKED 104; MRX104	0.001790884	0.02735737513525459
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.001790884	0.02735737513525459
BAKER-GORDON SYNDROME; BAGOS	0.001790884	0.02735737513525459
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001790884	0.02735737513525459
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.001790884	0.02735737513525459
FETAL TRIMETHADIONE SYNDROME	0.001790884	0.02735737513525459
MUCOLIPIDOSIS IV; ML4	0.001790884	0.02735737513525459
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.001790884	0.02735737513525459
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.001790884	0.02735737513525459
CHROMOSOME 17P13.1 DELETION SYNDROME	0.001790884	0.02735737513525459
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.001790884	0.02735737513525459
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.001790884	0.02735737513525459
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001790884	0.02735737513525459
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.001790884	0.02735737513525459
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.001790884	0.02735737513525459
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.001790884	0.02735737513525459
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.001790884	0.02735737513525459
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.001790884	0.02735737513525459
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.001790884	0.02735737513525459
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.001790884	0.02735737513525459
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.001790884	0.02735737513525459
PYRIDOXINE-DEPENDENT EPILEPSY	0.001790884	0.02735737513525459
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.001790884	0.02735737513525459
JOUBERT SYNDROME 31; JBTS31	0.001790884	0.02735737513525459
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.001790884	0.02735737513525459
SENIOR-LOKEN SYNDROME 9	0.001790884	0.02735737513525459
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001790884	0.02735737513525459
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.001790884	0.02735737513525459
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.001790884	0.02735737513525459
SCHIZENCEPHALY	0.001790884	0.02735737513525459
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.001790884	0.02735737513525459
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.001790884	0.02735737513525459
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001790884	0.02735737513525459
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.001790884	0.02735737513525459
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.001790884	0.02735737513525459
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.001790884	0.02735737513525459
MENTAL RETARDATION, X-LINKED 90	0.001790884	0.02735737513525459
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001790884	0.02735737513525459
MONOSOMY 9P	0.001790884	0.02735737513525459
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.001790884	0.02735737513525459
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.001790884	0.02735737513525459
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.001790884	0.02735737513525459
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.001790884	0.02735737513525459
COENZYME Q10 DEFICIENCY	0.00178253	0.02722976021888931
ANIRIDIA 3	0.00178253	0.02722976021888931
ANIRIDIA 2	0.00178253	0.02722976021888931
EXUDATIVE VITREORETINOPATHY 6; EVR6	0.00178253	0.02722976021888931
DERMATITIS, ATOPIC	0.00178253	0.02722976021888931
COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR MENTAL RETARDATION; COB1	0.00178253	0.02722976021888931
BIRDSHOT CHORIORETINOPATHY	0.00178253	0.02722976021888931
AUTOSOMAL RECESSIVE PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA	0.00178253	0.02722976021888931
CATARACT-MICROCORNEA SYNDROME	0.00178253	0.02722976021888931
PHENYLKETONURIA	0.00178253	0.02722976021888931
HYPERTROPHIC NEUROPATHY AND CATARACT	0.00178253	0.02722976021888931
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.00178253	0.02722976021888931
TRIPLOIDY	0.00178253	0.02722976021888931
GALACTOKINASE DEFICIENCY	0.00178253	0.02722976021888931
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 1	0.00178253	0.02722976021888931
MEGALOCORNEA	0.00178253	0.02722976021888931
ANIRIDIA AND ABSENT PATELLA	0.00178253	0.02722976021888931
ANIRIDIA, MICROCORNEA, AND SPONTANEOUSLY REABSORBED CATARACT	0.00178253	0.02722976021888931
ANIRIDIA	0.00178253	0.02722976021888931
LEBER CONGENITAL AMAUROSIS, TYPE II	0.00178253	0.02722976021888931
CEREBROTENDINOUS XANTHOMATOSIS	0.00178253	0.02722976021888931
BARDET-BIEDL SYNDROME 18; BBS18	0.00178253	0.02722976021888931
MONILETHRIX	0.00178253	0.02722976021888931
AMOEBIC KERATITIS	0.00178253	0.02722976021888931
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.00178253	0.02722976021888931
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.00178253	0.02722976021888931
HYDROCEPHALY-CEREBELLAR AGENESIS SYNDROME	0.00178253	0.02722976021888931
CLOVERLEAF SKULL-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00178253	0.02722976021888931
HEREDITARY HYPERFERRITINEMIA-CATARACT SYNDROME	0.00178253	0.02722976021888931
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.00178253	0.02722976021888931
ISOLATED ECTOPIA LENTIS	0.00178253	0.02722976021888931
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00178253	0.02722976021888931
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 24; SCAR24	0.00178253	0.02722976021888931
%225200 ECTOPIA LENTIS ET PUPILLAE;;ECTOPIA LENTIS WITH ECTOPIA OF PUPIL	0.00178253	0.02722976021888931
CATARACT, CRYSTALLINE CORALLIFORM	0.00178253	0.02722976021888931
WEILL-MARCHESANI SYNDROME 2; WMS2	0.00178253	0.02722976021888931
HEREDITARY MUCOEPITHELIAL DYSPLASIA	0.00178253	0.02722976021888931
MYOTONIC DYSTROPHY 1	0.00178253	0.02722976021888931
HEMOCHROMATOSIS, TYPE 4; HFE4	0.00178253	0.02722976021888931
CARDIOMYOPATHY-CATARACT-HIP SPINE DISEASE SYNDROME	0.00178253	0.02722976021888931
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00178253	0.02722976021888931
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.00178253	0.02722976021888931
COLOBOMA-OBESITY-HYPOGENITALISM-MENTAL RETARDATION SYNDROME	0.00178253	0.02722976021888931
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.00178253	0.02722976021888931
CATARACT 11, MULTIPLE TYPES; CTRCT11	0.00178253	0.02722976021888931
127200 DWARFISM WITH STIFF JOINTS AND OCULAR ABNORMALITIES;;MOORE-FEDERMAN SYNDROME	0.00178253	0.02722976021888931
ANTERIOR SEGMENT DYSGENESIS 2; ASGD2	0.00178253	0.02722976021888931
CHOREA, REMITTING, WITH NYSTAGMUS AND CATARACT	0.00178253	0.02722976021888931
X-LINKED IMMUNONEUROLOGIC DISORDER	0.00178253	0.02722976021888931
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.00178253	0.02722976021888931
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00178253	0.02722976021888931
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.00178253	0.02722976021888931
CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANTCHONDRODYSPLASIA PUNCTATA DUE TO VITAMIN K DEFICIENCY, INCLUDED	0.00178253	0.02722976021888931
GENETIC HYPERFERRITINEMIA WITHOUT IRON OVERLOAD	0.00178253	0.02722976021888931
HYPOSMIA-NASAL AND OCULAR HYPOPLASIA-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.00178253	0.02722976021888931
ALG8-CDG	0.00178253	0.02722976021888931
CONE-ROD DYSTROPHY 16	0.00178253	0.02722976021888931
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.00178253	0.02722976021888931
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.00178253	0.02722976021888931
ISOLATED ANIRIDIA	0.00178253	0.02722976021888931
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00178253	0.02722976021888931
LEBER CONGENITAL AMAUROSIS 8; LCA8	0.00178253	0.02722976021888931
OPTIC DISC ANOMALIES WITH RETINAL AND/OR MACULAR DYSTROPHY; ODRMD	0.00178253	0.02722976021888931
INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA; IDDRP	0.00178253	0.02722976021888931
VITREORETINAL DEGENERATION, SNOWFLAKE TYPE; SVD	0.00178253	0.02722976021888931
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.00178253	0.02722976021888931
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, AUTOSOMAL DOMINANT; KFSD	0.00178253	0.02722976021888931
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00178253	0.02722976021888931
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.00178253	0.02722976021888931
IDIOPATHIC PANUVEITIS	0.00178253	0.02722976021888931
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.00178253	0.02722976021888931
IRIS PIGMENT LAYER, CLEAVAGE OF	0.00178253	0.02722976021888931
CATARACT AND CONGENITAL ICHTHYOSIS	0.00178253	0.02722976021888931
MUSCULAR DYSTROPHY, CONGENITAL, WITH INFANTILE CATARACT AND HYPOGONADISM	0.00178253	0.02722976021888931
INTERMEDIATE UVEITIS	0.00178253	0.02722976021888931
RETINITIS PIGMENTOSA 84; RP84	0.00178253	0.02722976021888931
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00178253	0.02722976021888931
CONGENITAL OSTEOGENESIS IMPERFECTA-MICROCEPHALY-CATARACTS SYNDROME	0.00178253	0.02722976021888931
RETINITIS PIGMENTOSA 4; RP4	0.00178253	0.02722976021888931
MICROPHTHALMIA, ISOLATED 5	0.00178253	0.02722976021888931
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.00178253	0.02722976021888931
ALG2-CDG	0.00178253	0.02722976021888931
STROMME SYNDROME; STROMS	0.00178253	0.02722976021888931
GALACTOKINASE DEFICIENCY	0.00178253	0.02722976021888931
TRICHOMEGALY; TCMGLY	0.00178253	0.02722976021888931
ANTERIOR SEGMENT DYSGENESIS 8	0.00178253	0.02722976021888931
EXFOLIATION SYNDROME; XFS	0.00178253	0.02722976021888931
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.00178253	0.02722976021888931
%609376 CATARACT 35; CTRCT35;;CATARACT, CONGENITAL NUCLEAR, AUTOSOMAL RECESSIVE 1; CATCN1	0.00178253	0.02722976021888931
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.00178253	0.02722976021888931
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.00178253	0.02722976021888931
PACHYONYCHIA CONGENITA	0.00178253	0.02722976021888931
ANIRIDIA-ABSENT PATELLA SYNDROME	0.00178253	0.02722976021888931
ANIRIDIA-INTELLECTUAL DISABILITY SYNDROME	0.00178253	0.02722976021888931
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.00178253	0.02722976021888931
ABSENCE DEFORMITY OF LEG-CATARACT SYNDROME	0.00178253	0.02722976021888931
PROXIMAL MYOTONIC MYOPATHY	0.00178253	0.02722976021888931
ICHTHYOSIS-INTELLECTUAL DISABILITY-DWARFISM-RENAL IMPAIRMENT SYNDROME	0.00178253	0.02722976021888931
HYPOGONADISM-CATARACT SYNDROME	0.00178253	0.02722976021888931
ENHANCED S-CONE SYNDROME	0.00178253	0.02722976021888931
LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 1G; LGMD1G	0.00178253	0.02722976021888931
SPINAL MUSCULAR ATROPHY-DANDY-WALKER MALFORMATION-CATARACTS SYNDROME	0.00178253	0.02722976021888931
PAGET DISEASE OF BONE 4; PDB4	0.00151745	0.02318042313125366
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.00151745	0.02318042313125366
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.00151745	0.02318042313125366
CARDIOAUDITORY SYNDROME OF SANCHEZ CASCOS	0.00151745	0.02318042313125366
BARBER-SAY SYNDROME	0.00151745	0.02318042313125366
CONE-ROD DYSTROPHY 1; CORD1	0.00151745	0.02318042313125366
PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	0.00151745	0.02318042313125366
EPIPHYSEAL DYSPLASIA OF FEMORAL HEAD, MYOPIA, AND DEAFNESS	0.00151745	0.02318042313125366
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.00151745	0.02318042313125366
ADRENOLEUKODYSTROPHY	0.00151745	0.02318042313125366
ABCD SYNDROME	0.00151745	0.02318042313125366
RENAL, GENITAL, AND MIDDLE EAR ANOMALIES	0.00151745	0.02318042313125366
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.00151745	0.02318042313125366
MYASTHENIA GRAVIS	0.00151745	0.02318042313125366
ARACHNOIDITIS	0.00151745	0.02318042313125366
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 2	0.00151745	0.02318042313125366
CAMURATI-ENGELMANN DISEASE	0.00151745	0.02318042313125366
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00151745	0.02318042313125366
DEAFNESS, AUTOSOMAL DOMINANT 74; DFNA74	0.00151745	0.02318042313125366
BARBER-SAY SYNDROME; BBRSAY	0.00151745	0.02318042313125366
FETAL IODINE DEFICIENCY DISORDER	0.00151745	0.02318042313125366
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00151745	0.02318042313125366
DEAFNESS, AUTOSOMAL DOMINANT 24	0.00151745	0.02318042313125366
CANAVAN DISEASE	0.00151745	0.02318042313125366
DEAFNESS, CONGENITAL, WITH TOTAL ALBINISM	0.00151745	0.02318042313125366
MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS	0.00151745	0.02318042313125366
184705 STEINFELD SYNDROME	0.00151745	0.02318042313125366
INFANTILE ONSET SPINOCEREBELLAR ATAXIA	0.00151745	0.02318042313125366
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.00151745	0.02318042313125366
RICHARDS-RUNDLE SYNDROME	0.00151745	0.02318042313125366
185750 SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.00151745	0.02318042313125366
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.00151745	0.02318042313125366
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.00151745	0.02318042313125366
SPINOCEREBELLAR ATAXIA 13	0.00151745	0.02318042313125366
CHARCOT-MARIE-TOOTH DISEASE TYPE 1B	0.00151745	0.02318042313125366
CILIARY DYSKINESIA, PRIMARY, 37; CILD37	0.00151745	0.02318042313125366
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.00151745	0.02318042313125366
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.00151745	0.02318042313125366
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.00151745	0.02318042313125366
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 13	0.00151745	0.02318042313125366
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 10	0.00151745	0.02318042313125366
TIETZ SYNDROME	0.00151745	0.02318042313125366
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.00151745	0.02318042313125366
ANUS, IMPERFORATE	0.00151745	0.02318042313125366
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.00151745	0.02318042313125366
DEAFNESS, X-LINKED 5; DFNX5	0.00151745	0.02318042313125366
KEARNS-SAYRE SYNDROME	0.00151745	0.02318042313125366
CHIARI MALFORMATION TYPE I	0.00151745	0.02318042313125366
AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA-BLINDNESS-DEAFNESS SYNDROME	0.00151745	0.02318042313125366
DEAFNESS, AUTOSOMAL RECESSIVE 106; DFNB106	0.00151745	0.02318042313125366
DEAFNESS, AUTOSOMAL RECESSIVE 107; DFNB107	0.00151745	0.02318042313125366
DEAFNESS, AUTOSOMAL DOMINANT 73; DFNA73	0.00151745	0.02318042313125366
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.00151745	0.02318042313125366
DEAFNESS, CONGENITAL, WITH KERATOPACHYDERMIA AND CONSTRICTIONS OFFINGERS AND TOES	0.00151745	0.02318042313125366
USHER SYNDROME, TYPE ID	0.00151745	0.02318042313125366
SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	0.00151745	0.02318042313125366
FRIEDREICH ATAXIA	0.00151745	0.02318042313125366
SPINOCEREBELLAR ATAXIA TYPE 18	0.00151745	0.02318042313125366
FACIAL PARESIS, HEREDITARY CONGENITAL, 2; HCFP2	0.00151745	0.02318042313125366
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.00151745	0.02318042313125366
3MC SYNDROME	0.00151745	0.02318042313125366
ISOLATED ANORECTAL MALFORMATION	0.00151745	0.02318042313125366
%615649 DEAFNESS, AUTOSOMAL DOMINANT 54; DFNA54	0.00151745	0.02318042313125366
DEAFNESS, AUTOSOMAL RECESSIVE 65; DFNB65	0.00151745	0.02318042313125366
HYPERTRICHOSIS LANUGINOSA CONGENITA	0.00151745	0.02318042313125366
%614187 HYPERTELORISM, PREAURICULAR SINUS, PUNCTAL PITS, AND DEAFNESS; HPPD	0.00151745	0.02318042313125366
BRITTLE CORNEA SYNDROME 2; BCS2	0.00151745	0.02318042313125366
DEAFNESS, AUTOSOMAL RECESSIVE 32, WITH OR WITHOUT IMMOTILE SPERM; DFNB32	0.00151745	0.02318042313125366
MENIERE DISEASE	0.00151745	0.02318042313125366
SENSORINEURAL DEAFNESS WITH DILATED CARDIOMYOPATHY	0.00151745	0.02318042313125366
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.00151745	0.02318042313125366
SPINOCEREBELLAR ATAXIA TYPE 31	0.00151745	0.02318042313125366
NEPHROSIS WITH DEAFNESS AND URINARY TRACT AND DIGITAL MALFORMATIONS	0.00151745	0.02318042313125366
CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE	0.00151745	0.02318042313125366
ATYPICAL RETT SYNDROME	0.00151745	0.02318042313125366
WAARDENBURG SYNDROME TYPE 3	0.00151745	0.02318042313125366
OTOSCLEROSIS 3; OTSC3	0.00151745	0.02318042313125366
%615654 DEAFNESS, AUTOSOMAL DOMINANT 58; DFNA58	0.00151745	0.02318042313125366
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.00151745	0.02318042313125366
OTOPALATODIGITAL SYNDROME TYPE 1	0.00151745	0.02318042313125366
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.00151745	0.02318042313125366
GRACILE SYNDROME	0.00151745	0.02318042313125366
%613916 DEAFNESS, AUTOSOMAL RECESSIVE 89; DFNB89	0.00151745	0.02318042313125366
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.00151745	0.02318042313125366
ACQUIRED PARTIAL LIPODYSTROPHY	0.00151745	0.02318042313125366
121450 CORNEAL DEGENERATION, RIBBONLIKE, WITH DEAFNESS;;BAND KERATOPATHY WITH DEAFNESS	0.00151745	0.02318042313125366
KERATODERMA, PALMOPLANTAR, WITH DEAFNESS	0.00151745	0.02318042313125366
WAARDENBURG-SHAH SYNDROME	0.00151745	0.02318042313125366
HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA; HH21	0.00151745	0.02318042313125366
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.00151745	0.02318042313125366
%614414 DEAFNESS, AUTOSOMAL RECESSIVE 96; DFNB96	0.00151745	0.02318042313125366
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.00151745	0.02318042313125366
HOLOPROSENCEPHALY-RADIAL HEART RENAL ANOMALIES SYNDROME	0.00151745	0.02318042313125366
AUROCEPHALOSYNDACTYLY	0.00151745	0.02318042313125366
NAGER SYNDROME	0.00151745	0.02318042313125366
DEAFNESS, AUTOSOMAL RECESSIVE 47	0.00151745	0.02318042313125366
DEAFNESS, AUTOSOMAL RECESSIVE 55	0.00151745	0.02318042313125366
CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC 1	0.00151745	0.02318042313125366
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.00151745	0.02318042313125366
LOCKED-IN SYNDROME	0.00151745	0.02318042313125366
DEAFNESS, AUTOSOMAL RECESSIVE 18B; DFNB18B	0.00151745	0.02318042313125366
PULMONIC STENOSIS AND DEAFNESS	0.00151745	0.02318042313125366
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00151745	0.02318042313125366
HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA; HH19	0.00151745	0.02318042313125366
OPTICOCOCHLEODENTATE DEGENERATION	0.00151745	0.02318042313125366
METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	0.00151745	0.02318042313125366
EPIDERMOLYSIS BULLOSA SIMPLEX WITH ANODONTIA/HYPODONTIA	0.00151745	0.02318042313125366
XYLOSIDASE DEFICIENCY	0.00151745	0.02318042313125366
HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA; HH17	0.00151745	0.02318042313125366
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.00151745	0.02318042313125366
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.00151745	0.02318042313125366
KNUCKLE PADS, LEUKONYCHIA, AND SENSORINEURAL DEAFNESS	0.00151745	0.02318042313125366
CONGENITAL VELOPHARYNGEAL INCOMPETENCE	0.00151745	0.02318042313125366
HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA; HH18	0.00151745	0.02318042313125366
CRIGLER-NAJJAR SYNDROME TYPE 1	0.00151745	0.02318042313125366
CAMPTODACTYLY-TALL STATURE-SCOLIOSIS-HEARING LOSS SYNDROME	0.00151745	0.02318042313125366
%614617 DEAFNESS, AUTOSOMAL RECESSIVE 86; DFNB86	0.00151745	0.02318042313125366
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE	0.00151745	0.02318042313125366
SPINOCEREBELLAR ATAXIA TYPE 36	0.00151745	0.02318042313125366
ISOLATED BRACHYCEPHALY	0.00151745	0.02318042313125366
HIDROTIC ECTODERMAL DYSPLASIA, HALAL TYPE	0.00151745	0.02318042313125366
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.00151745	0.02318042313125366
BRANCHIOOTIC SYNDROME 2	0.00151745	0.02318042313125366
PFEIFFER SYNDROME TYPE 3	0.00151745	0.02318042313125366
TIBIAL HEMIMELIA	0.00151745	0.02318042313125366
GLYCOGEN STORAGE DISEASE II	0.00151745	0.02318042313125366
DIABETIC EMBRYOPATHY	0.00151745	0.02318042313125366
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.00151745	0.02318042313125366
DEAFNESS, X-LINKED 7; DFNX7	0.00151745	0.02318042313125366
TUNE DEAFNESS	0.00151745	0.02318042313125366
CLEFT LIP WITH OR WITHOUT CLEFT PALATE	0.00151745	0.02318042313125366
HIRSCHSPRUNG DISEASE WITH POLYDACTYLY, RENAL AGENESIS, AND DEAFNESS	0.00151745	0.02318042313125366
RETINAL VENOUS BEADING	0.00151745	0.02318042313125366
DEAFNESS, AUTOSOMAL RECESSIVE 84; DFNB84	0.00151745	0.02318042313125366
DEAFNESS, AUTOSOMAL RECESSIVE 33	0.00151745	0.02318042313125366
PILI TORTI	0.00151745	0.02318042313125366
USHER SYNDROME, TYPE IID; USH2D	0.00151745	0.02318042313125366
%607683 DEAFNESS, AUTOSOMAL DOMINANT 52; DFNA52;;DEAFNESS, AUTOSOMAL DOMINANT 42; DFNA42	0.00151745	0.02318042313125366
OTOSCLEROSIS 8; OTSC8	0.00151745	0.02318042313125366
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.00151745	0.02318042313125366
BRITTLE CORNEA SYNDROME	0.00151745	0.02318042313125366
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.00151745	0.02318042313125366
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.00151745	0.02318042313125366
PFEIFFER SYNDROME TYPE 1	0.00151745	0.02318042313125366
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.00151745	0.02318042313125366
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.00151745	0.02318042313125366
DEAFNESS, AUTOSOMAL DOMINANT 71; DFNA71	0.00150376	0.022971295981978977
MYOPATHY AND DIABETES MELLITUS	0.00150376	0.022971295981978977
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 66; DFNB66	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT 72; DFNA72	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT 59	0.00150376	0.022971295981978977
HYPEROSTOSIS CRANIALIS INTERNA; HCIN	0.00150376	0.022971295981978977
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.00150376	0.022971295981978977
KEIPERT SYNDROME; KPTS	0.00150376	0.022971295981978977
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.00150376	0.022971295981978977
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.00150376	0.022971295981978977
HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE	0.00150376	0.022971295981978977
HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 57; DFNB57	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 51	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT 27	0.00150376	0.022971295981978977
FETAL CYTOMEGALOVIRUS SYNDROME	0.00150376	0.022971295981978977
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 27	0.00150376	0.022971295981978977
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 24	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 3	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 12	0.00150376	0.022971295981978977
SPINOCEREBELLAR ATAXIA 31	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT 53	0.00150376	0.022971295981978977
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 2	0.00150376	0.022971295981978977
KALLMANN SYNDROME	0.00150376	0.022971295981978977
SCLEROSTEOSIS	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 110; DFNB110	0.00150376	0.022971295981978977
%614211 DEAFNESS, AUTOSOMAL DOMINANT 33; DFNA33	0.00150376	0.022971295981978977
NEUTROPENIA-MONOCYTOPENIA-DEAFNESS SYNDROME	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 10	0.00150376	0.022971295981978977
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.00150376	0.022971295981978977
ENDOSTEAL HYPEROSTOSIS, WORTH TYPE	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 100; DFNB100	0.00150376	0.022971295981978977
256120 NEPHROPATHY, DEAFNESS, AND HYPERPARATHYROIDISM	0.00150376	0.022971295981978977
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 7	0.00150376	0.022971295981978977
3P25.3 MICRODELETION SYNDROME	0.00150376	0.022971295981978977
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, MENTAL RETARDATION,AND ABSENT SENSORY LARGE MYELINATED FIBERS	0.00150376	0.022971295981978977
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 5	0.00150376	0.022971295981978977
ENLARGED VESTIBULAR AQUEDUCT	0.00150376	0.022971295981978977
BRACHYDACTYLY, TYPE B2	0.00150376	0.022971295981978977
CEREBELLAR ATAXIA AND NEUROSENSORY DEAFNESS	0.00150376	0.022971295981978977
CONE-ROD DYSTROPHY AND HEARING LOSS 2; CRDHL2	0.00150376	0.022971295981978977
RETINITIS PIGMENTOSA 59; RP59	0.00150376	0.022971295981978977
KNUCKLE PADS-LEUKONYCHIA-SENSORINEURAL DEAFNESS-PALMOPLANTAR HYPERKERATOSIS SYNDROME	0.00150376	0.022971295981978977
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.00150376	0.022971295981978977
NEPHROPATHY-DEAFNESS-HYPERPARATHYROIDISM SYNDROME	0.00150376	0.022971295981978977
SENSORINEURAL HEARING LOSS-EARLY GRAYING-ESSENTIAL TREMOR SYNDROME	0.00150376	0.022971295981978977
ALBINISM-DEAFNESS SYNDROME	0.00150376	0.022971295981978977
KERATODERMA HEREDITARIUM MUTILANS WITH ICHTHYOSIS	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 9	0.00150376	0.022971295981978977
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.00150376	0.022971295981978977
DEAFNESS, Y-LINKED 2; DFNY2	0.00150376	0.022971295981978977
RENAL CALICEAL DIVERTICULI-DEAFNESS SYNDROME	0.00150376	0.022971295981978977
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.00150376	0.022971295981978977
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.00150376	0.022971295981978977
DEAFNESS, Y-LINKED 1	0.00150376	0.022971295981978977
FACIOSCAPULOHUMERAL DYSTROPHY	0.00150376	0.022971295981978977
RADIO-ULNAR SYNOSTOSIS-AMEGAKARYOCYTIC THROMBOCYTOPENIA SYNDROME	0.00150376	0.022971295981978977
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT 64; DFNA64	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 99	0.00150376	0.022971295981978977
NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 115; DFNB115	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 114; DFNB114	0.00150376	0.022971295981978977
WAARDENBURG SYNDROME, TYPE 4B; WS4B	0.00150376	0.022971295981978977
IMMUNODEFICIENCY 47	0.00150376	0.022971295981978977
DEAFNESS, CHILDHOOD-ONSET NEUROSENSORY, AUTOSOMAL RECESSIVE 8	0.00150376	0.022971295981978977
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 68	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 113	0.00150376	0.022971295981978977
DEAFNESS-OLIGODONTIA SYNDROME	0.00150376	0.022971295981978977
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 42	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT 66	0.00150376	0.022971295981978977
FAMILIAL ISOLATED DILATED CARDIOMYOPATHY	0.00150376	0.022971295981978977
HYPEROSTOSIS CORTICALIS GENERALISATA	0.00150376	0.022971295981978977
ADENOHYPOPHYSITIS	0.00150376	0.022971295981978977
PRUNE BELLY SYNDROME WITH PULMONIC STENOSIS, MENTAL RETARDATION, ANDDEAFNESS	0.00150376	0.022971295981978977
PANHYPOPHYSITIS	0.00150376	0.022971295981978977
SPLIT-FOOT MALFORMATION WITH MESOAXIAL POLYDACTYLY; SFMMP	0.00150376	0.022971295981978977
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.00150376	0.022971295981978977
CORNEAL DYSTROPHY-PERCEPTIVE DEAFNESS SYNDROME	0.00150376	0.022971295981978977
COGAN SYNDROME	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT 25	0.00150376	0.022971295981978977
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.00150376	0.022971295981978977
THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 26	0.00150376	0.022971295981978977
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00150376	0.022971295981978977
CARDIOMYOPATHY, DILATED, 1J; CMD1J	0.00150376	0.022971295981978977
ECTODERMAL DYSPLASIA AND NEUROSENSORY DEAFNESS	0.00150376	0.022971295981978977
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.00150376	0.022971295981978977
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00150376	0.022971295981978977
KERATODERMA HEREDITARIUM MUTILANS	0.00150376	0.022971295981978977
WOLFRAM SYNDROME 2; WFS2	0.00150376	0.022971295981978977
USHER SYNDROME, TYPE IIIA	0.00150376	0.022971295981978977
DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT	0.00150376	0.022971295981978977
SHEEHAN SYNDROME	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 103; DFNB103	0.00150376	0.022971295981978977
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2	0.00150376	0.022971295981978977
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT 30	0.00150376	0.022971295981978977
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.00150376	0.022971295981978977
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 6	0.00150376	0.022971295981978977
USHER SYNDROME, TYPE IG	0.00150376	0.022971295981978977
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.00150376	0.022971295981978977
ACROCALLOSAL SYNDROME	0.00150376	0.022971295981978977
%607017 DEAFNESS, AUTOSOMAL DOMINANT 21; DFNA21	0.00150376	0.022971295981978977
FAMILIAL LONG QT SYNDROME	0.00150376	0.022971295981978977
RENIER-GABREELS-JASPER SYNDROME	0.00150376	0.022971295981978977
SEVERE COMBINED IMMUNODEFICIENCY	0.00150376	0.022971295981978977
DEAFNESS-INFERTILITY SYNDROME	0.00150376	0.022971295981978977
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00150376	0.022971295981978977
OPTIC ATROPHY 8	0.00150376	0.022971295981978977
ERMINE PHENOTYPE	0.00150376	0.022971295981978977
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.00150376	0.022971295981978977
WORSTER-DROUGHT SYNDROME	0.00150376	0.022971295981978977
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT 69	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 97	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT 68	0.00150376	0.022971295981978977
%605818 DEAFNESS, AUTOSOMAL RECESSIVE 27; DFNB27	0.00150376	0.022971295981978977
THYROCEREBRORENAL SYNDROME	0.00150376	0.022971295981978977
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX	0.00150376	0.022971295981978977
HYPERLEUCINE-ISOLEUCINEMIA	0.00150376	0.022971295981978977
AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT, 1	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 13	0.00150376	0.022971295981978977
MENTAL RETARDATION, X-LINKED 46	0.00150376	0.022971295981978977
115250 COLLAGENOMA, FAMILIAL CUTANEOUS	0.00150376	0.022971295981978977
MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS	0.00150376	0.022971295981978977
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE	0.00150376	0.022971295981978977
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2	0.00150376	0.022971295981978977
BJÖRNSTAD SYNDROME	0.00150376	0.022971295981978977
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.00150376	0.022971295981978977
DEAFNESS-VITILIGO-ACHALASIA SYNDROME	0.00150376	0.022971295981978977
RETINITIS PIGMENTOSA INVERSA WITH DEAFNESS	0.00150376	0.022971295981978977
HEARING LOSS-FAMILIAL SALIVARY GLAND INSENSITIVITY TO ALDOSTERONE SYNDROME	0.00150376	0.022971295981978977
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 23	0.00150376	0.022971295981978977
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 18	0.00150376	0.022971295981978977
CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS	0.00150376	0.022971295981978977
LOWE-KOHN-COHEN SYNDROME	0.00150376	0.022971295981978977
PERRAULT SYNDROME 2; PRLTS2	0.00150376	0.022971295981978977
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.00150376	0.022971295981978977
ISOLATED SPLIT HAND-SPLIT FOOT MALFORMATION	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 13	0.00150376	0.022971295981978977
DEAFNESS, X-LINKED 1	0.00150376	0.022971295981978977
CONE-ROD DYSTROPHY AND HEARING LOSS; CRDHL	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 17; DFNB17	0.00150376	0.022971295981978977
ACUTE BILIRUBIN ENCEPHALOPATHY	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT 47	0.00150376	0.022971295981978977
HIRSCHSPRUNG DISEASE-DEAFNESS-POLYDACTYLY SYNDROME	0.00150376	0.022971295981978977
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.00150376	0.022971295981978977
FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURALDEAFNESS	0.00150376	0.022971295981978977
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT 43	0.00150376	0.022971295981978977
ARTHROGRYPOSIS-LIKE HAND ANOMALY AND SENSORINEURAL DEAFNESS	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 14	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 28	0.00150376	0.022971295981978977
MADRAS MOTOR NEURON DISEASE	0.00150376	0.022971295981978977
THYROCEREBRORETINAL SYNDROME	0.00150376	0.022971295981978977
PALMOPLANTAR KERATODERMA-DEAFNESS SYNDROME	0.00150376	0.022971295981978977
CADASIL	0.00150376	0.022971295981978977
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.00150376	0.022971295981978977
DEAFNESS, NERVE TYPE, WITH MESENTERIC DIVERTICULA OF SMALL BOWEL ANDPROGRESSIVE SENSORY NEUROPATHY	0.00150376	0.022971295981978977
RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS	0.00150376	0.022971295981978977
DEAFNESS, NEURAL, CONGENITAL MODERATE	0.00150376	0.022971295981978977
WOLFRAM SYNDROME	0.00150376	0.022971295981978977
DEAFNESS, NEURAL, WITH ATYPICAL ATOPIC DERMATITIS	0.00150376	0.022971295981978977
MENTAL RETARDATION, X-LINKED 21	0.00124533	0.019023543667365726
MENTAL RETARDATION, X-LINKED 1	0.00124533	0.019023543667365726
LEIGH SYNDROME	0.00124533	0.019023543667365726
%193003 NYSTAGMUS 4, CONGENITAL, AUTOSOMAL DOMINANT; NYS4;;VESTIBULOCEREBELLAR DISORDER WITH PREDOMINANT OCULAR SIGNS	0.00124533	0.019023543667365726
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00124533	0.019023543667365726
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.00124533	0.019023543667365726
SPASTIC PARAPLEGIA 16, X-LINKED	0.00124533	0.019023543667365726
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.00124533	0.019023543667365726
%300589 NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5	0.00124533	0.019023543667365726
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.00124533	0.019023543667365726
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.00124533	0.019023543667365726
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.00124533	0.019023543667365726
NON-DISTAL MONOSOMY 10Q	0.00124533	0.019023543667365726
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.00124533	0.019023543667365726
GAUCHER DISEASE, TYPE IIIC	0.00124533	0.019023543667365726
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.00124533	0.019023543667365726
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00124533	0.019023543667365726
X-LINKED RETINAL DYSPLASIA	0.00124533	0.019023543667365726
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.00124533	0.019023543667365726
OCULAR ALBINISM	0.00124533	0.019023543667365726
LERI PLEONOSTEOSIS	0.00124533	0.019023543667365726
SMITH-KINGSMORE SYNDROME; SKS	0.00124533	0.019023543667365726
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00124533	0.019023543667365726
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.00124533	0.019023543667365726
EEM SYNDROME	0.00124533	0.019023543667365726
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.00124533	0.019023543667365726
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.00124533	0.019023543667365726
X-LINKED INTELLECTUAL DISABILITY-DANDY-WALKER MALFORMATION-BASAL GANGLIA DISEASE-SEIZURES SYNDROME	0.00124533	0.019023543667365726
OCULOCUTANEOUS ALBINISM TYPE 3	0.00124533	0.019023543667365726
%153880 MACULAR EDEMA, CYSTOID;;CYSTOID MACULAR DYSTROPHY; CYMD;;MACULAR DYSTROPHY, DOMINANT CYSTOID; MDDC;;DCMD	0.00124533	0.019023543667365726
JACKSON-WEISS SYNDROME	0.00124533	0.019023543667365726
RETINAL CONE DYSTROPHY 3B	0.00124533	0.019023543667365726
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.00124533	0.019023543667365726
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.00124533	0.019023543667365726
CRANIOSYNOSTOSIS-DANDY-WALKER MALFORMATION-HYDROCEPHALUS SYNDROME	0.00124533	0.019023543667365726
JACOBSEN SYNDROME	0.00124533	0.019023543667365726
GLUTATHIONURIA	0.00124533	0.019023543667365726
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 36	0.00124533	0.019023543667365726
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.00124533	0.019023543667365726
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.00124533	0.019023543667365726
5Q14.3 MICRODELETION SYNDROME	0.00124533	0.019023543667365726
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00124533	0.019023543667365726
HAND-FOOT-GENITAL SYNDROME	0.00124533	0.019023543667365726
WHITE FORELOCK WITH MALFORMATIONS	0.00124533	0.019023543667365726
PTOSIS, STRABISMUS, AND ECTOPIC PUPILS	0.00124533	0.019023543667365726
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.00124533	0.019023543667365726
LAMBOTTE SYNDROME	0.00124533	0.019023543667365726
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	0.00124533	0.019023543667365726
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.00124533	0.019023543667365726
MOEBIUS SYNDROME-AXONAL NEUROPATHY-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.00124533	0.019023543667365726
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.00124533	0.019023543667365726
CONGENITAL STATIONARY NIGHT BLINDNESS	0.00124533	0.019023543667365726
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00124533	0.019023543667365726
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.00124533	0.019023543667365726
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.00124533	0.019023543667365726
GASTROCUTANEOUS SYNDROME	0.00124533	0.019023543667365726
NEPHRONOPHTHISIS 18; NPHP18	0.00124533	0.019023543667365726
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00124533	0.019023543667365726
ALBINISM, OCULOCUTANEOUS, TYPE III	0.00124533	0.019023543667365726
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1	0.00124533	0.019023543667365726
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00124533	0.019023543667365726
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.00124533	0.019023543667365726
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.00124533	0.019023543667365726
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.00124533	0.019023543667365726
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.00124533	0.019023543667365726
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00124533	0.019023543667365726
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.00124533	0.019023543667365726
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.00124533	0.019023543667365726
ABDUCENS PALSY	0.00124533	0.019023543667365726
OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS	0.00124533	0.019023543667365726
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00124533	0.019023543667365726
PETERS ANOMALY	0.00124533	0.019023543667365726
RENAL AND MULLERIAN DUCT HYPOPLASIA	0.00124533	0.019023543667365726
GAUCHER DISEASE TYPE 2	0.00124533	0.019023543667365726
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00124533	0.019023543667365726
MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	0.00124533	0.019023543667365726
RETINOPATHY, PERICENTRAL PIGMENTARY, AUTOSOMAL RECESSIVE	0.00124533	0.019023543667365726
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.00124533	0.019023543667365726
PSEUDOXANTHOMA ELASTICUM-LIKE SKIN MANIFESTATIONS WITH RETINITIS PIGMENTOSA	0.00124533	0.019023543667365726
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.00124533	0.019023543667365726
ANGELMAN SYNDROME	0.00124533	0.019023543667365726
NANOPHTHALMOS	0.00124533	0.019023543667365726
SPINOCEREBELLAR ATAXIA TYPE 27	0.00124533	0.019023543667365726
SPINOCEREBELLAR ATAXIA 27; SCA27	0.00124533	0.019023543667365726
223330 DIVERTICULOSIS OF BOWEL, HERNIA, AND RETINAL DETACHMENT	0.00124533	0.019023543667365726
GAUCHER DISEASE TYPE 3	0.00124533	0.019023543667365726
DESMOSTEROLOSIS	0.00124533	0.019023543667365726
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00124533	0.019023543667365726
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.00124533	0.019023543667365726
OPTIC ATROPHY 1; OPA1	0.00124533	0.019023543667365726
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.00124533	0.019023543667365726
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.00124533	0.019023543667365726
NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	0.00124533	0.019023543667365726
NOONAN SYNDROME 9; NS9	0.001197444	0.018292041646170158
CULLER-JONES SYNDROME; CJS	0.001197444	0.018292041646170158
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.001197444	0.018292041646170158
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001197444	0.018292041646170158
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.001197444	0.018292041646170158
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001197444	0.018292041646170158
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.001197444	0.018292041646170158
NETHERTON SYNDROME	0.001197444	0.018292041646170158
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001197444	0.018292041646170158
PITUITARY STALK INTERRUPTION SYNDROME	0.001197444	0.018292041646170158
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.001197444	0.018292041646170158
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001197444	0.018292041646170158
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.001197444	0.018292041646170158
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001197444	0.018292041646170158
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001197444	0.018292041646170158
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.001197444	0.018292041646170158
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.001197444	0.018292041646170158
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.001197444	0.018292041646170158
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001197444	0.018292041646170158
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.001197444	0.018292041646170158
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.001197444	0.018292041646170158
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001197444	0.018292041646170158
CEREBELLOFACIODENTAL SYNDROME	0.001197444	0.018292041646170158
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.001197444	0.018292041646170158
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.001197444	0.018292041646170158
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.001197444	0.018292041646170158
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.001197444	0.018292041646170158
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.001197444	0.018292041646170158
JOUBERT SYNDROME 26	0.001197444	0.018292041646170158
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.001197444	0.018292041646170158
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.001197444	0.018292041646170158
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.001197444	0.018292041646170158
ALAZAMI-YUAN SYNDROME	0.001197444	0.018292041646170158
HARTNUP DISORDER	0.001197444	0.018292041646170158
17Q11.2 MICRODUPLICATION SYNDROME	0.001197444	0.018292041646170158
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.001197444	0.018292041646170158
HOLOPROSENCEPHALY 1; HPE1	0.001197444	0.018292041646170158
MENTAL RETARDATION, X-LINKED 99	0.001197444	0.018292041646170158
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.001197444	0.018292041646170158
OXOGLUTARIC ACIDURIA	0.001197444	0.018292041646170158
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.001197444	0.018292041646170158
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.001197444	0.018292041646170158
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.001197444	0.018292041646170158
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.001197444	0.018292041646170158
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.001197444	0.018292041646170158
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.001197444	0.018292041646170158
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.001197444	0.018292041646170158
SEPTOOPTIC DYSPLASIA	0.001197444	0.018292041646170158
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.001197444	0.018292041646170158
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.001197444	0.018292041646170158
ISOLATED GLYCEROL KINASE DEFICIENCY	0.001197444	0.018292041646170158
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.001197444	0.018292041646170158
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.001197444	0.018292041646170158
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.001197444	0.018292041646170158
DIAMOND-BLACKFAN ANEMIA 5	0.001197444	0.018292041646170158
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.001197444	0.018292041646170158
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.001197444	0.018292041646170158
GRISCELLI SYNDROME	0.001197444	0.018292041646170158
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.001197444	0.018292041646170158
FRIAS SYNDROME	0.001197444	0.018292041646170158
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.001197444	0.018292041646170158
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.001197444	0.018292041646170158
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.001197444	0.018292041646170158
GRACILE BONE DYSPLASIA; GCLEB	0.001197444	0.018292041646170158
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.001197444	0.018292041646170158
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.001197444	0.018292041646170158
LISSENCEPHALY 4	0.001197444	0.018292041646170158
XQ25 DUPLICATION SYNDROME	0.001197444	0.018292041646170158
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001197444	0.018292041646170158
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.001197444	0.018292041646170158
XQ27.3Q28 DUPLICATION SYNDROME	0.001197444	0.018292041646170158
15Q11Q13 MICRODUPLICATION SYNDROME	0.001197444	0.018292041646170158
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.001197444	0.018292041646170158
XQ25 MICRODUPLICATION SYNDROME	0.001197444	0.018292041646170158
8P11.2 DELETION SYNDROME	0.001197444	0.018292041646170158
CHROMOSOME 15Q25 DELETION SYNDROME	0.001197444	0.018292041646170158
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.00065189	0.009958210178281293
COHEN SYNDROME	0.00065189	0.009958210178281293
ASTHMA, SHORT STATURE, AND ELEVATED IGA	0.00065189	0.009958210178281293
WILLIAMS-BEUREN SYNDROME (WBS)	0.00065189	0.009958210178281293
POTOCKI-LUPSKI SYNDROME (17P11.2 DUPLICATION SYNDROME)	0.00065189	0.009958210178281293
PYGMY	0.00065189	0.009958210178281293
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00065189	0.009958210178281293
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.00065189	0.009958210178281293
CYSTINOSIS, NEPHROPATHIC; CTNS	0.00065189	0.009958210178281293
GLYCOGEN STORAGE DISEASE IXB	0.00065189	0.009958210178281293
PFEIFFER-PALM-TELLER SYNDROME	0.00065189	0.009958210178281293
RETT SYNDROME	0.00065189	0.009958210178281293
260150 PALANT CLEFT PALATE SYNDROME	0.00065189	0.009958210178281293
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.00065189	0.009958210178281293
212135 CARDIOSKELETAL SYNDROME, KUWAITI TYPE	0.00065189	0.009958210178281293
X-LINKED EHLERS-DANLOS SYNDROME	0.00065189	0.009958210178281293
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE	0.00065189	0.009958210178281293
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.00065189	0.009958210178281293
SACCHAROPINURIA	0.00065189	0.009958210178281293
2Q33.1 DELETION SYNDROME	0.00065189	0.009958210178281293
MYOTONIA PERMANENS	0.00065189	0.009958210178281293
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00065189	0.009958210178281293
211120 BONE DYSPLASIA, LETHAL, HOLMGREN TYPE	0.00065189	0.009958210178281293
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.00065189	0.009958210178281293
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.00065189	0.009958210178281293
BIEMOND SYNDROME II	0.00065189	0.009958210178281293
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00065189	0.009958210178281293
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.00065189	0.009958210178281293
CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE III	0.00065189	0.009958210178281293
SMITH-MAGENIS SYNDROME	0.00065189	0.009958210178281293
PERIODONTAL EHLERS-DANLOS SYNDROME	0.00065189	0.009958210178281293
TIBIAL HEMIMELIA-POLYSYNDACTYLY-TRIPHALANGEAL THUMB SYNDROME	0.00065189	0.009958210178281293
CAT-EYE SYNDROME (TYPE I)	0.00065189	0.009958210178281293
HYPOPHOSPHATASIA, CHILDHOOD	0.00065189	0.009958210178281293
HYALURONIDASE DEFICIENCY	0.00065189	0.009958210178281293
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.00065189	0.009958210178281293
BRACHYOLMIA, MAROTEAUX TYPE	0.00065189	0.009958210178281293
ISOLATED SPINA BIFIDA	0.00065189	0.009958210178281293
COLE-CARPENTER SYNDROME 1; CLCRP1	0.00065189	0.009958210178281293
MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION	0.00065189	0.009958210178281293
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.00065189	0.009958210178281293
ANGEL-SHAPED PHALANGOEPIPHYSEAL DYSPLASIA	0.00065189	0.009958210178281293
46,XY DISORDER OF SEX DEVELOPMENT DUE TO ISOLATED 17,20-LYASE DEFICIENCY	0.00065189	0.009958210178281293
CONGENITAL ADRENAL HYPERPLASIA DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.00065189	0.009958210178281293
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.00065189	0.009958210178281293
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00065189	0.009958210178281293
236450 HUTTERITE CEREBROOSTEONEPHRODYSPLASIA SYNDROME;;COND;;CEREBROOSTEONEPHOSIS SYNDROME	0.00065189	0.009958210178281293
MACROEPIPHYSEAL DYSPLASIA WITH OSTEOPOROSIS, WRINKLED SKIN, AND AGED APPEARANCE	0.00065189	0.009958210178281293
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY	0.00065189	0.009958210178281293
X-LINKED INTELLECTUAL DISABILITY, STOLL TYPE	0.00065189	0.009958210178281293
SHORT FIFTH METACARPALS-INSULIN RESISTANCE SYNDROME	0.00065189	0.009958210178281293
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00065189	0.009958210178281293
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.00065189	0.009958210178281293
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.00065189	0.009958210178281293
AURICULOOSTEODYSPLASIA	0.00065189	0.009958210178281293
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 4	0.00065189	0.009958210178281293
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MISSOURI TYPE	0.00065189	0.009958210178281293
BRACHYDACTYLY TYPE C	0.00065189	0.009958210178281293
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00065189	0.009958210178281293
EIKEN SYNDROME	0.00065189	0.009958210178281293
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.00065189	0.009958210178281293
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.00065189	0.009958210178281293
OCULOPALATOCEREBRAL SYNDROME	0.00065189	0.009958210178281293
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.00065189	0.009958210178281293
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00065189	0.009958210178281293
MYOSCLEROSIS, AUTOSOMAL RECESSIVE	0.00065189	0.009958210178281293
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00065189	0.009958210178281293
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	0.00065189	0.009958210178281293
BRACHYDACTYLY TYPE E	0.00065189	0.009958210178281293
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00065189	0.009958210178281293
CHUDLEY-LOWRY-HOAR SYNDROME	0.00065189	0.009958210178281293
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.00065189	0.009958210178281293
FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	0.00065189	0.009958210178281293
MULTIPLE METAPHYSEAL DYSPLASIA	0.00065189	0.009958210178281293
BRACHYDACTYLY TYPE A4	0.00065189	0.009958210178281293
BRACHYDACTYLY TYPE A1	0.00065189	0.009958210178281293
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.00065189	0.009958210178281293
DYSOSTOSIS WITH BRACHYDACTYLY	0.00065189	0.009958210178281293
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.00065189	0.009958210178281293
CAREY-FINEMAN-ZITER SYNDROME	0.00065189	0.009958210178281293
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.00065189	0.009958210178281293
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.00065189	0.009958210178281293
RING CHROMOSOME 6 SYNDROME	0.00065189	0.009958210178281293
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.00065189	0.009958210178281293
PFEIFFER-PALM-TELLER SYNDROME	0.00065189	0.009958210178281293
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.00065189	0.009958210178281293
X-LINKED SKELETAL DYSPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.009958210178281293
BIEMOND SYNDROME TYPE 2	0.00065189	0.009958210178281293
HYPOPHOSPHATEMIC BONE DISEASE	0.00065189	0.009958210178281293
DIAMOND-BLACKFAN ANEMIA 8	0.00065189	0.009958210178281293
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.00065189	0.009958210178281293
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.00065189	0.009958210178281293
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.00065189	0.009958210178281293
TARSAL-CARPAL COALITION SYNDROME	0.00065189	0.009958210178281293
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00065189	0.009958210178281293
HYPERTELORISM, TEEBI TYPE; TBHS	0.00065189	0.009958210178281293
613005 SANTOS SYNDROME;;FIBULAR AGENESIS/HYPOPLASIA, OLIGODACTYLOUS CLUBFEET, AND ANONYCHIA/NAILHYPOPLASIA SYNDROME	0.00065189	0.009958210178281293
COLOBOMA OF MACULA-BRACHYDACTYLY TYPE B SYNDROME	0.00065189	0.009958210178281293
NEUROFACIODIGITORENAL SYNDROME	0.00065189	0.009958210178281293
WEILL-MARCHESANI SYNDROME 4; WMS4	0.00065189	0.009958210178281293
HEREDITARY HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA	0.00065189	0.009958210178281293
RADIAL-RENAL SYNDROME	0.00065189	0.009958210178281293
FAMILIAL BENIGN COPPER DEFICIENCY	0.00065189	0.009958210178281293
SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE; SCDO4	0.00065189	0.009958210178281293
CHROMOSOME 2Q31.1 DUPLICATION SYNDROME	0.00065189	0.009958210178281293
%613678 BRACHYOLMIA TYPE 2;;BRACHYOLMIA, MAROTEAUX TYPE	0.00065189	0.009958210178281293
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.00065189	0.009958210178281293
179830 RENAL TUBULAR ACIDOSIS, PROXIMAL;;RENAL TUBULAR ACIDOSIS II;;RTA, PROXIMAL TYPE;;RTA, RATE TYPE	0.00065189	0.009958210178281293
CRANIODIGITAL-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.009958210178281293
ISCHIOCOXOPODOPATELLAR SYNDROME WITH OR WITHOUT PULMONARY ARTERIAL HYPERTENSION	0.00065189	0.009958210178281293
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.00065189	0.009958210178281293
BRACHYDACTYLY, TYPE E2; BDE2	0.00065189	0.009958210178281293
LETHAL CONGENITAL CONTRACTURE SYNDROME TYPE 1	0.00065189	0.009958210178281293
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 2; ARHR2	0.00065189	0.009958210178281293
AUTOSOMAL RECESSIVE DISTAL OSTEOLYSIS SYNDROME	0.00065189	0.009958210178281293
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.00065189	0.009958210178281293
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00065189	0.009958210178281293
HYPOPHOSPHATEMIC RICKETS AND HYPERPARATHYROIDISM	0.00065189	0.009958210178281293
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.00065189	0.009958210178281293
BRACHYDACTYLY-ARTERIAL HYPERTENSION SYNDROME	0.00065189	0.009958210178281293
THYROID HORMONE METABOLISM, ABNORMAL; THMA	0.00065189	0.009958210178281293
STIMMLER SYNDROME	0.00065189	0.009958210178281293
APPARENT MINERALOCORTICOID EXCESS	0.00065189	0.009958210178281293
VENTRICULAR EXTRASYSTOLES WITH SYNCOPAL EPISODES-PERODACTYLY-ROBIN SEQUENCE SYNDROME	0.00065189	0.009958210178281293
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.00065189	0.009958210178281293
STÜVE-WIEDEMANN SYNDROME	0.00065189	0.009958210178281293
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.009958210178281293
BONNEMANN-MEINECKE-REICH SYNDROME	0.00065189	0.009958210178281293
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MINIEPIPHYSES	0.00065189	0.009958210178281293
CLASSIC MULTIMINICORE MYOPATHY	0.00065189	0.009958210178281293
LARYNX ATRESIA	0.00065189	0.009958210178281293
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.00065189	0.009958210178281293
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.00065189	0.009958210178281293
SEVERE EARLY-ONSET OBESITY-INSULIN RESISTANCE SYNDROME DUE TO SH2B1 DEFICIENCY	0.00065189	0.009958210178281293
CHONDROECTODERMAL DYSPLASIA WITH NIGHT BLINDNESS	0.00065189	0.009958210178281293
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00065189	0.009958210178281293
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.00065189	0.009958210178281293
GM2 GANGLIOSIDOSIS, AB VARIANT	0.00065189	0.009958210178281293
CATEL-MANZKE SYNDROME	0.00065189	0.009958210178281293
MIRROR POLYDACTYLY-VERTEBRAL SEGMENTATION-LIMBS DEFECTS SYNDROME	0.00065189	0.009958210178281293
CHITAYAT SYNDROME	0.00065189	0.009958210178281293
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.00065189	0.009958210178281293
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00065189	0.009958210178281293
NOONAN SYNDROME 4; NS4	0.00065189	0.009958210178281293
SCHIZOPHRENIA 1; SCZD1	0.00065189	0.009958210178281293
SHORT STATURE DUE TO PARTIAL GHR DEFICIENCY	0.00065189	0.009958210178281293
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.00065189	0.009958210178281293
LAMELLAR ICHTHYOSIS	0.00065189	0.009958210178281293
SATOYOSHI SYNDROME	0.00065189	0.009958210178281293
INTELLECTUAL DISABILITY-HYPOTONIA-BRACHYCEPHALY-PYLORIC STENOSIS-CRYPTORCHIDISM SYNDROME	0.00065189	0.009958210178281293
AROMATASE EXCESS SYNDROME	0.00065189	0.009958210178281293
SHOX-RELATED SHORT STATURE	0.00065189	0.009958210178281293
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.00065189	0.009958210178281293
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.00065189	0.009958210178281293
HYPOPLASTIC TIBIAE-POSTAXIAL POLYDACTYLY SYNDROME	0.00065189	0.009958210178281293
PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE	0.00065189	0.009958210178281293
ULNA METAPHYSEAL DYSPLASIA SYNDROME	0.00065189	0.009958210178281293
MESOMELIC DYSPLASIA, KANTAPUTRA TYPE	0.00065189	0.009958210178281293
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.00065189	0.009958210178281293
LOWRY-WOOD SYNDROME	0.00065189	0.009958210178281293
HYPOGONADISM-MITRAL VALVE PROLAPSE-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.009958210178281293
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.00065189	0.009958210178281293
HYPOGONADOTROPIC HYPOGONADISM-RETINITIS PIGMENTOSA SYNDROME	0.00065189	0.009958210178281293
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	0.00065189	0.009958210178281293
LEUKOMELANODERMA-INFANTILISM-INTELLECTUAL DISABILITY-HYPODONTIA-HYPOTRICHOSIS SYNDROME	0.00065189	0.009958210178281293
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.00065189	0.009958210178281293
PERIPHERAL DYSOSTOSIS	0.00065189	0.009958210178281293
OCULOMAXILLOFACIAL DYSOSTOSIS	0.00065189	0.009958210178281293
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00065189	0.009958210178281293
5Q35 MICRODUPLICATION SYNDROME	0.00065189	0.009958210178281293
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.00065189	0.009958210178281293
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.00065189	0.009958210178281293
HYDROCEPHALUS-OBESITY-HYPOGONADISM SYNDROME	0.00065189	0.009958210178281293
FIBULAR APLASIA-COMPLEX BRACHYDACTYLY SYNDROME	0.00065189	0.009958210178281293
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00065189	0.009958210178281293
GROWTH HORMONE DEFICIENCY, ISOLATED PARTIAL; GHDP	0.00065189	0.009958210178281293
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.00065189	0.009958210178281293
NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE; SCN6	0.00065189	0.009958210178281293
GLAUCOMA-ECTOPIA LENTIS-MICROSPHEROPHAKIA-STIFF JOINTS-SHORT STATURE SYNDROME	0.00065189	0.009958210178281293
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.00065189	0.009958210178281293
ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME	0.00065189	0.009958210178281293
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.00065189	0.009958210178281293
EPILEPSY-TELANGIECTASIA SYNDROME	0.00065189	0.009958210178281293
METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA AND BRACHYDACTYLY	0.00065189	0.009958210178281293
SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63	0.00065189	0.009958210178281293
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.00065189	0.009958210178281293
ENG-STROM SYNDROME	0.00065189	0.009958210178281293
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00065189	0.009958210178281293
PRECOCIOUS PUBERTY, CENTRAL	0.00065189	0.009958210178281293
AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC	0.00065189	0.009958210178281293
ARGININOSUCCINIC ACIDURIA	0.00065189	0.009958210178281293
CONGENITAL SHORT BOWEL SYNDROME	0.00065189	0.009958210178281293
ACROFRONTOFACIONASAL DYSOSTOSIS	0.00065189	0.009958210178281293
SANJAD-SAKATI SYNDROME	0.00065189	0.009958210178281293
WORMIAN BONE-MULTIPLE FRACTURES-DENTINOGENESIS IMPERFECTA-SKELETAL DYSPLASIA	0.00065189	0.009958210178281293
ISOLATED OSTEOPOIKILOSIS	0.00065189	0.009958210178281293
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.00065189	0.009958210178281293
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.00065189	0.009958210178281293
CRANIOECTODERMAL DYSPLASIA 4	0.00065189	0.009958210178281293
FEINGOLD SYNDROME 2; FGLDS2	0.00065189	0.009958210178281293
MULTIPLE EPIPHYSEAL DYSPLASIA DUE TO COLLAGEN 9 ANOMALY	0.00065189	0.009958210178281293
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.00065189	0.009958210178281293
XP22.3 MICRODELETION SYNDROME	0.00065189	0.009958210178281293
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.00065189	0.009958210178281293
NAIL-PATELLA-LIKE RENAL DISEASE	0.00065189	0.009958210178281293
CRANIOECTODERMAL DYSPLASIA 3	0.00065189	0.009958210178281293
DISTAL MONOSOMY 13Q	0.00065189	0.009958210178281293
BRACHYDACTYLOUS DWARFISM, MSELENI TYPE	0.00065189	0.009958210178281293
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.00065189	0.009958210178281293
LEGG-CALVE-PERTHES DISEASE	0.00065189	0.009958210178281293
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00065189	0.009958210178281293
FANCONI ANEMIA, COMPLEMENTATION GROUP T; FANCT	0.00065189	0.009958210178281293
HYPO- AND HYPERMELANOTIC CUTANEOUS MACULES-RETARDED GROWTH-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.009958210178281293
CONGENITAL LARYNGEAL WEB	0.00065189	0.009958210178281293
LEGG-CALVÉ-PERTHES DISEASE	0.00065189	0.009958210178281293
FAMILIAL CLUBFOOT DUE TO 17Q23.1Q23.2 MICRODUPLICATION	0.00065189	0.009958210178281293
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.00065189	0.009958210178281293
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.00065189	0.009958210178281293
SINGLETON-MERTEN SYNDROME 2; SGMRT2	0.00065189	0.009958210178281293
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.00065189	0.009958210178281293
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.00065189	0.009958210178281293
MASA SYNDROME	0.00065189	0.009958210178281293
WEILL-MARCHESANI SYNDROME 3	0.00065189	0.009958210178281293
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.00065189	0.009958210178281293
TRISOMY 18P	0.00065189	0.009958210178281293
ACROGERIA	0.00065189	0.009958210178281293
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.00065189	0.009958210178281293
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00065189	0.009958210178281293
FEMUR-FIBULA-ULNA COMPLEX	0.00065189	0.009958210178281293
FINGER LOCKING, RECURRENT, WITH INTRAUTERINE GROWTH RETARDATION ANDPROPORTIONATE SHORT STATURE	0.00065189	0.009958210178281293
SATOYOSHI SYNDROME	0.00065189	0.009958210178281293
RIGID SPINE MUSCULAR DYSTROPHY 1	0.00065189	0.009958210178281293
SIX2-RELATED FRONTONASAL DYSPLASIA	0.00065189	0.009958210178281293
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.00065189	0.009958210178281293
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.00065189	0.009958210178281293
PROTEINURIA, LOW MOLECULAR WEIGHT, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS	0.00065189	0.009958210178281293
NEPHROTIC SYNDROME, TYPE 17; NPHS17	0.00065189	0.009958210178281293
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.00065189	0.009958210178281293
TRIPHALANGEAL THUMBS AND DISLOCATION OF PATELLA	0.00065189	0.009958210178281293
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.00065189	0.009958210178281293
CORTICAL DEFECTS, WORMIAN BONES, AND DENTINOGENESIS IMPERFECTA	0.00065189	0.009958210178281293
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3; SEMDJL3	0.00065189	0.009958210178281293
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.00065189	0.009958210178281293
BRADDOCK SYNDROME	0.00065189	0.009958210178281293
POLYDACTYLY, POSTAXIAL, TYPE A8; PAPA8	0.00065189	0.009958210178281293
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.00065189	0.009958210178281293
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHORYLASE KINASE DEFICIENCY	0.00065189	0.009958210178281293
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00065189	0.009958210178281293
OVARIAN DYSGENESIS 5; ODG5	0.00065189	0.009958210178281293
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.00065189	0.009958210178281293
GLYCOGEN STORAGE DISEASE DUE TO LIVER GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.00065189	0.009958210178281293
STIFF SKIN SYNDROME	0.00065189	0.009958210178281293
NEONATAL SEVERE PRIMARY HYPERPARATHYROIDISM	0.00065189	0.009958210178281293
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.00065189	0.009958210178281293
DENTAL ANOMALIES AND SHORT STATURE; DASS	0.00065189	0.009958210178281293
600736 VELOFACIOSKELETAL SYNDROME	0.00065189	0.009958210178281293
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.00065189	0.009958210178281293
AUTOSOMAL DOMINANT MITOCHONDRIAL MYOPATHY WITH EXERCISE INTOLERANCE	0.00065189	0.009958210178281293
THUMB DEFORMITY AND ALOPECIA	0.00065189	0.009958210178281293
THORACOPELVIC DYSOSTOSIS	0.00065189	0.009958210178281293
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00065189	0.009958210178281293
GURRIERI SYNDROME	0.00065189	0.009958210178281293
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.00065189	0.009958210178281293
SPONDYLOEPIPHYSEAL DYSPLASIA WITH ATLANTOAXIAL INSTABILITY	0.00065189	0.009958210178281293
SPINAL DYSPLASIA, ANHALT TYPE	0.00065189	0.009958210178281293
SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX	0.00065189	0.009958210178281293
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.00065189	0.009958210178281293
ECTODERMAL DYSPLASIA WITH NATAL TEETH, TURNPENNY TYPE	0.00065189	0.009958210178281293
HUNTER-MCALPINE CRANIOSYNOSTOSIS SYNDROME	0.00065189	0.009958210178281293
INTRAUTERINE GROWTH RESTRICTION-SHORT STATURE-EARLY ADULT-ONSET DIABETES SYNDROME	0.00065189	0.009958210178281293
HYPOPHOSPHATASIA	0.00065189	0.009958210178281293
DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA	0.00065189	0.009958210178281293
EIKEN SYNDROME	0.00065189	0.009958210178281293
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.00065189	0.009958210178281293
STORMORKEN SYNDROME; STRMK	0.00065189	0.009958210178281293
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN DEBRANCHING ENZYME DEFICIENCY	0.00065189	0.009958210178281293
GROWTH HORMONE INSENSITIVITY, PARTIAL; GHIP	0.00065189	0.009958210178281293
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.00065189	0.009958210178281293
SKELETAL DYSPLASIA WITH DELAYED EPIPHYSEAL AND CARPAL BONE OSSIFICATION	0.00065189	0.009958210178281293
%607004 BRACHYDACTYLY, TYPE A1, B; BDA1B	0.00065189	0.009958210178281293
HYPOPHOSPHATEMIC RICKETS, X-LINKED RECESSIVE	0.00065189	0.009958210178281293
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.00065189	0.009958210178281293
MENTAL RETARDATION, X-LINKED 84	0.00065189	0.009958210178281293
MICROPHTHALMIA WITH LIMB ANOMALIES	0.00065189	0.009958210178281293
CHROMOSOME XP11.3 DELETION SYNDROME	0.00065189	0.009958210178281293
608028 THAI SYMPHALANGISM SYNDROME	0.00065189	0.009958210178281293
ANGEL-SHAPED PHALANGO-EPIPHYSEAL DYSPLASIA	0.00065189	0.009958210178281293
118980 CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL	0.00065189	0.009958210178281293
METAPHYSEAL ANADYSPLASIA	0.00065189	0.009958210178281293
ROIFMAN SYNDROME	0.00065189	0.009958210178281293
MENTAL RETARDATION, X-LINKED 45	0.00065189	0.009958210178281293
APHALANGY-SYNDACTYLY-MICROCEPHALY SYNDROME	0.00065189	0.009958210178281293
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.00065189	0.009958210178281293
MENTAL RETARDATION, X-LINKED 92	0.00065189	0.009958210178281293
CASPASE 8 DEFICIENCY	0.00065189	0.009958210178281293
DOUBLE OUTLET RIGHT VENTRICLE	0.00065189	0.009958210178281293
FRAXE INTELLECTUAL DISABILITY	0.00065189	0.009958210178281293
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, DI ROCCO TYPE; SEMDDR	0.00065189	0.009958210178281293
NON-ACQUIRED ISOLATED GROWTH HORMONE DEFICIENCY	0.00065189	0.009958210178281293
NIEMANN-PICK DISEASE, TYPE B	0.00065189	0.009958210178281293
DENT DISEASE 1	0.00065189	0.009958210178281293
AURICULOOSTEODYSPLASIA	0.00065189	0.009958210178281293
PELVIS-SHOULDER DYSPLASIA	0.00065189	0.009958210178281293
BARTTER SYNDROME	0.00065189	0.009958210178281293
SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17	0.00065189	0.009958210178281293
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.000545554	0.008333831467888865
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.008333831467888865
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.008333831467888865
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000545554	0.008333831467888865
CHROMOSOME 9P DELETION SYNDROME	0.000545554	0.008333831467888865
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.008333831467888865
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.000545554	0.008333831467888865
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000545554	0.008333831467888865
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.000545554	0.008333831467888865
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.008333831467888865
FOLATE MALABSORPTION, HEREDITARY	0.000545554	0.008333831467888865
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.008333831467888865
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.008333831467888865
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.000545554	0.008333831467888865
BARDET-BIEDL SYNDROME 2	0.000545554	0.008333831467888865
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.000545554	0.008333831467888865
MOSAIC TRISOMY 14	0.000545554	0.008333831467888865
ADULT-ONSET DYSTONIA-PARKINSONISM	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.000545554	0.008333831467888865
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.000545554	0.008333831467888865
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.000545554	0.008333831467888865
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.008333831467888865
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.000545554	0.008333831467888865
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.000545554	0.008333831467888865
TRISOMY 8Q	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.000545554	0.008333831467888865
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.008333831467888865
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.000545554	0.008333831467888865
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.008333831467888865
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.008333831467888865
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.000545554	0.008333831467888865
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.000545554	0.008333831467888865
MYOCLONIC-ASTASTIC EPILEPSY	0.000545554	0.008333831467888865
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.000545554	0.008333831467888865
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.000545554	0.008333831467888865
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.000545554	0.008333831467888865
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.000545554	0.008333831467888865
PHENOBARBITAL EMBRYOPATHY	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.000545554	0.008333831467888865
PFEIFFER SYNDROME TYPE 2	0.000545554	0.008333831467888865
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.000545554	0.008333831467888865
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.008333831467888865
AUSTRALIA ANTIGEN	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000545554	0.008333831467888865
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.000545554	0.008333831467888865
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.000545554	0.008333831467888865
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.008333831467888865
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000545554	0.008333831467888865
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000545554	0.008333831467888865
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.000545554	0.008333831467888865
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.000545554	0.008333831467888865
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.000545554	0.008333831467888865
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.008333831467888865
XQ28 (MECP2) DUPLICATION	0.000545554	0.008333831467888865
8Q22.1 MICRODELETION SYNDROME	0.000545554	0.008333831467888865
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000545554	0.008333831467888865
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.000545554	0.008333831467888865
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.000545554	0.008333831467888865
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.000545554	0.008333831467888865
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000545554	0.008333831467888865
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.000545554	0.008333831467888865
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.000545554	0.008333831467888865
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.008333831467888865
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.000545554	0.008333831467888865
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.000545554	0.008333831467888865
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.000545554	0.008333831467888865
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000545554	0.008333831467888865
GRISCELLI SYNDROME, TYPE 1	0.000545554	0.008333831467888865
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000545554	0.008333831467888865
JOUBERT SYNDROME 28	0.000545554	0.008333831467888865
JOUBERT SYNDROME 27	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000545554	0.008333831467888865
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.000545554	0.008333831467888865
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.000545554	0.008333831467888865
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.008333831467888865
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.000545554	0.008333831467888865
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.000545554	0.008333831467888865
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.000545554	0.008333831467888865
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.000545554	0.008333831467888865
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.000545554	0.008333831467888865
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000545554	0.008333831467888865
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.008333831467888865
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.000545554	0.008333831467888865
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.000545554	0.008333831467888865
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.008333831467888865
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.000545554	0.008333831467888865
RITSCHER-SCHINZEL SYNDROME 1	0.000545554	0.008333831467888865
RIGID SPINE SYNDROME	0.000545554	0.008333831467888865
ZEBRA BODY MYOPATHY	0.000545554	0.008333831467888865
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.008333831467888865
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.000545554	0.008333831467888865
PEHO-LIKE SYNDROME; PEHOL	0.000545554	0.008333831467888865
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.000545554	0.008333831467888865
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.000545554	0.008333831467888865
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.008333831467888865
IMMUNODEFICIENCY 49; IMD49	0.000545554	0.008333831467888865
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.000545554	0.008333831467888865
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.008333831467888865
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.000545554	0.008333831467888865
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.000545554	0.008333831467888865
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.000545554	0.008333831467888865
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.000545554	0.008333831467888865
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.008333831467888865
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.000545554	0.008333831467888865
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.000545554	0.008333831467888865
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.008333831467888865
JOUBERT SYNDROME 25	0.000545554	0.008333831467888865
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000545554	0.008333831467888865
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.008333831467888865
SPINOCEREBELLAR ATAXIA TYPE 7	0.000545554	0.008333831467888865
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.008333831467888865
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.000545554	0.008333831467888865
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.008333831467888865
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.000545554	0.008333831467888865
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.000545554	0.008333831467888865
JOUBERT SYNDROME 24	0.000545554	0.008333831467888865
DISTAL MONOSOMY 9P	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.000545554	0.008333831467888865
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.008333831467888865
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.000545554	0.008333831467888865
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.000545554	0.008333831467888865
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.000545554	0.008333831467888865
EVEN-PLUS SYNDROME	0.000545554	0.008333831467888865
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000545554	0.008333831467888865
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.008333831467888865
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000545554	0.008333831467888865
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.000545554	0.008333831467888865
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000545554	0.008333831467888865
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.000545554	0.008333831467888865
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000545554	0.008333831467888865
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.008333831467888865
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.000545554	0.008333831467888865
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.000545554	0.008333831467888865
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.000545554	0.008333831467888865
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.008333831467888865
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.000545554	0.008333831467888865
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.008333831467888865
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.008333831467888865
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000545554	0.008333831467888865
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.000545554	0.008333831467888865
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.008333831467888865
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.008333831467888865
MYOCLONIC EPILEPSY OF INFANCY	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000545554	0.008333831467888865
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.000545554	0.008333831467888865
ISOVALERIC ACIDEMIA	0.000545554	0.008333831467888865
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.000545554	0.008333831467888865
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.000545554	0.008333831467888865
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.000545554	0.008333831467888865
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.000545554	0.008333831467888865
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.008333831467888865
NIEMANN-PICK DISEASE, TYPE C2	0.000545554	0.008333831467888865
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.008333831467888865
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000545554	0.008333831467888865
PEHO SYNDROME; PEHO	0.000545554	0.008333831467888865
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.000545554	0.008333831467888865
LISSENCEPHALY 1; LIS1	0.000545554	0.008333831467888865
PROPIONIC ACIDEMIA	0.000545554	0.008333831467888865
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000545554	0.008333831467888865
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.008333831467888865
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.000545554	0.008333831467888865
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.000545554	0.008333831467888865
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.000545554	0.008333831467888865
HYPOTONIA-CYSTINURIA SYNDROME	0.000545554	0.008333831467888865
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.000545554	0.008333831467888865
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.000545554	0.008333831467888865
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.000545554	0.008333831467888865
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.000545554	0.008333831467888865
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000545554	0.008333831467888865
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000545554	0.008333831467888865
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.008333831467888865
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.008333831467888865
OROTIC ACIDURIA	0.000545554	0.008333831467888865
FILIPPI SYNDROME	0.000545554	0.008333831467888865
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.008333831467888865
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.000545554	0.008333831467888865
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.000545554	0.008333831467888865
HEREDITARY OROTIC ACIDURIA	0.000545554	0.008333831467888865
611961 STEVENSON-CAREY SYNDROME	0.000545554	0.008333831467888865
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.000545554	0.008333831467888865
TEMPLE-BARAITSER SYNDROME; TMBTS	0.000545554	0.008333831467888865
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000545554	0.008333831467888865
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.008333831467888865
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.000545554	0.008333831467888865
JOUBERT SYNDROME 6	0.000545554	0.008333831467888865
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.000545554	0.008333831467888865
NETHERTON SYNDROME; NETH	0.000545554	0.008333831467888865
ALG1-CDG	0.000545554	0.008333831467888865
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.000545554	0.008333831467888865
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.008333831467888865
ALG3-CDG	0.000545554	0.008333831467888865
ALG6-CDG	0.000545554	0.008333831467888865
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.000545554	0.008333831467888865
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.008333831467888865
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.008333831467888865
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.008333831467888865
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000545554	0.008333831467888865
LISSENCEPHALY 2; LIS2	0.000545554	0.008333831467888865
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.008333831467888865
GOLDBERG-SHPRINTZEN SYNDROME	0.000545554	0.008333831467888865
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.000545554	0.008333831467888865
ABETAL34V AMYLOIDOSIS	0.000545554	0.008333831467888865
STT3A-CDG	0.000545554	0.008333831467888865
STT3B-CDG	0.000545554	0.008333831467888865
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.008333831467888865
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.000545554	0.008333831467888865
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.008333831467888865
GM2-GANGLIOSIDOSIS, AB VARIANT	0.000545554	0.008333831467888865
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000545554	0.008333831467888865
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000545554	0.008333831467888865
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.008333831467888865
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.008333831467888865
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.008333831467888865
TARP SYNDROME; TARPS	0.000545554	0.008333831467888865
WAISMAN SYNDROME; WSMN	0.000545554	0.008333831467888865
MENTAL RETARDATION, X-LINKED 9	0.000545554	0.008333831467888865
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.000545554	0.008333831467888865
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.000545554	0.008333831467888865
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.000545554	0.008333831467888865
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.008333831467888865
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.008333831467888865
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000545554	0.008333831467888865
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.008333831467888865
MAPLE SYRUP URINE DISEASE	0.000545554	0.008333831467888865
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000545554	0.008333831467888865
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.000545554	0.008333831467888865
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.000545554	0.008333831467888865
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.008333831467888865
MENTAL RETARDATION, X-LINKED 88	0.000545554	0.008333831467888865
MENTAL RETARDATION, X-LINKED 41	0.000545554	0.008333831467888865
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.000545554	0.008333831467888865
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.000545554	0.008333831467888865
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.008333831467888865
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.008333831467888865
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000545554	0.008333831467888865
SULFOCYSTEINURIA	0.000545554	0.008333831467888865
LOWRY-MACLEAN SYNDROME	0.000545554	0.008333831467888865
EPILEPSY, PYRIDOXINE-DEPENDENT	0.000545554	0.008333831467888865
PYRUVATE CARBOXYLASE DEFICIENCY	0.000545554	0.008333831467888865
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.000545554	0.008333831467888865
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.000545554	0.008333831467888865
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.000545554	0.008333831467888865
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.000545554	0.008333831467888865
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.000545554	0.008333831467888865
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.008333831467888865
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.008333831467888865
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.008333831467888865
DYSTONIA-APHONIA SYNDROME	0.000545554	0.008333831467888865
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.000545554	0.008333831467888865
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.000545554	0.008333831467888865
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.000545554	0.008333831467888865
REVESZ SYNDROME	0.000545554	0.008333831467888865
COG2-CDG	0.000545554	0.008333831467888865
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.000545554	0.008333831467888865
ALPERS-HUTTENLOCHER SYNDROME	0.000545554	0.008333831467888865
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.008333831467888865
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000545554	0.008333831467888865
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.000545554	0.008333831467888865
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.008333831467888865
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.000545554	0.008333831467888865
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.000545554	0.008333831467888865
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.008333831467888865
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.008333831467888865
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.008333831467888865
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000545554	0.008333831467888865
JOUBERT SYNDROME 8	0.000545554	0.008333831467888865
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.008333831467888865
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.008333831467888865
HARTSFIELD SYNDROME; HRTFDS	0.000545554	0.008333831467888865
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000545554	0.008333831467888865
ARGININEMIA	0.000545554	0.008333831467888865
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.008333831467888865
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.008333831467888865
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.008333831467888865
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.008333831467888865
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.000545554	0.008333831467888865
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.008333831467888865
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.000545554	0.008333831467888865
MICROVILLUS INCLUSION DISEASE	0.000545554	0.008333831467888865
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000545554	0.008333831467888865
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.000545554	0.008333831467888865
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.008333831467888865
AICARDI-GOUTIERES SYNDROME 6	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.000545554	0.008333831467888865
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.000545554	0.008333831467888865
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.000545554	0.008333831467888865
CENTRAL BILATERAL MACROGYRIA	0.000545554	0.008333831467888865
NIEMANN-PICK DISEASE TYPE C	0.000545554	0.008333831467888865
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.008333831467888865
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000545554	0.008333831467888865
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.008333831467888865
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.000545554	0.008333831467888865
DPAGT1-CDG	0.000545554	0.008333831467888865
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.000545554	0.008333831467888865
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.000545554	0.008333831467888865
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.000545554	0.008333831467888865
GRISCELLI SYNDROME TYPE 1	0.000545554	0.008333831467888865
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.008333831467888865
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.000545554	0.008333831467888865
FOIX-CHAVANY-MARIE SYNDROME	0.000545554	0.008333831467888865
HOLOPROSENCEPHALY 2; HPE2	0.000545554	0.008333831467888865
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.000545554	0.008333831467888865
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.000545554	0.008333831467888865
SPINOCEREBELLAR ATAXIA TYPE 29	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000545554	0.008333831467888865
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.000545554	0.008333831467888865
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.000545554	0.008333831467888865
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.008333831467888865
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.000545554	0.008333831467888865
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.000545554	0.008333831467888865
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.000545554	0.008333831467888865
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.008333831467888865
17Q21.31 MICRODUPLICATION SYNDROME	0.000545554	0.008333831467888865
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.000545554	0.008333831467888865
17P13.3 MICRODUPLICATION SYNDROME	0.000545554	0.008333831467888865
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.000545554	0.008333831467888865
HYPERPROLINEMIA, TYPE I	0.000545554	0.008333831467888865
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.008333831467888865
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.000545554	0.008333831467888865
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000545554	0.008333831467888865
KETOADIPICACIDURIA	0.000545554	0.008333831467888865
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.000545554	0.008333831467888865
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.008333831467888865
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.000545554	0.008333831467888865
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000545554	0.008333831467888865
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.000545554	0.008333831467888865
OKAMOTO SYNDROME	0.000545554	0.008333831467888865
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.008333831467888865
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.008333831467888865
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.000545554	0.008333831467888865
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.008333831467888865
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.000545554	0.008333831467888865
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000545554	0.008333831467888865
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.000545554	0.008333831467888865
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.008333831467888865
BETA-UREIDOPROPIONASE DEFICIENCY	0.000545554	0.008333831467888865
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.000545554	0.008333831467888865
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.000545554	0.008333831467888865
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.008333831467888865
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.008333831467888865
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.000545554	0.008333831467888865
AICARDI-GOUTIERES SYNDROME 5	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.000545554	0.008333831467888865
JAWAD SYNDROME	0.000545554	0.008333831467888865
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.000545554	0.008333831467888865
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.000545554	0.008333831467888865
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.000545554	0.008333831467888865
1P21.3 MICRODELETION SYNDROME	0.000545554	0.008333831467888865
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.000545554	0.008333831467888865
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000545554	0.008333831467888865
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.008333831467888865
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.000545554	0.008333831467888865
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.000545554	0.008333831467888865
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.000545554	0.008333831467888865
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.000545554	0.008333831467888865
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.000545554	0.008333831467888865
LANDAU-KLEFFNER SYNDROME	0.000545554	0.008333831467888865
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.000545554	0.008333831467888865
CHROMOSOME 16Q22 DELETION SYNDROME	0.000545554	0.008333831467888865
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.000545554	0.008333831467888865
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.000545554	0.008333831467888865
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.008333831467888865
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.000545554	0.008333831467888865
JOUBERT SYNDROME 15	0.000545554	0.008333831467888865
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.000545554	0.008333831467888865
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.008333831467888865
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.000545554	0.008333831467888865
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.000545554	0.008333831467888865
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.008333831467888865
MACDERMOT-WINTER SYNDROME	0.000545554	0.008333831467888865
HOLOPROSENCEPHALY 11	0.000545554	0.008333831467888865
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.000545554	0.008333831467888865
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.008333831467888865
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000545554	0.008333831467888865
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.008333831467888865
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.008333831467888865
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.000545554	0.008333831467888865
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000545554	0.008333831467888865
